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Chapter I 
INTRODUCTION 
 
Siddha system of medicine is simple practical traditional, sasthric and bearing the 
cultural heritage of ancient India. The strength of siddha medicine is it’s effect in 
balancing and strengthening the body’s own healing mechanism instead of suppressing or 
disturbing it as many modern drugs tends to do knowing that medicinal herbs are not 
enough and efficient to cure the diseases completely siddhar’s have made thorough study 
on the utility of mineral substances and formulated the medicinal preparation consisting 
of  
a. Metals 
b. Organic secondary minerals (uparasam) 
c. Organic salts (karasaram) 
d. Arsenic compounds(padanams) 
and thereby attained prominence in the field of medicine.This was explained by Theraiyar 
as, 
Ý¾¸ó¾¢ ¾¡ÐÀüÀõ ¦º¡ýÉ¿¡ð ¼¡÷º¢¸¢î¨º 
µ¾ Â ãÄ¢ÂõÁý ß÷îº¢¸ ¢î¨º - §Å¾¼Õõ 
ºì¾¢Ãº¡ Ã¡ì¸¢É¢¿¢ º¡ºÃîº¢ ¸¢î¨º¦Âý§È 
Óò¾Ãò¾ ¾¡Ìõ ¦Á¡Æ¢. 
                                         -À¾¡÷ò¾Ì½ º¢ó¾¡Á½¢ 
 
 The single most important factor that determines the harmfulness or safeness of a 
substance is the dose (i.e) the amount or “how much” chemical is taken up by the living 
system. Though Indian system of medicine documented safe usage of drugs since 2500 
years, modern medicine propounded that hazardous effect of heavy metals would cause 
toxic accumulation which made the world to view the herbo- metallic compounds with 
suspicion. 
 Since Kirubakara shanmuga chenduram (KSC) is a sasthric preparation being in 
use still today. As the medicine includes mostly metallic ingredients,  cures many 
threatful and challenging diseases,but the  toxicological evaluation has not yet been 
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studied .So using  globally accepted scientific methodology OECD for toxicological 
profile ,the author planned to observe the acute and  28 days repeated oral toxicity study 
for Kirubakara shanmuga chenduram (KSC) in  the animal model wistar albino rats . 
Animal research is usually done for the benefit of human (i.e) prevention or treatment of 
human diseases and sufferings. 
 The type nature and extent of the effect obtained during toxicological study help 
to differentiate the medicine(kirubakara shanmuga chenduram) as non-toxic, moderately 
toxic or severely toxic on the selected  biological system.       
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Chapter II 
AIM AND OBJECTIVES 
 
Aim 
 To evaluate the acute and 28 days repeated oral toxicity study on “Kirubakara Shanmuga 
Chenduram (KSC)” on animal model (Wistar albino rat). 
 Objectives 
 Collecting literary evidence in Gunapadam. Chemical, Bio chemical and toxicological 
aspects of “Kirubakara Shanmuga Chenduram (KSC)”. 
 Collection and Identification of raw drugs 
 Method of purification and detoxification 
 Preparation of KSC as per Siddha literary evidence 
 Physico Chemical analysis of KSC 
 To find out maximum tolerated dose and toxic effects on single dose administration of 
KSC in rodents 
 To find out toxic effects of drugs when it is used in repeated oral dose 
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Chapter III 
REVIEW OF LITERATURE  
Vaalai Rasam 
(Mercury) 
 
Siddha Aspect 
Áõø» Cµ\® 
÷ÁÖ ö£¯º 
 £v¯õÚ öÁÒÍõøÚ Azvö¯ßÖ® ÷£¸ 
  £µ¨¤µ© Â¢öußÖ ªuØS¨ ÷£¸ 
 \v¯õÚ ¦¸÷åõzu© ö©ßÖ® ÷£¸ 
  ø\ußÛ¯ ö©ßuØS Ázu¨ ÷£¸ 
 ©v¯õÚ Á¬ºu Â¢öußÖ® ÷£¸ 
  vµÂö¯ßÖ® `¶¯ß Â¢öußÖ® 
 Âv¯õÚ ©õ©øÓ÷¯õº Â¢öußÖ® ÷£¸ 
  ÂÍ[Q÷Úõ® Áõø» µ\©v Ýøh¯¨ ÷£÷µ. 
 -APìv¯º H©uzxÁ® GßÝ® £g\PõÂ¯ |Psk, £UP Gs.63 
_zu µ\zvß ö£¯º 
 ÷£ÓõÚ {õuÂ¢xøÁ {ßÓõ´a ÷\ºzuõÀ 
  ö£»zx v¢uU Põ¯©x _zuµ\©õa_ 
 ÁõÓõÚ Áõø»¯õg _zu ¬xshõU 
  Áa]µõP ö©ßÖ ªuØS Ázu¨÷£¸ 
 ÷uÓõÚ ÷uPÁa]µ ö©ßÖ® ÷£¸ 
  v¸µ\® Ä¸µ\® S¸µ\¢ uõöÚßÖ® 
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 ¯õÓõÚ ÁÇø»µ\® ¤shÁsh µ\¢uõß 
  Aèhvø\ µ\ö©ßÖg _zuµ\zvß ÷£¸. 
 ©ø»PÎÀ EÒÍ C¯ØøP `Ì|ø»¯õÀ ÷©õuÀPÒ EshõS®. 
§P®£® EshõQ G¶©ø»z w öÁÎÁ¢uÄhß |»zvß S¬ÓÀ 
Ah[SQÓx. G¶©ø»°À öÁizx ]uÔ¯ SÇ®¦PÒ öPõvUS® }µõP 
|»zvÀ Á¢x ÷u[SQÓx. Auß {kÂ¼¸US® £SvPÒ BÂ¯õP ©õÔU 
SÎº¢uÄhß ]» ÁøP¨ ö£õ¸mPÒ QøhUQßÓÚ. A¨£iU 
Qøh¨£xuõß £õuµ\®. Cx µ\©õP÷Áõ C¼[P©õP÷Áõ QøhUQßÓx. 
QøhUS® Ch[PÒ 
 ìö£°ß, P¼÷£õºÛ¯õ, Czuõ¼, µè¯õ, ø\Úõ, ƒ¨£õß ¬u¼¯ 
{õkPÎÀ Cx QøhUQÓx. C¢v¯õÂÀ C¼[PzvÀ C¸¢x Áõø» 
µ\©õP¨ ¤¶UP¨£kQÓx. 
ÁøPPÒ : (5) ÁøP¨£k® 
1. Cµ\®   : ö\¢|Ó¬øh¯x 
 2. Cµ÷\¢vµß  : P¸ø© |Ó¬øh¯x 
 3. `u®   : ©g\Ò |Ó¬øh¯x 
 4. ª\µ®   : £» |Ó¬øh¯x 
 5. £õuµ\®  : öÁsoÓ® Eøh¯x 
_øÁ 
AÖ_øÁPøÍ²® Eøh¯x. 
 ]Ó¨£õP CÛ¨¦ _øÁ Eøh¯x. 
 G¢u ö£õ¸Îß xøn²® CÀ»õ©À uÛz÷u ö\¯À£hUTi¯x. 
 uõx uõÁµ E°º¨ ö£õ¸mPÒ AøÚzv¾® EÒÍ Sn[PøÍ Âh 
J¨¦Áø© CÀ»õu uÛa]Ó¨¦ £õµuµ\zvØS Esk.  
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Ã¶¯®: ^uÍ®, öÁ¨£® 
 G¢u Ã¶¯[PÎÀ EÒÍ ö£õ¸÷Íõk ÷\ºQÓ÷uõ A¢u¨ ö£õ¸Îß 
Ã¶¯zxhß ÷\º¢x Á¼ø© EshõS®. 
ö\´øP : EhÀ ÷uØÔ, EhÀ Eµ©õUQ, ©»®÷£õUQ, ¤zu }º APØÔ, 
 ÃUP¬¸UQ, EªÌ}º ö£¸UQ, ]Ö}º ö£¸UQ, ÷©P}º ÷£õUQ 
£õuµ\zvß ö£õxSn®: 
ÂÈ÷{õ´ Qµ¢v Sß©® ö©´a`ø» ¦sSm 
    hÈPõ¼À Â¢xÂÚõÀ Azøu & ÁÈ¯õ´  
    ¦¶² Âv ¯õx ¦¶°÷Úõ ö¯À»õ®  
   C¶²Âv ¯õx ªÀø»''. 
{ØSn® 
 µzu _zv, £]zwzysi, Q¸ª{õ]Û, øÍUS PÁÚ \Uvø¯z 
u¸uÀ, ©Úøua ^º£kzv AÔøÁ ÁÍºzuÀ, }sh B²øÍ ÁÍºzuÀ. 
 CuøÚ Es£ÁºPÒ Põ¯]zv²hß ö£õß©¯©õÚ Ehø»¨ 
ö£ÖÁº. 
Áõø» µ\® GkUS® ¬øÓPÒ 
 C¼[Pzv¼¸¢x GkUP¨£kQßÓ Áõø»µ\®. y´ø©¯õÚuõ²® 
EmöPõÒÐuØS ]Ó¢uuõ²® P¸u¨£kQÓx. 
 ]zvµ » ÷Áº¨£møh 4 £[S Gkzx Cizx C¼[PzyÒ J¸ 
£[S ÷\ºzx¨ £u[PU P¸Â°¼mk ¬øÓ¨£i G¶UP, Cµ\® 
÷©Ø\mi°À Jmi öPõÒÐ®. Aøua \õUQµøu¯õP¨ ¤¶zx 
Gkzx ©°ºUSa]°ÚõÀ ÷\P¶zxU öPõÒÍÄ®. CuØS C¼[Pµ\® 
Gß£x ö£¯º. 
Sn¨£õh® uõx ^Á ÁS¨¦ £UP Gs.281 
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 ©g\ÒyÒ 4 £[S Gkzx C¼[PzyÒ 1 £[Shß P»¢x Áºzv 
÷£õ»a ^ø»°¼mkz v¶zx, Kº AP¼À _ØÔ øÁzxU öPõÐzv, 
RÈ¼¸¢x PõØÖ¨ ¦SÁuØS Ch®Âmk, J¸ ö£¶¯ \õ¼øÚ, 
AP¼ß ÷©À PÂÌUPÄ®. BÔÚ ¤ß GkUP, Cµ\® ÷©À\mi°À 
£i¢x C¸US®. _µsi GkzxU öPõÒÍÄ®. 
Sn¨£õh® uõx ^Á ÁS¨¦ £UP Gs.281 
Áõø» µ\ øÁ¨¦: 
 Áõø»µ\® ö\´²® ¬øÓ, \õv¼[Pzøu {ßS ö£õizx J¸ ]Ö 
£õøÚUSÒ ÷£õmk ö£õizu {ßÚõ¶÷Á¸® öPõg\® Th¨ ÷£õh 
÷Ásk®. Auß ÷©À ÷ÁÖ ]Ö£õøÚø¯²® øÁzx 7 ^ø»©s ö\´¯ 
÷Ásk®. Ax {ßS E»º¢u ¤ß¦ Pn£vUS¨ §ø\ ö\´x 
Ak¨¤÷»ØÔ PõhõUQÛ¯õP 1 \õ©® G¶UP ÷Ásk®. 1 \õ©® {ßS 
G¶zu ¤ß¦ AuøÚ°ÓUQ ^ø»©søn AÂÌzx Âh ÷Ásk®. 
÷©÷»²ÒÍ £õøÚ°ÛÝÒ÷Í £ßÔ ¬i öPõsk xøhzx GkUP 
AuÝÒ Jmi C¸US® Cµ\zøu¨ ¤È¢x SkøÁ°À Aøhzx øÁzxU 
öPõÒÍ ÷Ásk®. 
APzv¯º £¶§µn® 400 £UP Gs (45,46) 
÷\¸® ©¸¢xPÒ: 
 uõx ¦èh SÎøP 
 AÍÄ: PÇØ]Põ¯ÍÄ 1 E¸søh 
 AÝ£õÚ® : \ºUPøµ 
 w¸® ÷{õ´ : Â¢x u®£Ú©øh²®. 
APzv¯º £¶§µn® 400 £UP Gs. 48 
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 §µa ö\¢yµ® 
 AÍÄ : 1/2  & 1 SßÔ 
 AÝ£õÚ® : ÷uß, ö{´ 2 ÷ÁøÍ, 5,7 {õÒ  
 w¸® ÷{õ´ : Áõu Søha\À, `ø», Qµ¢v, ÷©Pµn®, _µ®, \ßÛ, 
£» ÷µõP[PÒ |Áºzv¯õS®. 
APzv¯º £¶§µn® 400 £UP Gs.136 
 Áõø» µ\ ö©ÊS 
 AÍÄ : SßÔ¯ÍÄ 
 £øÚöÁÀ»® : 2 ÷ÁøÍ 
 w¸® ÷{õ´PÒ : ¤i¨¦, ui¨¦, ö\õÔ, ]µ[S, öÁsSmh®, 
¦ÊöÁmk, P¸÷©P®, u¢x öÁÒøÍ. 
(]Qa\õµzÚ w£® 2 £õP® øÁzv¯ ]¢uõ©o) £UP Gs.257 
 
Cµ\ {g_ SÔSn®: 
 \¶¯õÚ ¬øÓ°À ¬iUPõ©À E£÷¯õQ¨£uõÀ HØ£k® ÷PkPøÍ¨ 
£õºzx® ÷Pmk¬ÒÍ £siuºPÐ® £õ©µºPÐ® Cøu 
öÁÖ¨£õºPÒ. 
 _zv ö\´¯õu Cµ\zøu E£÷¯õQ¨£uõÀ, EhÀ ¬ØÖ® öÁ¢x 
÷£õÁußÔ £ØPöÍÀ»õ® PÇßÖ ÷£õ´Âk®. 
 £Ø\¢xPÎÀ DÖPmk®. 
 Aa\µzøu¨÷£õÀ ¦s EshõS®. 
 £Ú[PÒøÍ¨ ÷£õÀ Áõ´ SÇ®¦. 
 Áõ´ öuõsøh öÁ¢x Ã[S®. 
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 ShÀ Á°Ö CøÁPÒ ¦snõS®. 
 Á°ØÔß «x £møh £møh¯õPz ÷u©À £h¸®. 
 Põx ö\Âk£hÀ, Ps£õºøÁ CÇzuÀ. 
 ¤zuß ÷£õÀ Áõ´ ¤uØÖ®, xoPøÍU QÈzx AÂÌzöuÔ¯a 
ö\´²®. PÀ»õÀ AiUPÄ®, usp¶À ÂÊ¢x ÌS® BQ¯ 
SÔSn[PøÍ²® Põmk®. 
 ©µnzøu²® Esk £sq®. 
Cµ\ {g_ ¬ÔÄ 
 Ssiø¯¨ ¤izuUPõÀ, \õ¯¨£møhø¯¨ ö£õizx 
öÁÀ»zxh÷Ú P»¢x öPõkUPÄ®. 
 £Àø»UPmiÚõÀ ÷PõøÁz uska \õØøÓ {õUQÀ ¤È¯z w¸®. 
 ö{g_ÁØÔ, EÒöÁx®¤, ÷©À G¶Ä Gkzx, øP PõÀ ©si G¶¢x 
|øÚÂÀ»õ©Ø Qh¢uõÀ, AÖP[QÇ[øP B´¢x Gkzx 
Aøµzx, öÁÒÍõmk¨£õÀ, £_Âß £õÀ £¸zvUöPõmøh¨ £õÀ, 
÷©õº  CøÁPÎÀ HuõÁöuõßÔÀ Pøµzx ÁiPmiU öPõkUPÄ®. 
Sn¨£õh® uõx ^Á ÁS¨¦ £UP Gs.243 
 ¬ÔÂ, \[PÛø», £õP¼ø», ]ÖSÔg\õÛø», öÁØÔø», 
¤µsøh CøÁPÎß Q¯õÇ® vÚ® 2 ÷ÁøÍ 3 {õÒ uµÄ®.  
 Pzu¶UPõ´USÒ }µõøµU Røµø¯ Aøµzx ]Ôx öÁx¨¤ Cµsk 
vÚ® öPõkUPÄ®. 
£uõºzu Sn ÂÍUP® (uõx ^Á ÁºUP®) £UP Gs.31.  
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 xÍ] ÷Áº¨£møhU Si}º & 10, 20, 30, 40 {õmPÒ Áøµ SiUP 
÷Ásk®. 
 P¸÷ÁØ öPõ¨£ÎU Si}º & 3 ÷ÁøÍ öPõ¨£ÎUP ÷Ásk®. 
 AÖP[Si}º & Cµ\ {g_ w¸® Áøµ SiUP ÷Ásk®. 
 _øµUP¸¨¦ &  4 Qµõ® 80 ª¼ ¦Îzu £_ ÷©õ¶À Põø», ©õø» uµ 
÷Ásk®. 
 u°º öÁÀ»® & ^u®, S¸v²©õP¨ ÷£õS® Pk¨¦ }[S®. 
 G¸USU öPõ¨£ÎU Si}º & 4 {õÒ öPõ¨£Îzx EªÌ¢uõÀ 
Áõ´a`ø», `ø» w¸®. 
{a_ ¬ÔÄ ¡À £UP Gs.23,24 
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Modern Aspect 
Mercury 
Mercury is a transition metal. A transition metal is one of the elements found 
between Groups 2 (IIA) and 13 (IIIA) on the periodic table. Mercury has long been 
known as quicksilver, because it is a silver liquid. The chemical symbol also reflects this 
property. The symbol, Hg, comes from the Latin term hydrargyrum, meaning "watery 
silver." Mercury has been known for thousands of years. In many cultures, people learned 
to make mercury metal from its most important ore, cinnabar. When heated cinnabar 
releases mercury as a vapour (gas). The vapour is cooled and captured as liquid mercury.  
Some mercury compounds are known to be poisonous. For example, mercuric 
chloride (corrosive sublimate) was often used to kill pests and, sometimes, people. On the 
other hand, some mercury compounds have been used as medicines. For instance, 
mercurous chloride (calomel) was long used as a cure for skin rashes. In the last forty 
years, the dangers of mercury have become better known. As a result, mercury use is now 
being phased out.   
 
General Mercury Informatipon 
 
Composition  :Molecular Weight = 200.59 gm (100.00 %  Hg) 
Empirical Formula :Hg 
Environment :Secondary mineral resulting from oxidation of cinnabar deposits. 
Solid below -38.9°C 
IMA Status  :Valid Species (Pre-IMA) Prehistoric 
Locality  :Most notable occurrences are Almaden mines in Spain and the  
Idria mines in Yugoslavia.  
Name Origin  :From the Arabic. 
Synonym  :Hydrargyrum, Liquid silver, Native mercury, Quicksilver 
 
Physical Properties 
Atomic Number  :  80  
Atomic mass   : 200.59  
Family    : Group 12 (IIB), Transition metal 
Cleavage   : None 
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Color    : Tin white, Gray white 
Density   : 13.6 
Diaphaneity   : Opaque 
Habit    : Liquid - Occurs as a liquid at room temperatures. 
Hardness   : 0 – Liquid 
Luminescence   : Non-fluorescent. 
Luste    : Metallic 
Magnetism   : Nonmagnetic 
Streak    : none 
Boiling point   : 357oC / 675oF / 630K  
Electrical conductivity : 0.0104 X 106 / cm Ohm  
Thermal conductivity  : 0.0834 W / cmK  
Density   : 13.546 g / cm3 @ 300K  
Melting point   : -38.72oC / -37.7oF / 234.28K  
Molar volume   : 14.81 cm3 / mole  
Vapor pressure  : 0.0002Pa @ -38.72oC  
Heat of vaporization  : 59.229 kJ / mol  
Specific gravity  : 13.5 
 
Chemical Properties 
Valence states  : elementar Hg0, mercurous Hg+1, mercuric Hg+2 
Most stable form : elementar mercury 
Thermally unstable both forms Hg+1, Hg+2, decompose to elemental mercury 
Ionic forms  : Hg22+, Hg2+ 
Inorganic mercury mainly in a form of salts, mostly week soluble in water 
Common impurities : Au, Ag. 
Mercury does not react with most acids, such as dilute sulfuric acid, although 
oxidizing acids such as concentrated sulfuric acid and nitric acid or aqua regia dissolve it 
to give sulfate, nitrate, and chloride salts. Like silver, mercury reacts with atmospheric 
hydrogen sulfide. Mercury even reacts with solid sulfur flakes, which are used in mercury 
spill kits to absorb mercury vapors (spill kits also use activated carbon and powdered 
zinc) 
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Applications 
Mercury is used primarily for the manufacture of industrial chemicals or for electrical 
and electronic applications. It is used in some thermometers, especially ones which are 
used to measure high temperatures. A still increasing amount is used as gaseous mercury 
in fluorescent lamps, while most of the other applications are slowly phased out due to 
health and safety regulations and is in some applications replaced with less toxic but 
considerably more expensive Galinstan alloy. 
Common Mineral Associations 
Cinnabar, Calomel, Quartz, Dolomite 
Uses 
 Mercury is used to manufacture chlorine and caustic soda (35%). As mercury 
conducts electricity making it useful in electronics and electrical applications 
(30%) for example, is necessary in fluorescent light tubes,important ingredient in 
batteries, but newer types of batteries use other metals. The remaining 35% of 
mercury usage is in scientific measuring instruments such as thermometers and 
barometers, and is combined with other metals and used for in fillings for teeth 
(called amalgams by dentists). 
 Mercury as an element has many industrial uses, as it is the only metal that is a 
liquid at room temperature. When mercury combines with any of the true metals 
(excluding platinum and iron), the result is an amalgam. Amalgams are used to 
extract precious metals from their ore. 
 Ingested mercury and mercury mixtures are health hazards, and be lethal if a large 
amount is ingested. In fact, some mercury mixtures are used as poison. Hands 
should be washed after handling any minerals containing mercury. Mercury 
should also never be heated, as the vapor can be deadly if inhaled. 
 As electrodes in some types of electrolysis, batteries (mercury cells), sodium 
hydroxide and chlorine production, handheld games, catalysts, insecticides. 
 Mercury was once used as a gun barrel bore cleaner.  
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Medicine 
 Mercury and its compounds have been used in medicine, Thiomersal (called 
Thimerosal in the United States) is an organic compound used as a preservative in 
vaccines, though this use is in decline.  
 Mercury compounds are found in some over-the-counter drugs, including topical 
antiseptics, stimulant laxatives, diaper-rash ointment, eye drops, and nasal sprays.  
 The FDA has "inadequate data to establish general recognition of the safety and 
effectiveness", of the mercury ingredients in these products. Mercury is still used 
in some diuretics, although substitutes now exist for most therapeutic uses. 
 The mercury battery is a non-rechargeable electrochemical battery, a primary cell, 
that was common throughout the middle of the 20th century. Its constant voltage 
output and long shelf life gave it a  use for camera light meters and hearing aids.. 
 Mercury compounds have been used in antiseptics, laxatives, antidepressants, and in 
antisyphilitics. 
Historic Medicinal Uses 
 Mercury (I) chloride (also known as calomel or mercurous chloride) has been used in 
traditional medicine as a diuretic, topical disinfectant, and laxative. Mercury (II) 
chloride (also known as mercuric chloride or corrosive sublimate) was once used to 
treat syphilis (along with other mercury compounds), although it is so toxic that 
sometimes the symptoms of its toxicity were confused with those of the syphilis it 
was believed to treat.. Blue mass, a pill or syrup in which mercury is the main 
ingredient, was prescribed throughout the 19th century for constipation, depression, 
child-bearing and toothaches. In the early 20th century, mercury was administered to 
children yearly as a laxative and dewormer, and it was used in teething powders for 
infants. The mercury-containing organohalide merbromin (sometimes sold as 
Mercurochrome) is still widely used but has been banned in some countries such as 
the U.S. 
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Toxicological  Aspect 
Health and Mercury 
Mercury poisoning is known as mercuralism. It is easily absorbed through the 
skin, respiratory and gastrointestinal tissues in humans. It attacks the central nervous 
system and endocrine system, adversely affecting the mouth, gums, and teeth. High 
exposure of mercury and over a longer period of time, it results in brain damage which 
can even lead to death. 
Mercury also poses major health risk to the unborn fetus. Poisoned humans or animals 
often manifest excessive salivation. It is a condition known as mercurial ptyalism. The 
disease Minamata is also a form of mercury poisoning. 
 
Systematic Description of Clinical Effects 
 
Cardiovascular 
Acute 
Tachycardia with dull heart sounds and a gallop rhythm have been reported secondary to 
severe pneumonitis after acute exposure to mercury vapour. 
Chronic 
EEG changes have been recorded in chronically exposed workers. 
 
Respiratory 
Acute 
  In acute accidental exposure to high concentrations of mercury vapour causes 
erosive bronchitis and bronchiolitis with interstitial pneumonitis. Chest pain, dyspnoea, 
cough, haemoptysis, and evidence of interstitial pneumonitis have been reported 
atelectasis, emphysema, haemorrhage and pneumothorax often follow. The cause of death 
is progressive respiratory failure. The mortality rate is higher in children than adults. 
 Aspiration of metallic mercury may result in severe pulmonary toxicity or death. 
In some case only mild symptoms have developed. 
 
Neurological 
Chronic 
 Most information focuses on effects on the CNS following occupational 
exposure. Characteristic signs are tremor, motor disturbances and mental deterioration. 
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The most common psychiatric signs and symptoms are depression, irritability, and 
exaggerated response to stimulation, with excessive shyness, loss of confidence, vague 
fears, insomnia, emotional instability, forgetfulness and confusion. In advanced cases 
there may be loss of memory, hallucinations or intellectual deterioration, suicidal 
melancholia, or even manic-depressive psychoses.  
 Four out of nine workers exposed to mercury vapour had clinical signs 
suggesting involvement of the peripheral nervous system in addition to the features of 
chronic poisoning. Electromyographic changes consistent with denervation were 
demonstrated in eight. Sensory effects are uncommon with poisoning by inorganic salts. 
However, constriction of visual fields, difficulties in counting objects at a low 
illumination and poor depth and colour perception have been reported in a patient with 
chronic mercury poisoning. 
 
Gastrointestinal 
Acute 
 The gastrointestinal system is usually affected after acute exposure to inorganic 
mercury compounds (e.g. mercuric chloride). One of the earliest symptoms is metallic 
taste, followed by thirst, severe abdominal pain, vomiting and diarrhoea. The toxic effects 
are usually evident within 10-15 minutes of ingestion. Ashen discoloration of the mouth 
and pharynx are seen. Stomatitis develops in about 24 hours. Colitis with prolonged 
haemorrhagic diarrhoea may also occur. 
Chronic 
 Excessive salivation with loosening of the teeth is a sign of advanced poisoning, 
as is a blue line along the gum margin. 
 
Hepatic 
Chronic 
 Disturbed liver function with raised serum alkaline phosphatase have been 
reported in 6 out of 70 patients following chronic use of ammoniated mercury ointment. 
 
Renal 
Acute 
 Renal failure due to necrosis of the proximal tubular epithelium typically occurs 
within 24 hours after acute exposure to inorganic mercury compounds. Apart from the 
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corrosive damage there may also be a local vasospasm due to activation of the 
angiotensin system. 
Chronic 
 With chronic exposure to inorganic mercury the kidney is the critical organ. 
Two type of renal damage can occur: 
 
1) a glomerular injury caused by the toxic effect of mercury on the cells of the basal 
membrane of the glomeruli. An autoimmune reaction is induced due to formation of 
antigen against the glomerular tissue, and a nephrotic syndrome develops with proteinuria 
and the classical signs of glomerulonephritis. 
     
2) Tubular damage may also occur. Mercury accumulation causes necrosis and damage of 
the distal and middle portion of the proximal tubuli. 
 
 WHO (1976) states that effects of elemental mercury on the kidney had been 
reported only at doses higher than those associated with the onset of the CNS toxicity 
sign and symptoms. Since then several new studies have been carried out, and kidney 
effects have been seen at lower exposure levels (WHO, 1991). 
 
Endocrine and Reproductive Systems 
 Enlargement of the thyroid gland has been reported but the incidence in relation 
to exposure to mercury is uncertain. 
Dermatological 
 The soluble inorganic compounds of mercury are irritating to the skin and 
mucous membranes; this effect is particularly marked with mercuric chloride.  
Eye, Nose, Throat- Local Effects 
Acute: 
 Mercurous and mercuric salts are corrosive to the eyes, the latter are more 
corrosive.  
Chronic 
 Mercurialentis is the name given to an unusual appearance of the anterior 
surface of the lens seen in people exposed to mercury. The change in the lens consists of 
greyish or light-to-coffee brown granular discoloration, detected by slit-lamp. The change 
 18 
 
is bilateral and symmetrical, and the visual activity is unaffected. It has been seen in 
people who have had prolonged exposure.  
 
Treatment 
 Immediate chelation therapy is the standard of care for a patient showing 
symptoms of severe mercury poisoning or the laboratory evidence of a large total 
mercury load. 
 Chelation therapy for acute inorganic mercury poisoning can be done with 
DMSA, 2,3-dimercapto-1-propanesulfonic acid (DMPS), D-penicillamine 
(DPCN), or dimercaprol (BAL).  Only DMSA is FDA-approved for use in 
children for treating mercury poisoning.  
 Alpha-lipoic acid (ALA) has been shown to be protective against acute mercury 
poisoning in several mammalian species when it is given soon after exposure; 
correct dosage is required, as inappropriate dosages increase toxicity.  
 Glutathione and N-acetylcysteine (NAC) are recommended by some physicians, 
but have been shown to increase mercury concentrations in the kidneys and the 
brain.  Experimental findings have demonstrated an interaction between selenium 
and methylmercury, but epidemiological studies have found little evidence that 
selenium helps to protect against the adverse effects of methylmercury. 
 
Post Moterm Appearance 
The tongue is white and sodden in appearance, Mucous membranes of alimentary 
diffuse grayish white escharotic appearance. Tract are inflamed and corroded. The 
muscular coats are softened, so that removing an organ causes its entire rupture. 
Sub endocardial Liver shows fatty degeneration. Kidneys show toxic nephritis. 
Hemorrhages are present in the heart. Drastic changes in the large intestine, with 
spreading necrosis, which may even involve whole of the large intestine.  
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Lingam  
(Cinnabar) 
 
Siddha Aspect 
þÄ¢í¸õ 
 
þÄ¢í¸Á¡ÉÐ À¡¼¡½í¸Ç¢ø þÂü¨¸ À¡¼¡½ Å¨¸¨Âî º¡÷ó¾Ð. 
Àïºâ¾ À¡¼¡½í¸Ç¢ø ¬¸¡Âì Üü¨Èî º¡÷ó¾Ð. º¢Åý ¾¢ ÒÃò¨¾ ± ò¾ 
¸¡ÄòÐ ¦¿üÈ¢ì ¸ñ½¢ý ¦À¡È¢ þÃºÁ¢Õì¸¢ýÈ âÁ¢Â¢ø ÀðÎ þÄ¢í¸ 
À¡ ¡½õ ¬Â¢üÚ ±ýÚõ, þÐ §ÁÕ×ìÌ ¸¢Æì§¸ Åí¸Á¢Õì¸¢ýÈ âÁ¢Â¢ø 
Á¨ÄÂ¢ý «ÊÂ¢ø þÃºÓõ ¸ó¾¢Ôõ ÜÊ ¯ñ¼¡Â¢üÚ ±ýÚõ, þ¾ý À¢ÈôÒ 
ÅÃÄ¡Ú ÜÈôÀÎ¸¢ÈÐ. 
 
Å¨¸¸û 
 À¢ÈÅ¢ þÄ¢í¸õ 
 ¨ÅôÒ þÄ¢í¸õ 
 
§ÅÚ ¦ÀÂ÷¸û 
¬ñÌÈ¢, þíÌÄ¢¸õ, þÃ¡ºõ, ¸¨¼ÅýÉ¢, ¸÷ôÀõ, ¸Ä¢ì¸õ, 
¸¡ïºÉõ, ¸¡Ã½õ, ºñ¼¸õ, ºÁÃºõ, º¡É¢Âõ, ¦ºóàÃõ, Á½¢Ã¡¸õ, 
Á¢§Äîºõ, ÅÉ¢, ÅýÉ¢ 
 
Íò¾¢ Ó¨È¸û 
 þÄ¢í¸ì ¸ðÊ¨Â §¾É¢ø ´Õ ¿¡û °È¢Â À¢ý «Á¢÷¾À¡Ä¢ø ´Õ 
¿¡û °È ¨ÅòÐ À¢ý ±ÖÁ¢î¨º º¡Ú, Ìô¨À§ÁÉ¢îº¡Ú, 
«Á¢÷¾À¡Ä¢ø 3 º¡Áõ ºÁÁ¡ö ¸ÄóÐ ¨ÅòÐ¦¸¡ñÎ ´Õ ºðÊ¨Â 
«Îô§ÀüÈ¢ ¸¡Â¨ÅòÐ «ó¾ ºðÊìÌû Ä¢í¸ò¨¾ ¨ÅòÐ 
Ò¨¸Â¡Áø ÍÕìÌ ¦¸¡ÎòÐ ±Îì¸ Íò¾¢Â¡Ìõ. 
Â¡§¸¡Ò ¨Åò¾¢Âõ- 300. Àì¸õ ±ñ: 5 
 
 Ó¨ÄôÀ¡Ä¢Öõ, ±ÖÁ¢îºí¸É¢ þÃºò¾¢Öõ Ó¨È§Â ´ù¦Å¡Õ¿¡û 
°È¨Åò¦¾Îì¸î Íò¾¢Â¡Ìõ. 
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 273  
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 ¾¡öôÀ¡Ä¢ø 12 Á½¢§¿Ãõ °È ¨Åì¸ Íò¾¢Â¡Ìõ. 
ºÃìÌ Íò¾¢ Ó¨È¸û. Àì¸ ±ñ: 51 
 
 ±ÖÁ¢î¨º º¡üÈ¢ø 2 Á½¢ §¿Ãõ °È¨ÅòÐ ±ÎòÐ À¢ýÉ÷ 
±Õ¨ÁôÀ¡Ä¢ø ¸ØÅ¢ ¯Ä÷ò¾¢ ±Îì¸ Íò¾¢Â¡Ìõ. 
ºÃìÌ Íò¾¢ Ó¨È¸û. Àì¸ ±ñ: 51 
 
 ¾¡öôÀ¡Ä¢ø ´Õ ¿¡û, ±ÖÁ¢î¨º º¡üÈ¢ø 1 ¿¡û °È ¨Åì¸ 
Íò¾¢Â¡Ìõ 
ºÃìÌ Íò¾¢ Ó¨È¸û. Àì¸ ±ñ: 51 
 
 ¦¸¡õÁðÊì¸¡ö, Á¡ÐÇí¸¡ö º¡üÈ¢ø °È¨ÅòÐ ¯Ä÷ò¾¢ ±Îì¸ 
Íò¾¢Â¡Ìõ 
ºÃìÌ Íò¾¢ Ó¨È¸û. Àì¸ ±ñ: 51 
 
 ±ÖÁ¢î¨º º¡üÈ¢ø 9 Á½¢ §¿Ãõ ± òÐ ¦ÅûÇ¡ðÎ §¸¡Á¢Âò¾¢ø 
§À¡ðÎ °È ¨Åì¸×õ 
ºÃìÌ Íò¾¢ Ó¨È¸û. Àì¸ ±ñ: 52 
 
 ±ÖÁ¢î¨º º¡Ú, ÀÕò¾¢ô À¡ø, Ìô¨À§ÁÉ¢îº¡Ú ºÁý ÜðÊ 
Ä¢í¸ò¨¾ «¸Ä¢Ä¢ðÎ ÍÕì¸¢ðÎ ±Îì¸×õ 
ºÃìÌ Íò¾¢ Ó¨È¸û. Àì¸ ±ñ: 52 
 
§ºÕõ ÁÕóÐ¸û 
 
1. ÀÊ¸ þÄ¢í¸î ¦ºóàÃõ 
«Ç×: 3 - 5 ÌýÈ¢ 
«ÛÀ¡Éõ: ¦¿ö, ¦Åñ¦½ö 
¾£Õõ §¿¡ö¸û: º£¾§À¾¢, þÃò¾ §À¾¢, ¦ÀÕõÀ¡Î, °Æ¢, ÍÃòÐ¼ý ÜÊÂ 
§À¾¢ 
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 279 
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2. ÀÈí¸¢ôÀð¨¼ À¾í¸õ 
«Ç×: ¸ÆïºÇ×, 1 Áñ¼Äõ 
¾£Õõ §¿¡ö¸û: 21 Å¨¸ §Á¸í¸û, Ý¨Ä ¨¸ì¸ÕôÒ, þÃ½í¸û, º¢ÃíÌ, 
Ìð¼õ, ¾ó¾ Ý¨Ä, Å¡ö ¿¡üÈõ 
º¢ò¾ ¨Åò¾¢Â ¾¢ÃðÎ. Àì¸ ±ñ: 165 
3. Àïºâ¾î ¦ºóàÃõ 
«Ç×: ÌýÈ¢ÂÇ× 
«ÛÀ¡Éõ: §¾ý, ¦¿ö 
¾£Õõ §¿¡ö¸û: À¡ º Å¡¾õ, ¨¸¸¡ø À¢ÊôÒ, º÷Å¡í¸ Å¡Ô, Ì¨¼îºø, 
§Á¸Ã½õ. 
¸ñqº¡Á¢Âõ ±ýÛõ ¨Åò¾¢Â §º¸Ãõ. Àì¸ ±ñ: 106 
4. ºñ¼Ãº ÀüÀõ 
«Ç×: À½¦Å¨¼ 
«ÛÀ¡Éõ: ¿øÄ ¦ÅøÄõ 
¾£Õõ §¿¡ö¸û: ¸¡Á¡¨Ä, À¡ñÎ, ¿£÷ì¸ðÎ, ¿£Ã¨¼ôÒ, ÁÄì¸ðÎ, ãÄõ, 
Å¡¾ ºó¿¢, ±ñÅ¨¸ì ÌýÁõ. 
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 278 
5. º¡¾¢ ºõÀ£Ãì ÌÆõÒ 
þÄ¢í¸õ 1 ÀÄõ 
±ÖÁ¢îºõ ÀÆîº¡Ú 15 ÀÄõ 
¸üâÃõ 21/2 ÅÃ¡¸¦É¨¼ 
    þÄ¢í¸ò¨¾ àû ¦ºöÐ ±ÖÁ¢îºõ ÀÆîº¡üÈ¢ø ¸ÄóÐ ¦¸¡ñÎ, 
¸üâÃòÐìÌ ÍÕìÌ ¦¸¡ÎòÐ þ¨¾ ÌÆõÒ ÀìÌÅò¾¢ø ±ÎòÐì 
¦¸¡ûÇ×õ. 
¾£Õõ §¿¡ö¸û: ¿¡ì¸¢ø ¾¼Å Å¡ó¾¢, À¢ò¾õ, ¾¡¸õ, §À¾¢ ¾£Õõ 
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 279 
 
6. ¸¡Êì¸¡Ã ¦ºóàÃõ 
«Ç×: 1/2 Ó¾ø 1 « º¢ ±¨¼ 
«ÛÀ¡Éõ: §¾ý, þïº¢î º¡Ú, ÐÇº¢î º¡Ú 
¾£Õõ §¿¡ö¸û: À¡ º Å¡¾õ, °Æ¢ 
º¢ò¾ ¨Åò¾¢Â ¾¢ÃðÎ. Àì¸ ±ñ: 157 
 
 
 
 22 
 
¿ïÍì ÌÈ¢Ì½õ 
 
 Å¡ö, ¯ñ½¡ìÌ Ó¾ø ÌÃøÅ¨Ç, Á¡÷Ò, ¦ÀÕíÌ¼ø ¬¸¢Â 
þ¨Å¸û ¦ÅóÐ Òñ½¡¸¢ ¦ÅÂ¢Ä¢ø ¸ºì¸¢Â ÀÕò¾¢ôâô 
§À¡Ä¢ÕìÌõ. ¸¡Ãõ À¼ ÓÊÂ¡Ð, ¾¡¸ï ¦ºöÂ¦Å¡ð¼¡Ð. §Àº 
ÓÊÂ¡Ð 
 Å¡Â¢ø ¦¸ð¼Å¡º¨É, ÅÂ¢üÈ¢ø ± îºø ¯ñ¼¡Ìõ 
 Å¡ö¿£÷ ¦¸ðÎô§À¡É ÀÉí ¸û¨Çô §À¡ýÈ¡ÅÐ, ¸¡Êò¾ñ½£÷ 
§À¡ýÈ¡ÅÐ þÕìÌõ 
 
ÓÈ¢× 
º¡¾¢ì¸¡ö, Å¡øÁ¢ÇÌ, ¦ºõÀÕò¾¢ §Å÷ôÀð¨¼ ¬¸¢Â ãý¨ÈÔõ 
Å¨¸ìÌ 4 ¸¢Ã¡õ Å£¾õ ±ÎòÐ ¿ýÈ¡¸ þÊòÐ 850 Á¢.Ä¢ð. ¿£÷ Å¢ðÎ «øu 
±ðÊø ´ýÈ¡¸ ¸¡öîº¢ «¾¢ø 35 ¸¢Ã¡õ ¸ü¸ñ¨¼ô ¦À¡ÊòÐô§À¡ðÎì 
¸¡¨ÄÂ¢Öõ Á¡¨ÄÂ¢ÖÁ¡¸ ´Õ Áñ¼Äõ Å¨Ã ¯ð¦¸¡ûÇ þÄ¢í¸ ¿ïÍ 
ÓÈ¢Ôõ.  
¿ïÍ ÓÈ¢× áø. Àì¸õ ±ñ: 26 
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Modern Aspect 
Cinnabar 
Cinnabar is a mercury sulfide mineral and the most important ore of mercury. It is 
a colourful mineral that adds a unique colour to the mineral colour palette. Cinnabar is 
usually found in rocks that form near volcanic activity or in hot springs. It’s produced 
near the Earth’s surface from hot liquids that bubble up from deeper in the Earth. Major 
cinnabar producers today include Spain, China, Italy, Serbia, Slovenia and parts of the 
United States. In ancient times cinnabar was ground into a powder and used as a pigment 
for art and decoration and in cosmetics. Cinnabar is still used in artists’ paints today. It’s a 
mercury ore and is made of a compound called mercury (II) sulfide (also known as 
mercuric sulfide), which has the chemical formula HgS. Most of the world’s mercury 
supply is obtained from cinnabar. Mercury and mercury compounds are toxic to humans, 
although cinnabar is not as poisonous as some other forms of mercury. 
Vernacular Name 
 English : Cinnabar or Vermilion 
 Tamil  : Lingam 
 Mah & Can : Ingilika 
 Hindi  : Sinjraph 
 Guj  : Hingalo 
Synonyms 
 Almaden 
 Beta mercury sulfide 
 Chinese vermilion 
 Cinnabarite 
 Ethiopes mineral 
 Mercury monosulfide 
 Mercury sulfide 
 Mercury II sulfide 
 Orange vermilion 
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Chemistry 
 Cinnabar is the common ore of mercury. Mercury (II) sulfide (HgS), native 
vermilion.  
Molecular Weight = 232.66 gm. (Mercury 86.22%, Sulfur 13.78% ) 
Physical Characteristics 
 Color: Bright scarlet or cinnamon red to a brick red.  
 Luster is adamantine to submetallic in darker specimens.  
 Transparency crystals are translucent to transparent.  
 Crystal System is trigonal; 32  
 Crystal Habits: individual, well formed, large crystals are scarce; crusts and 
crystal complexes are more common; may be massive, or in capilary needles. 
Crystals that are found tend to be the six sided trigonal scalahedrons that appear to 
have opposing three sided pyramids. It also forms modified rhombohedrons, 
prismatic and twinned crystals as discribed above.  
 Cleavage is perfect in three directions, forming prisms.  
 Fracture is uneven to splintery.  
 Hardness is 2 - 2.5.  
 Specific Gravity is approximately 8.1+ (very heavy for a non-metallic mineral)  
 Streak is red  
 Associated Minerals: realgar, pyrite, dolomite, quartz, stibnite and mercury.  
 Other Characteristics: silghtly sectile and crystals can be striated.  
 Notable Occurances include Almaden, Spain; Idria, Serbia; Hunan Prov., China 
and California, Oregon, Texas, and Arkansas, USA.  
 Best Field Indicators are crystal habit, density, cleavage, softness and color.  
Environment 
Since Mercury is a liquid, it is rarely found in a native state. Although it is the 
only mineral aside from Water found in a liquid state, it is never found in "pools". It only 
occurs as tiny blobs on top of the mercury ores Cinnabar and Calomel. The tiny blobs are 
lodged in small crevices or pores, or they just stick to the associating mineral. The blobs 
do not roll around or fall off the associating mineral, but stay in a single place unless they 
are tampered with. 
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Structure 
HgS adopts two structures, i.e. it is dimorphous. The more stable form is cinnabar, 
which has a structure akin to that for HgO: each Hg center has two short Hg-S bonds, and 
four longer Hg---S contacts.  The black form of HgS has the zinc blende structure.  
 Identification and Diagnostics 
Recognized usually by color, streak and high specific gravity. The mineral is 
slightly sectile. It is transparent, translucent or opaque, is of a cochineal-red color, 
often inclining to brown. From all red minerals but arsenic disulfide it may easily be 
distinguished by its sulfur reaction. From arsenic disulfide it is distinguished by its 
great density and its greater hardness. Wholly volatile when free from gangue. Gives 
black sublimate of mercury sulfide when heated alone in closed tube. It is circularly 
polarizing and is a nonconductor of electricity.  
 Occurrence and Localities 
The only important ore of mercury, but found in quantity at comparatively few 
localities. Cinnabar is usually found in veins cutting serpentine, limestones, slates, 
shales and various schists. It is associated with gold, various sulfides, especially pyrite 
and marcasite, calcite , barite, fluorite, gypsum, opal, and quartz. It is also found 
impregnating sandstones and other sedimentary rocks, and sometimes as a deposit 
from hot springs. Always found in the neighborhood of igneous rock masses from 
which it is thought that the mercury was derived. Its deposition is thought to be the 
result of precipitation from ascending hot water. Deposits of cinnabar are being 
formed to-day by the hot springs at Steamboat Springs, Nevada, and at Ohaiawai, 
New Zealand.  
Mining and Extraction of Mercury 
 To produce liquid mercury (quicksilver), crushed cinnabar ore is roasted in rotary 
furnaces. Pure mercury separates from sulfur in this process and easily evaporates. A 
condensing column is used to collect the liquid metal, which is most often shipped in iron 
flasks. Since mercury is a relatively noble metal, it easily separates from its ores. 
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Uses of Cinnabar 
 Cinnabar is the naturally occurring mineral with mercury in combination with 
sulfur, is red in color so called red mercury sulfide. Cinnabar powder has been 
used as an important ingredient in traditional INDIAN medicines and in 
CHINESE medicines. Cinnabar- gold was used as an alchemical drug of 
longevity, in India. 
 Used traditionally for pigments in many cultures. 
 Has been found to be used in burial practices to color the bodies red in Southeast 
Asia dating back to Mesolithic time periods. 
 Used to make jewelry and sculptures in ancient cultures. 
 Cinnabar is mined as the major ore of mercury. Mercury is used for scientific 
apparatuses (like thermometers and barometers), the manufacture of chlorine and 
caustic soda, creating fluorescent light tubes, and historically to obtain gold from 
placer deposits, which is no longer used. 
 Cinnabar is used to colour paints and as one of red coloring agents used in tattoo 
dyes. 
  Small doses of mercury composition diminishes oxidation of tissues and increase 
the amount of red corpuscles while the body gains weight and the general 
nutrition is improved. 
 The cinnabar powder is used in secondary syphilitic eruption. 
 It has been proved to be anti inflammatory, analgesic and anti- pyretic. It is 
considered to be the highly efficacious drug in combating peptic ulcer. 
 Mercury is used in instruments, electrical controls and as a fungicide. It was once 
used to recover gold from stream sediments and crushed ore. 
 Cinnabar has been used as a tonic to reduce the incidence of palpitation, 
restlessness and insomnia. It is also used to treat sore throats and cold sores that 
occur in mouth and tongue.  
 The dosage of cinnabar is between 0.3 gm and 1 gm, ground into powder and 
mixed with water as a decoction for oral use. Larger amounts can be applied to the 
skin as necessary. 
 Cinnabar is available as a powder in pill, capsule and tablet forms. It is often 
included with other herbs as a part of larger formula. 
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Prevention 
 Cinnabar contains mercury, it should not be used for extended periods of time, nor 
should not be taken in large doses.  
  Cinnabar should not be taken by patients diagnosed with liver or kidney 
problems.  
 
Varieties of Cinnabar 
 Hepatic cinnabar  
It is an impure variety from the mines of Idrija in the Carniola region of Slovenia, 
in which the cinnabar is mixed with bituminous and earthy matter. 
 Metacinnabarite  
It is a black-colored form of HgS, which crystallizes in the cubic form. 
 Synthetic cinnabar  
It is produced by treatment of Hg(II) salts with hydrogen sulfide to precipitate 
black, synthetic metacinnabarite, which is then heated in water. 
 Hypercinnabar  
Crystallised in the hexagonal form. 
 Minum 
The former name applied to the “Sulphuret of Mercury”. It is used in painting, this 
cinnabar minimum came from “The quicksilver mine Miniaria”.  
 Natural Vermilion 
The term applied in the marketplace, apparently because powdered cinnabar was 
so- named red pigment. 
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Toxicological Aspect 
Cinnabar (HgS) Main source of mercury; Very insoluble (Ksp = 10-53.3) 
However, when oxidized, can be methylated by sulfate-reducing bacteria, producing 
methyl mercury and dimethyl mercury.Causes developmental and nervous system 
disorders in fetuses and children.   
Because of its mercury content, cinnabar can be toxic to human beings. Though 
ancient peoples in South America often used cinnabar for art, or processed it into refined 
mercury (as a means to gild silver and gold to objects) "the toxic properties of mercury 
were well known. It was dangerous to those who mined and processed cinnabar, it caused 
shaking, loss of sense, and death...data suggest that mercury was retorted from cinnabar 
and the workers were exposed to the toxic mercury fumes.  Overexposure to mercury, 
mercurialism, was seen as an occupational disease to the ancient Romans. 
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Veeram 
(Mercury II Chloride) 
 
Siddha Aspect 
Ãµ® 
(Hydrargyrum Perchloride) 
÷ÁÖ ö£¯º: 
 «Úõæø©¢uß, öPõa]Ãµ®, §Â¢x ÷\ÁPß, \µUS _sn®, 
 £Ó[Q¨ £õåõn®, \õµzvß \zx¸, £Ôªzx¸ 
_øÁ : Põº¨¦, E¨¦    Ã¶¯®: öÁ¨£®   ¤¶Ä : Põº¨¦ 
ö\´øP: EhÀ÷uØÔ, Q¸ª{õ]Û,  AÊP»PØÔ, ¦sqshõUQ 
ö£õxSn®: 
""Sß©ö©õk Smh[ öPõi¯ÁÛ »zvµmk 
xß©õ[ Q\¨ö£¸UPg `ø»÷{õ´ & Áßø©²Ö 
Põª¯¨¦s nõv¯ ÷{õ´ PshõØ\Æ 
ÃµöÚÝg \õª{õ ©zøu²a \¶''. 
 \ÆÃµzvß {õ©zøu Ea\¶zuõ÷» Sß©®, SøÓ÷{õ´, w[øP 
ÂøÍÂUQßÓ ©PõÁõu ÷µõP[PÎß Tmh®, xº©õª\ ÁÍºa], 
`ø»÷{õ´PÒ, Áßø© ö£õ¸¢v¯ ö£s ÷£õPzvÚõÀ ÂøÍQßÓ 
(öPõÖUS, Aøµ¯õ¨¦) ¦sPÒ }[S®. 
 CuøÚ¨ £»ÁøP¨£mh Ps÷nõ´PÐUS® E£÷¯õQUQßÓÚº. 
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Ãµ® ¤Ó¨¤h® 
 64 £õåõn[PÐÒ Ãµ® C¯ØøP°À QøhUPU Ti¯x. 
 ©ß©uøÚ \[Põµ® ö\´²® Põ»zvÀ ]Áö£¸©õÛß ö{ØÔU 
Pso¼¸¢x ÷uõßÔ¯ ö{¸¨¦¨ ö£õÔ, `u® C¸¢u ChzvÀ£h Ax 
öPõÊ¢x £hº¢x ÁÍº¢x Ãµ® B°ØÖ. öPõi¯ {g_. 
÷\¸® ©¸¢xPÒ 
1. A¯Ãµ ©õzvøµ  
AÍÄ :  2 ©õzvøµ 
 AÝ£õÚ® : \ºUPøµ (A) £øÚöÁÀ»® 
 w¸® ÷{õ´PÒ : Áõu¤zu `ø», ¬hUS, AshÁõu®, Cøµ¨¦, 
C¸©À, PÀ»øh¨¦, Søha\À. 
Psq\õª¯® GßÝ® øÁzv¯÷\Pµ® £UP Gs.47 
2. P¢uPz øu»® 
 AÍÄ : ÷ÁøÍUS 7&8 xÎ 
 xøn ©¸¢x : 1 ÁµõPß öÁÒøÍ \ºUPøµ 
 {õÍÍÄ : 1/2  ©sh»® 
 w¸® ÷{õ´PÒ : Qµõo, vªº, Smh®, Sß©®, ö\®£øh, P¸®£øh, 
FÓÀ, £øh, `ø», ¦s¦øµPÒ, ¦ØÖ, Psh©õø» w¸®. 
Psq\õª¯® GßÝ® øÁzv¯÷\Pµ® £UP Gs.78 
3. Ãµ µ\¨ £u[P® 
 AÍÄ : SßÔ¯ÍÄ 
 {õÍÍÄ : 3 {õÒ 
 w¸® ÷{õ´PÒ : Qµ¢v, öPõ¸US, ÷©PÁõ´Ä, ¤i¨¦, ÷©PÂµn®. 
Psq\õª¯® GßÝ® øÁzv¯ ÷\Pµ® £UP Gs.78 
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4. BÖ¬Pa ö\¢yµ® 
 AÍÄ : 1/4 -&  1/2  SßÔ 
 AÝ£õÚ® :  ÷uß, ö{´ 
 w¸® ÷{õ´PÒ : £õsk, Á°ØÖÁ¼, G¶a\À, ÷uPUPkzuÀ, 
÷\õøP, Sß©®, _µUPmi, Áõu÷µõP[PÒ, øPPõÀ ¤i¨¦, ©÷Põuµ®. 
Psq\õª¯® GßÝ® øÁzv¯÷\Pµ® & £UP Gs.107 
5. Aèh £°µÁU SÎøP 
 AÍÄ : ªÍPÍÄ ©õzvøµ 
 w¸® ÷{õ´PÒ : ¬ø»¨£õÀ & 64 & _µ[PÒ, ÷uÛÀ & wµõu 
÷uõh[PÐ® C»Á[PU Si}º & Âå ÷uõh[PÒ w¸®. 
]zu øÁzv¯ vµmk £UP Gs.3 
6. ©PõÃµ ö©ÊS 
 AÍÄ : 1&2 £¯ÓÍÄ 
 w¸® ÷{õ´PÒ : Áõu ÷µõP®, ÷©P÷µõP[PÒ w¸®. 
 £zv¯® & £õ¾® ÷\õÖ®. 
]zu øÁzv¯ vµmk £UP Gs.200 
7. Áõß ö©ÊS  
AÍÄ: EÐ¢uÍÄ  
AÝ£õÚ®: £øÚöÁÀ»®, 2÷ÁøÍ, 8&5 {õÒ 
 w¸® ÷{õ´PÒ : ©÷Põuµ®, ÷\õøP, ©g\mPõ©õø», \zv, £Äzvµ®, 
PÀ»øh¨¦, Á¼¨¦, Qµ¢v, Psh©õø». }¶ÈÄ, ©¢uõµPõ\® w¸®. 
]zu øÁzv¯ vµmk £UP Gs.197 
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Å£Ã ¿ïÍì ÌÈ¢Ì½õ 
þ·Ð þÃò¾ò¾¢ø Å¢¨ÃÅ¢ø ¸ÄóÐ Å¢¼ò¨¾ Å¢¨ÃÅ¢ø ¯ñ¼¡ìÌõ. 
þ¾É¡ø ¸Ç¢õÒ Í¨ÅÔõ, Å¡ö ¿£ÕÈø, Å¡ö ,¦¾¡ñ¨¼,¬Á¡ºÂõ þ¨Å 
Å£í¸¢ô Òñ½¡¾ø, Å¡ó¾¢, §À¾¢, þÃò¾ §À¾¢, ±îº¢ø Å¢Øí¸ ´ð¼¡ÁüÀÊ 
¦¾¡ñ¨¼ §¿¡¾ø, Ó¸õ Å£í¸ø, §¾¡ø ¦ÅÊòÐ º¢¨Ä ¿£÷ ÅÊ¾ø, Àì¸ ÅÄ¢, 
¾¡¸õ, Å¢ì¸ø , ÁÂì¸õ, ã÷î¨º, ÅÄ¢ Ó¾Ä¢ÂÉ×õ ¯ñ¼¡Ìõ. «ýÈ¢Ôõ 
ÁÃ½õ ¯ñ¼¡Ìõ. 
 
¿ïÍ ÓÈ¢× 
 
 º¢Ú¦¿Õïº¢ü º¡Ú , ¿£Ä¢§Å÷ôÀð¨¼ì ¸ü¸õ ,¦¿öîºðÊì ¸£¨Ãîº¡Ú, 
¦¾ýÉí¸û þ¨Å¸Ç¢ø ´ý¨È ¿ïº¢ý Åý¨ÁìÌò ¾ì¸ «ÇÅ¢ø 
¿ïÍ ÓÈ¢Ôõ ÁðÎõ ¾Ã×õ. 
 20 Á¢øÄ¢ Ä¢ð¼÷ º¢Ú¦¿Õïº¢ü º¡ü¨Èì ¸¡¨ÄÂ¢Öõ Á¡¨ÄÂ¢Öõ 
ÌÊòÐ ÅÃ §ÅñÎõ.  
 ¿£Ä¢§Å÷ôÀð¨¼¨Â ¦Åó¿£÷ Å¢ðÎ «¨ÃòÐ ´Õ Íñ¨¼ì¸¡ö Å£¾õ 
±ÎòÐ 80 Á¢øÄ¢ Ä¢ð¼÷ þÇ ¦Åó¿£Ã¢ø ¸¨ÃòÐì ¸¡¨ÄÂ¢Öõ 
Á¡¨ÄÂ¢Öõ ÌÊòÐ ÅÃ §ÅñÎõ.«òÐ¼ý þ¨¾ì ÌÊ¿£÷ ¦ºöÐ 
ÌÊòÐ ÅÃÄ¡õ.  
 
 
 
 
 
 
 
 
 
 
 
 33 
 
Modern Aspect 
Mercury II Chloride 
Mercury(II) chloride, also known as mercuric chloride and corrosive sublimate, is 
a chemical compound. Its chemical formula is HgCl2. It has mercury and chloride ions in 
it. The mercury is in +2 oxidation state. This white crystalline solid is a laboratory reagent 
and a molecular compound. Once used as a treatment for syphilis, it is no longer used for 
medicinal purposes because of mercury toxicity and the availability of superior 
treatments. 
Synonym 
Calogreen, Cyclosan, Mercury monochloride, Mercury protochloride, Mercury 
subchloride, Mild mercury chloride, Precipite blanc 
Physical Properties 
 Chemical group : Chlorides 
 Color   : White 
 Atomic weight : 472.09 
 Vapor Pressure : 1 mm Hg at 277.16 ° F (EPA, 1998)  
 Specific Gravity : 5.44 at 77.0 ° F (EPA, 1998)  
 Molecular Weight : 271.52 (EPA, 1998)  
 Water Solubility : 5-10 mg/mL at 72° F (NTP, 1992)  
 IDLH   : 10 mg/m3 (as Hg) (NIOSH, 2003) 
 Appearance White, heavy crystalline powder or rhombic crystals 
 Solubility Slightly soluble in hydrochloric acid 
 Melting point Sublimes at 400 - 500°C without melting 
 Boiling point 384ºC (decomposed by alkalis) 
 Density (g/ml) 7.15 
 Incompatible substances Acacia, alkali chlorides, ammonia, bromides, carbonates, 
cocaine, copper salts, cyanides, golden antimony, hydrogen peroxide, hydroxides, 
iodides, iodine, iodoform, lead salts, lime water, sulphide, silver salts, soap, 
sulphates, sulphides, sulphites 
 Hazardous material Harmful 
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Uses 
 Until recently, the main application of mercuric chloride is as a catalyst for  
the conversion of acetylene to vinyl chloride, the precursor to polyvinylchloride  
(PVC).  
  
 Historical uses included use as a photographic intensifier to produce positive  
pictures in the collodion process of the 1800s.  When applied to a negative,  
the mercury(II) chloride whitens and thickens the image, thereby increasing the  
opacity of the shadows and creating the illusion of a positive image.  
  
 For the preservation of anthropological and biological specimens during the late  
19th and early 20th centuries, objects were dipped in or were painted with a  
"mercuric solution."  Objects in drawers were protected by scattering crystalline  
mercuric chloride over them.  
  
 Mercuric chloride is sometimes used in dilute solution as an antiseptic for  
inanimate objects and as a fungicide.  It is also used in preparing other  
mercury compounds.  It reacts with mercury metal to form mercurous chloride.  
  
Other significant applications of mercuric chloride include its use as a depolarizer  
in batteries and as a reagent in organic synthesis and analytical chemistry.  
   
 Mercuric chloride is occasionally used to form an amalgam with metals, such  
as aluminum.  Upon treatment with an aqueous solution of mercuric chloride,  
aluminum strips quickly become covered by a thin layer of the amalgam.    
Normally, aluminum is protected by a thin layer of oxide making it inert.  Once  
amalgamated, aluminum can undergo a variety of reactions.  For example, it  
will dissolve in water.  Amalgamated aluminum is also used as a reducing agent  
in organic synthesis.  Zinc is also commonly amalgamated using mercuric 
chloride.  
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Toxicological Aspect 
Mercuric chloride is extremely poisonous and must be handled with great care at 
all times. Repeated small exposures can accumulate over time to produce serious toxic 
effects. All used material, including all water washes, paper towels etc.  
Due to its toxicity and its ability to enter the food chain, accumulating in tissues of 
top level predators (including humans) there has been a move in some jurisdictions to 
stop using this heavy metal. This applies to non-fixation uses as well as fixation. Some 
jurisdictions may already have banned its use. If your jurisdiction has not yet done so, 
please give serious consideration as to whether this fixing agent could be replaced by 
another, or a completely different fixative could be used instead. 
Inhalation 
Causes irritation to the respiratory tract. Symptoms include sore throat, coughing, 
pain, tightness in chest, breathing difficulties, shortness of breath and headache. 
Pneumonitis may develop. Can be absorbed through inhalation with symptoms to parallel 
ingestion. Vapor inhalation can burn the mucous membrane of the nose and throat. 
 
Ingestion 
Highly Toxic! Average lethal dose for inorganic mercury salts is about 1 gram. 
May cause burning of the mouth and pharynx, abdominal pain, vomiting, corrosive 
ulceration, bloody diarrhea. May be followed by a rapid and weak pulse, shallow 
breathing, paleness, exhaustion, central nervous system problems, tremors and collapse. 
Delayed death may occur from renal failure. 
 
Skin Contact 
Causes irritaton and burns to skin. Symptoms include redness and pain. May cause 
skin allergy and sensitization. Can be absorbed through the skin with symptoms to 
parallel ingestion. 
 
Eye Contact 
Causes irritation and burns to eyes. Symptoms include redness, pain, blurred 
vision; may cause serious and permanent eye damage. 
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Chronic Exposure 
Chronic exposure through any route can produce central nervous system damage. 
May cause muscle tremors, personality and behavior changes, memory loss, metallic 
taste, loosening of the teeth, digestive disorders, skin rashes, brain damage and kidney 
damage. Can cause skin allergies and accumulate in the body. Repeated skin contact can 
cause the skin to turn gray in color. Teratogen: can damage the developing fetus and 
decrease fertility in males and females. 
 
Aggravation of Pre-Existing Conditions 
Persons with nervous disorders, or impaired kidney or respiratory function, or a 
history of allergies or a known sensitization to mercury may be more susceptible to the 
effects of the substance.  
 
First Aid 
Signs and Symptoms of Acute Mercuric Chloride Exposure 
Signs and symptoms of acute exposure to mercuric chloride may be severe and 
include increased salivation, foul breath, inflammation and ulceration of the mucous 
membranes, abdominal pain, and bloody diarrhea. Dermal exposure may result in 
dermatitis (red, inflamed skin) and burns. Oliguria (scanty urination), anuria (suppression 
of urine formation), and acute renal failure may be noted. Weak pulse, seizures, psychic 
disturbances, circulatory collapse, chest pain, and dyspnea (shortness of breath) may be 
observed. 
 
Emergency Life-Support Procedures 
Acute exposure to mercuric chloride may require decontamination and life support 
for the victims. Emergency personnel should wear protective clothing appropriate to the 
type and degree of contamination. Air-purifying or supplied-air respiratory equipment 
should also be worn, as necessary. Rescue vehicles should carry supplies such as plastic 
sheeting and disposable plastic bags to assist in preventing spread of contamination. 
 
Dermal/Eye Exposure 
1. Remove victims from exposure. Emergency personnel should avoid self- exposure to 
mercuric chloride.  
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2. Evaluate vital signs including pulse and respiratory rate, and note any trauma. If no 
pulse is detected, provide CPR. If not breathing, provide artificial respiration. If breathing 
is labored, administer oxygen or other respiratory support.  
3.Remove contaminated clothing as soon as possible.  
4. If eye exposure has occurred, eyes must be flushed with lukewarm water for at least 15 
minutes. 
5. Wash exposed skin areas for 15 minutes with soap and water. 
6. Obtain authorization and/or further instructions from the local hospital for 
administration of an antidote or performance of other invasive procedures. 
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Pooram 
(Calomel)  
 
Siddha Aspect 
§µ® 
Hydragyrum Subchloride (Calomel) 
Cµ\®, E¨¦ CøÁPÎß TmiÚõÀ ö\´¯¨£kQßÓ \µUPõS®. 64 
£õhõn[PÐÒ Põn¨£hõv¸¢x® §µ® ©¸zxÁºPÍõÀ £õhõn 
ÁøPPÐÒ JßÓõP÷Á P¸u¨£kQßÓx.  
_øÁ&  E¨¦, Põº¨¦  
Ã¶¯®& öÁ¨£®  
¤¶Ä & Põº¨¦  
 
ö\´øP& Pkø©¯õÚ ÷{õ´PøÍ \©Ú® ö\´¯U Ti¯ ußø©²®, 
÷£vø¯ Esk£sq® Sn¬® Eøh¯x ÷©¾®, ¤zu }øµ 
AvP¨£kzx®, EhÀ÷uØÔ, EªÌ}ºö£¸UQ, Q¸ª{õ]Û ö\´øP 
Eøh¯x. 
ö£õx Sn®: 
CøhÁõu `ø» ö¯¶`ø» Sß©¢  
öuõøhÁõøÇ Áõu©õg ÷\õo & °øh¯õ÷uõ  
öÁõUSµ\ Pº¨§µ ö©õß÷Ó ¯ÍöÁõk{À  
CUSöÁÀ»z ÷uÊ{õ Ï'”. 
 ÷©¾® _µ®, ©g\mPõ©õø», ¤zu ÷uõh®, ^u÷£v, }ºU÷PõøÁ, 
Âµn\¢|, BÓõu Âµn[PÒ, ÷©PÂ¯õv, ö\¶¯õø©, RÀÁõu®, ö\õÔ, 
]µ[S, ©»£¢u®, uø»Á¼ w¸®. 
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_zv ¬øÓPÒ 
1. §µzøu J¸ \mi°À öÁØÔø» S¸P A¶¢x ÷£õmk ªÍS® 
Jøhzx Azxhß ÷£õmk 1/2  £i uspº ÂmkU Q¯õÇ©õUQ 
AvÀ §µzøu QÈPmi 3 {õÒ FÓøÁzx GkzxU öPõÒÍ 
_zv¯õS®. 
¯õ÷Põ¦ øÁzv¯® & 300 £UP Gs.5 
2. §µ® & 1 £»®, Jmi¼mk Ak¨÷£ØÔ 1/4  £i ¬_¬_UøPa\õÖ 
Âmk _¸US öPõkzx ¤ß 1/4 £i £õ¼À ¬ß÷£õ»÷Á _¸UQmk 
öPõÒÍÄ®. ¤ß ÷©÷» £i¢xÒÍ P¸UøP _µsi Pmiø¯ 
E£÷¯õQUPÄ®. 
AÝ÷£õP øÁzv¯ {Á}u®&£UP Gs.92 
3. §µ® & 1 £»® (]Ö xskPÍõP ö\´x ö©À¼¯ xo°À 
uÍºa]¯õP ¬i¯Ä®). J¸ ©s£õshzvÀ 2 £i £_®£õÀÂmk AvÀ 5 
£»® Pg\õ yÒ ö\´x (A) uspºÂmk Aøµzx ¬ß ¬i¨ø£ 
QÈPmi £õ¾USÒ öuõ[P ÂhÄ®. ¬i¨£õÚx £õøÚ°Úi°À  
£hõ©¼¸UPÄ®. £õÀ _si 1/4  £i C¸US® ÷£õx CÓUQ BÔÚ¤ß 
§µzøu _zv¯õUQÂk®. 
¯õ÷Põ¦ øÁzv¯® & 300 £UP Gs.91 
÷\¸® ©¸¢xPÒ 
{Á E¨¦ vµõÁP® 
 AÍÄ : 3&5 xÎ 
 AÝ£õÚ® : \»® 2 ÷ÁøÍ 
 w¸® ÷{õ´ : £UP`ø», ©õµøh¨¦, ©õº¦ ÷{õ´, Á°ØÖ ÷{õ´, 
¦Î÷¯¨£®, Ck¨¦ ÷{õ´, Áõ¢v, Aãµn®, Sh¼øµa\À Sn©õS®. 
Psq\õª¯® GßÝ® øÁzv¯ ÷\Pµ® £UP Gs.150 
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©PõÃµ ö©ÊS 
 AÍÄ : 1 &2 £¯ÓÍÄ 
 w¸® ÷{õ´ : Áõu ÷µõP®, ÷©P ÷µõP[PÒ w¸®. 
 £zv¯® : £õ¾® ÷\õÖ®. 
]zuøÁzv¯ vµmk £UP Gs.200 
§µ ©õzvøµ 
 AÍÄ : öPõzx©À¼ Âøu¯ÍÄ ©õzvøµ 
 AÝ£õÚ® :  ©õ¢u[PÐUS uUPÁõÖ Si}¶÷»Ý® _µ\zv÷»Ý® 
uµ»õ®. 
]zu øÁzv¯ vµmk £UP Gs.35 
Cµ\PØ§µU SÎøP 
 AÍÄ : 1 ©õzvøµ 2 ÷ÁøÍ 7 {õÒ 
 w¸® ÷{õ´ : ÁÎQµ¢v, C¼[P¨¦ØÖ, ö\õÔ, Qµõ¢v, ÷¯õÛ¨¦ØÖ, 
SÈ£mh Âµn®, SÈQµ¢v w¸®. 
Sn£õh® uõx ^Á ÁS¨¦ £UP Gs.286 
uõªµ ö©ÊS 
 AÍÄ : 1/2  & 3/ 4 SßÔ 2 ÷ÁøÍ, 5&7 {õÒ  
 AÝ£õÚ® : £øÚöÁÀ»® 
 w¸® ÷{õ´ : Sß©®, ö£¸Á°Ö, ¤i¨¦, Âµn®, _Áõ\Põ\®, vªº, 
ui¨¦, Áõu ÷µõP[PÒ w¸®. 
 £zv¯® : Ca\õ £zv¯® 
]Qa\õµzvÚ w£® £UP Gs.270 
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§µ {g_ SÔSn®: 
 ÂøµÁõP }¶À Pøµ¯õx. AvPÍÄ  Eh®¤ØSÒ ö\ßÓõÀ {g_z 
ußø©ø¯U Põmk®. 
 £À½ÖPÐ®, {õÄ®, Áõ²®, E¢v²®, uõøh°ß Em£UP¬® 
¦snõS®, Áõ´ vÓUP ¬i¯õx. 
 ¬PzvÀ ÷ÁºUS¸Ä®, £¸ÄshõS®. ©õº¤À £¸UPmi 
EshõQ¨ ¦snõS®. 
 Ck¨¤À Á¼ EshõS®. Âøµ Ã[S® 
 EsnõUS ¦s£k® 
 ÷£v°À Cµzu® Á¸® 
§µ {g_ ¬ÔÄ: 
 xÍ]a\õÖ (A) ]ØÓõ©nUS ö{´ (A) £õPÀ Cø»a\õÖ 
BQ¯øÁPÎÀ JßøÓU öPõkUP ÷Ási¯ ¬øÓ¨£i 3&5 {õÒ 
(A) {g_ w¸®Áøµ öPõkUP ÷Ásk®. 
 AÄ¶ ÷Áº¨£møhø¯ öÁ¢}º Âmhøµ¢x J¸ ÷ÁøÍUSa 
_søhUPõ¯ÍÄ Ãu® Põø»°¾® ©õø»°¾©õP {g_ w¸® Áøµ 
öPõkzx Áµ öÁsk®. 
 |»¨£øÚUQÇ[S, ÁÀ»õøµ ÷Áº, ö£õßÚõ[Põo ÷Áº, 
Psk£µ[Q ÷\ºzx Si}º ö\´x Põø»°¾®, ©õø»°¾©õP 2&3 
Áõµ® öPõkzxÁµ §µzvß ÃÖ uo²®. 
{g_ ¬ÔÄ ¡À £UP Gs.25,26 
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Modern Aspect 
Mercury I Chloride 
Calomel (Hg2Cl2), also called mercurous chloride or mercury(I) chloride,  a very 
heavy, soft, white, odourless, and tasteless halide mineral formed by the alteration of 
other mercury minerals, such as cinnabar or amalgams. Calomel is found together with 
native mercury, cinnabar, calcite, limonite, and clay at Moschellandsberg, Germany; 
Zimapán, Mexico; and Brewster county, Texas, U.S. 
Physical Characteristics 
 Color          : white, gray or yellow.  
 Luster   : Adamantine.  
 Transparency  : Crystals are translucent.  
 Crystal System : Tetragonal; 4/m 2/m 2/m  
 Crystal Habits  : Small tabular to pyramidal or horn-like crystals usually  
      seen as coatings or crusts on other minerals. 
 Cleavage  : Distinct in one direction.  
 Fracture  : Conchoidal.  
 Hardness  : 1 - 2.  
 Specific Gravity : 6.4 - 6.5 (very heavy for translucent minerals)  
 Streak   : white.  
 Density (measured) : 7.15 g/cm3 
 Density (calculated) : 7.23 g/cm3 
 Other Characteristics : Fluorescent red and crystals darken upon exposure to light 
over time.  
 Associated Minerals : mercury, cinnabar, metacinnabar and other mercury 
   minerals.  
 Notable Occurrences : Include Almaden, Spain; Idria, Serbia; Hunan Prov., 
China and New Idria, California, Oregon, Terlingua, Texas, and Arkansas, USA.  
 Best Field Indicators : Density, associations, fluorescence, hardness and crystal  
    habit. 
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Chemical Properties 
Formula   : (Hg2+)Cl2 
Essential elements  : Cl. Hg 
All elements listed in formula : Cl, Hg 
Uses 
 Calomel possesses certain special properties and uses in medicine which are dealt 
with here as a supplement to the general discussion of the pharmacology and 
therapeutics of mercury. Calomel exerts remote actions in the form of mercuric 
chloride.  
 The specific value of mercurous chloride is that it exerts the valuable properties of 
mercuric chloride in the safest and least irritant manner, as the active salt is 
continuously and freshly generated in small quantities.  
 Internally the salt is given in doses - for an adult of from one-half to five grains. It 
is an admirable aperient, acting especially on the upper part of the intestinal canal, 
and causing a slight increase of intestinal secretion. The stimulant action occurring 
high up in the canal (duodenum and jejunum), it is well to follow a dose of 
calomel with a saline purgative a few hours afterwards. The special value of the 
drug as an aperient depends on its antiseptic power and its stimulation of the liver. 
The stools are dark green, containing calomel, mercuric sulphide and bile which, 
owing to the antiseptic action, has not been decomposed.  
 The salt is often used in the treatment of syphilis, but is probably less useful than 
certain other mercurial compounds. It is also employed for fumigation; the patient 
sits naked with a blanket over him, on a cane-bottomed chair, under which twenty 
grains of calomel are volatilized by a spirit-lamp; in about twenty minutes the 
calomel is effectually absorbed by the skin.  
 Sometimes, calomel is also used as a teething powder for young children. 
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Toxicological Aspect 
Mercurous Chloride is a recognized developmental toxicant and exposure to it has 
the potential to negatively affect a developing baby. Developmental toxicity can include 
such things as low birth weight, birth defects, fetal death and behavioral and 
psychological problems. Sometimes the effects may not manifest until the baby becomes 
older. 
 
Routes of Entry 
Eye contact, Inhalation, Ingestion. 
 
Chronic Effects on Humans 
The substance is toxic to blood, kidneys, lungs, the nervous system, mucous 
membranes. 
 
Other Toxic Effects on Humans 
Very hazardous in case of ingestion. Hazardous in case of skin contact (irritant), 
of inhalation. Slightly hazardous in case of skin contact (permeator). 
 
Treatment 
 Identifying and removing the source of the calomel is crucial. Decontamination 
requires removal of clothes, washing skin with soap and water, and flushing the 
eyes with saline solution as needed. Inorganic ingestion such as mercuric chloride 
should be approached as the ingestion of any other serious caustic. Immediate 
chelation therapy is the standard of care for a patient showing symptoms of severe 
calomel poisoning or the laboratory evidence of a large total calomel load. 
 Chelation therapy for acute inorganic mercury poisoning can be done with 
DMSA, 2,3-dimercapto-1-propanesulfonic acid (DMPS), D-penicillamine 
(DPCN), or dimercaprol (BAL).  Only DMSA is FDA-approved for use in 
children for treating calomel poisoning.  
 Alpha-lipoic acid (ALA) has been shown to be protective against acute calomel 
poisoning in several mammalian species when it is given soon after exposure; 
correct dosage is required, as inappropriate dosages increase toxicity. Although it 
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has been hypothesized that frequent low dosages of ALA may have potential as a 
mercury chelator, studies in rats have been contradictory.   
 Glutathione and N-acetylcysteine (NAC) are recommended by some physicians, 
but have been shown to increase calomel concentrations in the kidneys and the 
brain.  Experimental findings have demonstrated an interaction between selenium 
and methyl mercury, but epidemiological studies have found little evidence that 
selenium helps to protect against the adverse effects of methyl mercury. 
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Thaalagam 
(Arsenic Trisulphide) 
 
Siddha Aspect 
¾¡Ç¸õ 
§ÅÚ ¦ÀÂ÷ 
À£¾¸¢, ¬ÄõÀ¢, À¢ïºÉõ, ÀØôÒ, §¸¡¾ó¾õ, Á¡Äõ, « ¾¡Ãõ, ¸¡øÒò¾¢, 
¦À¡ýÅ÷½¢, Á¡ø§¾Å¢, « ¾Çõ. 
Å¨¸¸û 
 Àò¾¢Ã ¾¡Ç¸õ- ¯¼ø §¾üÈ¢, ÍÃÁ¸üÈ¢ 
 À¢ñ¼ ¾¡Ç¸õ- Å÷½ ¦À¡Õû¸Ç¡¸×õ, ¾¡û¸¨Ç 
¯ÕÅ¸ôÀÎòÐÅ¾üÌõ, º¢¾ø âîº¢¸û À¡úÀÎò¾¡Áø À¡Ð¸¡ì¸×õ 
ÀÂýÀÎ¸¢ÈÐ. 
 
       º¢Åó¾ « ¾¡Ãõ-º¢Åó¾¸ø §À¡ø þÕôÀÐ 
       Á¼ø « ¾¡Ãõ-þÃñÎ ¸ÃÎ (¸ðÊ) þÕôÀÐ 
       ¦À¡ý «Ã¾¡Ãõ-¦À¡ý ¿¢ÈÁ¡¸ þÕôÀÐ 
       ¾¢ÃðÎ « ¾¡Ãõ-«Îì¸Îì¸¡¸ þÕôÀÐ  
±øÄ¡ Å¨¸¸Ùõ ´§Ã Ì¨½ò¨¾ ¯¨¼ÂÉ.þÅüÈ¢ø            
À¡ ¡½¡Óõ ¸ó¾¸Óõ ¸Äó¾¢Õì¸¢ýÈÉ. 
      º¢Åó¾ « ¾¡Ãõ,Á¼ø « ¾¡Ãõ ¬¸¢Â þÃñÎõ Á§É¡º¢¨Ä ±ýÚõ 
º¢Ä÷ ÜÚ¸¢ýÈÉ÷. 
¦ºö¨¸  
§¸¡¨ÆÂ¸üÈ¢,ÍÃÁ¸üÈ¢,Å¡ó¾¢ ¯ñ¼¡ì¸¢,¯¼ø§¾üÈ¢,¯¼ø ¯ÃÁ¡ì¸¢. 
 
¦À¡ÐÌ½õ: 
“¾¡Ç¸ò¾¢ý §ÀÕ¨Ãì¸ ¾¡Ö¸×û §¿¡öìÌ ¼õ 
¿£Çì ÌÇ¢÷¸¡öîºø ¿£Î¸Àõ - ¿¡Ç¸í ¦¸¡û 
Ð ¼ô ÀÈí¸¢ôÒñ ÝÆØ¸ñ Áñ¨¼ §¿¡ö 
¸¢ð¼ô ÀÎÀÁ¡ ¸¢ÇòÐ”. 
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¾¡Ç¸ò¾¢É¡ø ¿¡ìÌ, ¸À¡Äõ þ¨Å¸¨Çô ÀüÈ¢Â §¿¡ö, Ìð¼õ, 
ÌÇ¢÷ ÍÃõ, ¸Àõ, ãò¾¢Ã ¿¡Çò¨¾ô ÀüÈ¢Â ÀÈí¸¢ô Òñ, «Ø¸ñ, Áñ¨¼ 
§¿¡ö Ó¾Ä¢Â¨Å ¿£íÌõ. 
þÐ þÕõÒ¼ý ¸ÄóÐ ¸¢¨¼ì¸¢ýüÐ. ¸¨¼¸Ç¢ø Å¢ü¸ôÀÎõ ¦À¡ý 
¾¡Ç¸õ ÐÕì¸¢Â¢Ä¢ÕóÐ ÅÕÅ¾¡¸×õ ¦¾ ¸¢ÈÐ. ¾¡Ç¸õ ¸Éõ ¯¨¼ÂÐ. 
¦¿ÕôÀ¢Ä¢ð¼¡ø ¿£Ä ¿¢Èô Ò¨¸ ¸¢ÇõÒõ. 
 
Íò¾¢ Ó¨È¸û: 
 
 ¾¡Ç¸ò¨¾ À½õ§À¡Ä¦ÅðÊ, º£¨ÄÂ¢ø ÓÊóÐ, §¸¡ÁÂõ, ¸¡Ê, 
Íñ½ ¿£÷, âº½¢ì¸¡ö ¿£÷, ¬Å¢ý À¡ø, «ÃºõÀð¨¼ì ¸ ¡Âõ 
þ¨Å¸û ´ù¦Å¡ýÈ¢Öõ ¾É¢ò¾É¢Â¡ö °È¨ÅòÐò 
§¾¡Ä¡Âó¾¢ÃÁ¡¸ ¿£÷ Óì¸¡ø À¡¸õ ÍñÎõ Å¨Ã «Å¢òÐ ±Îì¸î 
Íò¾¢Â¡õ.  
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 328 
 
 ´Õ ÀÄõ ¾¡Ç¸ì ¸ðÊ¨Â ±ÎòÐ, Íñ½¡õÒì ¸øÄ¢ý þ¨¼Â¢ø 
¨ÅòÐô ÀÉí¸ûÇ¢É¡ø 10 ¾ÃòÐìÌ Ì¨ÈÂ¡Áø ¾¡Ç¢òÐ ±ÎòÐì 
¸ØÅ¢ ¯Ä÷ò¾¢ì ¦¸¡ûÇî Íò¾¢Â¡õ. 
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 328 
 
 ¿£üÈ¡¾ Íñ½¡õÒì ¸ø ¦¸¡ñÎ ÅóÐ ¸£§Æ ÀÃôÀ¢ «¾ý §Á§Ä 
Íñ½¡õÒì ¸ø §À¡ðÎ ¿¢ÃôÀ¢ ¸Ø¨¾ «Ó Å¢ðÎ Íñ½¡õ¨À 
¿£üÈ×õ. þôÀÊ 7 ¾Ãõ ¿£üÈ¢ ¾Ç¸ò¨¾ ±ÎòÐ ¿£ ø ¸ØÅ¢ ±Îì¸ 
Íò¾¢Â¡Ìõ. 
Â¡§¸¡Ò ¨Åò¾¢Âõ 300. Àì¸ ±ñ: 11 
 
 ÓýÒ Íò¾¢ò¾ ¾¡Ç¸ò¨¾ ±ÎòÐ âº½¢ÀÆò¨¾ §Á§Ä¸£È¢ 3 
ÅÃ¡¸¦É¨¼ þóÐôÒ «¾üÌû §À¡ðÎ «ÊÂ¢ø º¢ÚÐÅ¡Ãõ §À¡ðÎ 
¯ Â¢ø¨ÅòÐì ¸£§Æ À£í¸¡ý¨Åì¸ âº½¢ ¿£÷ þÈíÌõ. «ó¾ ¿£Õõ, 
¾Â¢Õõ, ¸¡ÊÔõ, Íñ½ ¿£Õõ, ¦¸¡ûÙì ¸¢Â¡ÆÓõ þù¨ÅóÐõ 
´ýÈ¡¸ ´Õ ºðÊÂ¢ÖûÇ «¸ò¾¢¸£¨Ã Å¢¨¾ò¾Â¢Äõ Å¡í¸¢ ´ýÚ 
§º÷òÐ 2 º¡Áõ ÍÕìÌ ¦¸¡ÎòÐ ±Îì¸î Íò¾¢Â¡Ìõ.   
Â¡§¸¡Ò ¨Åò¾¢Âõ 300. Àì¸ ±ñ: 11 
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 ¾¡Ç¸ò¨¾ì ¸üÍñ½ò¾¢Ä¢ðÎì ¸Ø¨¾ ¿£ Ä¢ðÎò ¾¡Ç¢òÐ 
±Îò¾¡ø Íò¾¢Â¡Ìõ 
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 329 
§ºÕõ ÁÕóÐ¸û 
1. À¡ ¡½ «ñ¼¨¾Äõ 
¾¢ÉÓõ 2 §Å¨Ç ¦ÅÇ¢ôÀ¢Ã§Â¡¸õ 
¾£Õõ §¿¡ö¸û: À¡ º Å¡¾õ, À¢ÊôÒ, ¸¢Ãó¾¢, ¦¸¡ÕìÌ, §Á¸ Å¡ö×, À¢ÊôÒ, 
§Á¸ Å¢Ã½õ. 
          ¸ñ½¢º¡Á¢Âõ ±ýÛõ ¨Åò¾¢Â §º¸Ãõ. Àì¸ ±ñ: 70 
2. ¾¡Ç¸ ÀüÀõ 
«Ç×:  2 - 3 « º¢ ±¨¼  
«ÛÀ¡Éõ: §¾ý, ¦¿ö 
¾£Õõ §¿¡ö¸û: Âõ, ¸¡ºõ, ®¨Ç, ÍÃõ, §Á¸Ã½õ, Òñ, Ò¨Ã¸û 
¸ñqº¡Á¢Âõ ±ýÛõ ¨Åò¾¢Â §º¸Ãõ. Àì¸ ±ñ: 99 
 
3.¸¡Ç§Á¸ ¿¡ÃÂ½ ¦ºóàÃõ 
«Ç×: 1/2 ÌýÈ¢ 
«ÛÀ¡Éõ: ¾¢ôÀ¢Ä¢ ¦À¡Ê 
¾£Õõ §¿¡ö¸û: Ìð¼õ, Å¢Ã½õ, ¸ÊÅ¢ õ, «¨ÈÂ¡ôÒ, ÒüÚ, À£É¢ºõ, 
¦¿ïÍ §¿¡ö, ¸¡¾¨¼ôÒ, Á¡Ã¨¼ôÒ ¾£Õõ. 
¸ñqº¡Á¢Âõ ±ýÛõ ¨Åò¾¢Â §º¸Ãõ. Àì¸ ±ñ: 120 
 
4. ¾¢Õã÷ò¾¢ ¦ºóàÃõ 
«Ç×: 1/4 - 1/2 ÌýÈ¢, 2 §Å¨Ç 
¾£Õõ §¿¡ö¸û: ÍÃõ, ºýÉ¢, À¡ º Å¡Ô, ®¨Ç, ÍÅ¡º¸¡ºõ. 
¸ñqº¡Á¢Âõ ±ýÛõ ¨Åò¾¢Â §º¸Ãõ. Àì¸ ±ñ: 164 
 
5. ÀïºÀ¡ ¡½î ¦ºóàÃõ 
«Ç×: À½¦Å¨¼  
«ÛÀ¡Éõ: §¾ý, þïº¢ º¡Ú 
¾£Õõ §¿¡ö¸û: ÒüÚ, ¸ñ¼Á¡¨Ä, Ì¨È§¿¡ö, « ¸ÃôÀ¡ý, «ñ¼Å¡¾õ, 
¸ýÉôÒüÚ, ¸À¡ÄÌð¼õ, À×ò¾¢Ãõ. 
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 346 
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6.Ý¨ÄÌ¼¡Ã Á¡ò¾¢¨Ã: 
«Ç×: ÌýÈ¢ «Ç× 
«ÛÀ¡Éõ: þïº¢ º¡Ú 
¾£Õõ §¿¡ö¸û: Ý¨Ä, ÌýÁõ 
º¢ò¾ ¨Åò¾¢Â ¾¢ÃðÎ. Àì¸ ±ñ: 63 
7.ºïº£Å¢ Á¡ò¾¢¨ Ã: 
«Ç×: ÌýÈ¢ «Ç×, 1 ÌÇ¢¨¸ 
«ÛÀ¡Éõ ÁüÚõ ¾£Õõ §¿¡ö¸û: º¡¾¢ì¸¡ö ÌÊ¿£÷- ãÄ Å¡ö×, º¢Õ¿£÷- ÀÄ 
Å¡Ô, ÀÆîº¡Ú- À¡õÒì¸Ê, ¦¿¡îº¢º¡Ú- ãÄ §¿¡ö, ÅÄ¢ ÌýÁõ, 
ÓÕí¨¸Àð¨¼ º¡Ú- Ý¨Ä ÅÄ¢ 
º¢ò¾ ¨Åò¾¢Â ¾¢ÃðÎ. Àì¸ ±ñ: 19 
  
¿ïÍìÌÈ¢Ì½õ: 
 ¿¸ì¸ñ¸Ç¢ø þÃò¾õ ÍÅÚ¾ø 
 ÀìÌ¸ðÊô Òñ½¡¸¢î º£ú ÅÊ¾ø 
 ÅÂ¢üÈ¢ø ± îºø, ÌÃø Á¡Èø 
 ãì¸¢Ä¢ÕóÐ þÃò¾õ À¡ö¾ø 
 «Õº¢, ¯½× §Åñ¼¡¨Á 
 ¾¨ÄÂ¢ø ¿¨Á ¯ñ¼¡¸¢ ÁÂ¢÷ Ó¨É º¢Åò¾ø 
 §Áø ÍÅ¡ºò¨¾ì ¸¢ÇôÀ¢ô Àó¾¢ì¸î ¦ºö¾ø 
 À¢Ã¨Á, «ÊÅÂ¢üÈ¢ø Å£ì¸î º¡Â¨Äì ¸¡ð¼ø 
 þ¨¼, Àì¸õ þ¨Å¸Ç¢ø ¾£Ã¡¾ ÅÄ¢¨Âì ¦¸¡Îò¾ø 
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 342 
ÓÈ¢×  
 º¢ò¾¢Ã ãÄ §Å÷ôÀð¨¼, Á¢ÇÌ, ¸È¢ÔôÒ þ¨Å¸Ç¢ø Ó¾ø þÃñÎõ 
¸¡øÀÄÓõ (8.75 ¸¢Ã¡õ), ãýÈ¡ÅÐ 1/8 ÀÄÓõ (4.37 ¸¢Ã¡õ) ÜðÊ, 
ÓýÉ¢Ãñ¨¼ì ÌÊ¿£ ðÎì ¸È¢Ôô¨Àî §º÷òÐì ¸¡¨Ä, 
Á¡¨Ä¸Ç¢ø, §¿¡Â¢ý Å¢¼ò¾ý¨ÁìÌ ²üÀ «¨Ã Áñ¼ÄÁ¡ÅÐ, 
Óì¸¡ø Áñ¼ÄÁ¡ÅÐ, ´Õ Áñ¼ÄÁ¡ÅÐ ¦¸¡ûÇò ¾£Õõ. 
 
 ¿£Ä¢§Å÷, ¬Å¡Ãõâ, ¦ÅðÊ§Å÷, º£Ã¸õ, Á¡Ð¨ÇÅ¢òÐ, 
¦¾ýÉíÌÕõ¨À, ¸¡º¢É¢§Å÷ þ¨Å¸¨Ç Å¨¸ìÌ ¸¡ø ÀÄõ 
ÜðÊì ÌÊ¿£÷ ¦ºö¾Õó¾ ¾¡Ç¸ò¾¡ø Å¢¨ÇÔõ ¿ïÍ ¾£Õõ.  
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. Àì¸ ±ñ: 342 
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Modern Aspect 
Arsenic Trisulfide 
Arsenic Trisulfide is an odorless, yellow or orange, crystalline powder. It is used 
in the manufacture of glass, oil cloth, linoleum, electrical semi-conductors, 
photoconductors, and fireworks, as a pigment, and in tanning and pesticides. 
Arsenic trisulfide is the inorganic compound with the formula As2S3. This bright 
yellow solid is a well known mineral orpiment (Latin: auripigment), has been used as a 
pigment, and has played a role in the analysis of arsenic compounds. Arsenic trisulphide 
is insoluble in water and so poorly absorbed. It therefore represents much less of an acute 
toxic hazard than soluble arsenic compounds. 
Synonyms 
 Kings gold 
 Arsenous sulphide 
 Arsenic sequisulphide 
 Diarsenic trisulphide 
 Arsenic sulphide 
 Arsenious sulphide 
Properties 
Group   : 15 or VA 
Atomic weight : 74.9216 
Period   : 4 
Molecular formula : AS2S3 
Molecular Weight : 246 (USCG, 1999)  
Odor Threshold : Odorless 
Flash Point  : Nonflammable 
Specific Gravity : 3.4 (water = 1) 
Water Solubility : Slightly soluble 
Boiling Point    : 707 oC 
Melting Point  : 300 oC 
Appearance and Odor : Yellow powder or crystal, rotten egg odor. 
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Structure 
As2S3 occurs both in crystalline and amorphous forms. Both forms feature polymeric 
structures consisting trigonal pyramidal As(III) centres linked by sulfide centres.  
Uses 
 As2S3 and As4S4 have been investigated as treatments for acute promyelocytic 
leukemia (APL). The mode of action is thought to be similar to that for As2O3. 
 The ancient Egyptians reportedly used orpiment, natural or synthetic, as a pigment 
in artistry and cosmetics. 
 Arsenic trisulfide is also used as a tanning agent. It was formerly used with indigo 
dye for the production of pencil blue, which allowed dark blue hues to be added to 
fabric via pencil or brush. 
 Precipitation of arsenic trisulfide is used as an analytical test for presence of 
dissimilatory arsenic-reducing bacteria (DARB). 
 It is added to animal food to prevent disease and to promote growth. 
 It is used in combination with other materials in pigments, poison gases and 
insecticides (such as Paris Green, calcium arsenate and lead arsenate) and is well 
known from former use as a rat poison. 
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Toxicological Aspect 
 Exposure to inorganic arsenic compounds in drugs, food, and water as well as in 
an occupational setting have been causally associated with the development of cancer, 
primarily of the skin and lungs.IARC has determined that there is sufficient evidence for 
carcinogenicity for arsenic compounds to humans. 
Effects of Exposure 
 Inorganic arsenic compounds are confirmed human carcinogens producing tumors 
of the mouth, esophagus, larynx, bladder and para nasal sinus.  A recognized 
carcinogen of the skin, lungs, and liver.  Poisoning from arsenic usually results 
from swallowing arsenic compounds; chronic poisoning from either swallowing 
or inhaling.  
Human Acute Toxicity 
Arsenic trisulfide can affect you when breathed in and may enter the body thought 
the skin. Arsenic trisulfide is a carcinogen; handle with extreme caution. Contact can 
cause burning, itching, thickened skin; rash and color changes. Exposure can irritate the 
nose and throat; and may cause an ulcer or hole in the inner nose. High or repeated 
exposures can cause disturbed sleep; “pins and needles,” numbness and weakness of arms 
and legs. High or repeated exposure can cause poor appetite; nausea, vomiting, diarrhea 
and death. 
 
Human Chronic Toxicity 
Arsenic trisulfide is a carcinogen in humans; it has been shown to cause skin, liver 
and lung cancer. It may be a teratogen, causing reproductive damage, such as reduced 
fertility and interference with the menstrual cycle. May cause liver damage and lower the 
red blood cell count. Repeated skin contact can cause thickened skin and pigmentation 
changes. Some persons develop white lines on the fingernails. High or repeated exposure 
can cause nerve damage with burning, “pins and needles” sensation and weakness of the 
extremities. 
 
 53 
 
Inhalation:  May cause chronic arsenic poisoning, ulceration of the nasal septum, liver 
damage and cancer/disease of the blood, kidneys and nervous system. 
Ingestion:  May cause chronic arsenic poisoning, gastrointestinal disturbances, liver 
damage and cancer/disease of the blood, kidneys and nervous system. 
Skin:  May cause irritation, occasional ulceration, spotty pigmentation, dermatitis, skin 
cancer and keratoses (especially on soles and palms). 
Eye:  No chronic health effects recorded. 
Medical Conditions Generally Aggravated by Exposure:  Pre-existing respiratory 
disorders. 
Emergency and First Aid Procedures 
Inhalation 
Remove to fresh air, keep warm and quiet, give oxygen if breathing is difficult and seek 
immediate medical attention. 
Ingestion 
Give 1-2 glasses of milk or water, DO NOT Induce vomiting.  Seek medical attention 
immediately. 
Skin 
Remove contaminated clothing, brush material off skin, and wash area with soap and 
water, seek medical attention immediately. 
Eyes 
Flush eyes with lukewarm water, lifting upper and lower eyelids, for at least 15 minutes 
and seek medical attention. 
Treatment 
Chelation 
Chemical and synthetic methods are now used to treat arsenic poisoning. 
Dimercaprol and dimercaptosuccinic acid are chelating agents which sequester the arsenic 
away from blood proteins and are used in treating acute arsenic poisoning. The most 
important side effect is hypertension. Dimercaprol is considerably more toxic than 
succimer.  
 Mineral supplements 
Supplemental potassium decreases the risk of experiencing a life-threatening heart 
rhythm problem from arsenic trioxide.  
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Nutritional intervention 
Rats daily dosed with arsenic in their water, in levels equivalent to those found in 
groundwater in Bangladesh and West Bengal were found to respond to garlic extracts, 
with 40 percent less arsenic in their blood and liver, and passed 45 percent more arsenic 
in their urine. The conclusion is that sulfur-containing substances in garlic scavenge 
arsenic from tissues and blood. 
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Gandhagam 
(Sulfur) 
 
Siddha Aspect 
P¢uP® 
÷ÁÖ ö£¯º: 
 Põ¶øÇ°ß {õu®, £øµ Ã¶¯®, Azu¨ ¤µPõ\®, ¥á®, ö\ÀÂ Â¢x, 
\Uv, \Uv ¥\®, ö\¢yµzuõv, uÚ®, ÷uÂ²µ®, {õu®, {õØÓ®, £øµ {õu®, 
ö£õßÁºo, Cµ\ _÷µõou®. 
_øÁ :   øP¨¦, xÁº¨¦ 
ö\´øP : ¤zu}º ö£¸UQ, ©»ªÍUQ, EhÀ÷uØÔ, Â¯ºøÁ ö£¸UQ, 
Q¸ª{õ]Û 
 Â¯ºøÁ, £õÀ, ]Ö}º Áõ°»õP öÁÎ¨£kÁøuU Põn»õ®. 
 ÷uõÀ, A_P[PÎß \Îa \ÆÂ¾ÒÍ ÷PõÍ[PÎß _µ¨ø£ 
AvP¨£kzx®. 
 Â÷µQ°À ]Ó¨£õPa ö\¯À£mk _µ¨ø£ AvP¨£kzx®. 
 P¢uPzøu AvP AÍÂÀ A¸¢u ÷£vø¯ Esk£sq®. 
ÁøPPÒ :  64 ÁøP £õhõn[PÐÒ JßÖ. 
 4 ÁøP¨£k® 1. ¤Ó¨¦ P¢uP® 
2. øÁ¨¦ P¢uP® 
3. ÷PõÈzuø» öP¢v øÁ¨¦ 
4. ÁõnöP¢v øÁ¨¦ 
* öÁsø© |Ózøu²øh¯x; GÀ»õ ÷{õ´PøÍ²® wºUS®. 
* QÎ US ]Á¨¦ |Ózøu²øh¯x, {Á÷»õPzøu H©©õUS®. 
 56 
 
* ö£õßø© |Ó¬øh¯x. SØÓ©ØÓ ö{À¼UPõ´ ÷£õßÖ C¸US®, 
`uz÷uõk EÓÁõQa _zu©õ´ C¸US®. 
* PõPzvß |Ózøu²øh¯x; AP¨£hõx; AP¨£mhõÀ {øµ vøµPÒ 
AØÖ¨÷£õS®. 
QøhUS® Ch[PÒ: 
÷{£õÍ®, Põè«º, B¨PõÛìuõÚ®, £º©õ ¬u¼¯ Ch[PÎÀ P¢uP® 
QøhUQßÓx. 
ö£õx Sn®: 
""ö{À¼UPõ´U P¢vUS }Ò£vöÚs Smh©¢u® 
ÁÀø» PÂø\Sß© Áõ²Ps÷nõ -´& ö£õÀ»õ  
ÂhUPiÁß ÷©P÷{õ´ ÃÖ_µ® ÷£v 
vhUQµP pP£®÷£õ¢ ÷uº'' 
 ö{À¼UPõ´ P¢uPzvÚõÀ £vönßSmh®, ©¢u® PÀ½µÀ, 
ÃUP®, ö£¸Á°Ö, Sß©Áõ², Ps÷nõ´PÒ, ÂåUPiPÒ, ÷©P 
÷{õ´PÒ, Áõu _µ®, ÷£v {õm£mh QµPo P£® }[S®. 
""ÁõnU SÇõ´UP¢v Áõ\øÚø¯U PshÄhß 
PõnU Q¸ª ö\õÔ PõnõÁõ®& ÷uõq®  
ö£¸Â¯õ vUTmh® ÷£¸©u Þ¼ß 
©¸Â¯õ Ê[öPõi÷¯ ÁõÌzx''.  
 P¢uP®, uõ´ ©PøÁ ÁÍº¨£x ÷£õ» ÷{õ´PÎß öÁ¨£zøu ©õØÔ 
Eh®ø£z ÷uØÖÂUS®. 
P¢uP _zv ¬øÓPÒ: 
 P¢uPzøu, J¸ \mi°À £_®£õø»Âmk \mi°ß ÷©÷» xo°À 
÷ÁkPmi Azxo÷©À P¢uPzøu¨ £µ¨¤ Auß÷©À PÁ\® 
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÷£õmk i Ak¨÷£ØÔ AÂUP P¢uP® ¯õÄ® E¸Q¨ £õ¼À 
ÂÊ®. C¨£i 7 ¬øÓ ö\´¯Ä®. 
¯õ÷Põ¦ øÁzv¯® & 300 £UP Gs.10 
 ¦Î¯®£Ç ÷Áõmøh¨ £ØÔ°¸US® P]øÁ FÓøÁz |Özu }º, 
Põi}º, ¦Îzu÷©õº, PõÍõß \õÖ uÛzuÛ 6 £õP©õP GkzxU 
P»¢x J¸ \mi°¼mk Aa\miUS ^ø»°ÚõÀ ÷Ák Pmi, 
Auß÷©À J¸ £»® P¢uPzøu øÁzx ÷©À i, Ak¨÷£ØÔ 
w£õUQÛ¯õ´ Cµsk \õ©® G¶UP, ©¼Ú® ÷©À u[Q P¢uP® 
RÈÓ[S®. 
Sn¨£õh® uõx ^Á ÁS¨¦ £UP Gs.304 
 ©¸÷uõßÔ PØPzøu £_Âß u°¶À P»¢x, J¸ \mi°¼mk 
^ø»¯õÀ ÷Ák Pmi, ÷©À P¢uPzøu øÁzx ©ØöÓõ¸ \mi¯õÀ 
ia ^ø» ö\´x, SÈ°À ¦øuzx, ÷©À \mi÷©À 5 ÁÓmi 
öPõsk ¦hªh, P¢uP® E¸Q RÈÓ[S®. CÆÂu® 7 ¬øÓ 
ö\´¯Ä®. 
Sn£õh® uõx ^Á ÁS¨¦ £UP Gs.305. 
 £õ¾US¨ £vÀ, ÁõøÇUPmøh }¶À öP¢vø¯¨ 10 ¬øÓ E¸UQ 
E¸UQa \õ´zöukUPa _zv¯õ®. 
Sn£õh® uõx ^Á ÁS¨¦ £UP Gs.305 
÷\¸® ©¸¢xPÒ: 
1. P¢uPz øu»®  
AÍÄ: 7&8 xÎ ÷ÁøÍUS   
 AÝ£õÚ®: öÁÒøÍ \ºUPøµ  
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 w¸® ÷{õ´PÒ : Qµõo, vªº, Smh®, Sß©®, ö\®£øh, P¸®£øh, 
FÓÀ, £øh, `ø», ¦s¦øµPÒ, ¦ØÖ, Psh©õø» w¸®. 
Psq\õª¯® GßÝ® øÁzv¯ ÷\Pµ® £UP Gs.47 
2. BÖ¬Paö\¢yµ® 
 AÍÄ : 1/4  & 1/2  SßÔ 
 AÝ£õÚ® :  ÷uß, ö{´ 
 w¸® ÷{õ´PÒ : £õsk, Á°ØÖÁ¼, G¶a\À, ÷uPSzuÀ, ÷\õøP, 
Sß©®, _µUPmi, Áõu÷µõP[PÒ, ©÷Põuµ®. 
Psq\õª¯® GßÝ® øÁzv¯÷\Pµ® £UP Gs.107 
3. ÷©P]¢uõ©o ö\¢yµ® 
 AÍÄ : SßÔ, 2 ÷ÁøÍ 
 AÝ£õÚ® : ö{´, öÁsön´ 
 w¸® ÷{õ´ : }¶¾ÒÍ CÛ¨¦, ÷uP AÇø», uõP®, öÁS zvµ®, 
\Uv SøÓÄ Sn©õS®. 
 Psq\õª¯® GßÝ® øÁzv¯ ÷\Pµ® £UP Gs.113. 
4. åmSna ö\¢yµ® 
 AÍÄ : 1/4  SßÔ  ¤µ©õÚ® 
 AÝ£õÚ® : ö{´, ÷uß 
 wµ® ÷{õ´ : ÷£v, Qµõo, »®, ÷©P Âµn®, ö£¸®£õk. 
5. PõÍ÷©P {õµõ¯n ö\¢yµ® 
 AÍÄ :  1/2  SßÔ 
 AÝ£õÚ® : v¨¤¼ ö£õi 
 59 
 
 w¸® ÷{õ´ : Smh®, Âµn®, PiÂå®, Aøµ¯õ¨¦, ¦ØÖ, ¥Û\®, 
ö{g_÷{õ´, Põuøh¨¦, ©õµøh¨¦ w¸®. 
Psq\õª¯® GßÝ® øÁzv¯ ÷\Pµ® £UP Gs.120. 
6. ]ÁÚõº Aªºu® 
 AÍÄ : £nöÁøh 
 w¸® ÷{õ´ : 20 ÁøP P£®, 80 ÁøP Áõu[PÒ, 40 ÁøP ¤zu[PÒ, 
Smh®, Sß©®, \ßÛ, »÷µõP®, Aµøn, ÷uÒ ¬u¼¯ PiÂh[PÒ, 
S©µPsh Á¼ }[S®. 
Sn£õh® uõx ^Á ÁS¨¦&£UP Gs.350 
7. £g\£õåõn ö\¢yµ® 
 AÍÄ : £nöÁøh 
 AÝ£õÚ® : ÷uß, Cg] \õÖ 
 w¸® ÷{õ´PÒ : Psh©õø», SøÓ ÷{õ´, A¶Pµ¨£õß, ÷u©À, 
ÁskPi, PÇÀÁõu®, AshÁõu®, £Äzvµ®, Qµ¢v, Aøµ¯õ¨¦, 
»¬øÍ w¸®. 
Sn£õh® uõx ^Á ÁS¨¦ & £UP Gs.285 
P¢uP {g_ SÔSn® 
 PsPÒ ©g\Ò |Ó©õP¨ §zv¸US®. 
 Eh®¦ uß C¯ØøP JÎ SßÔ ¥ºUP®§¨ ÷£õßÓ 
|Ó©øh¢v¸US®. 
 £ØPÒ PÖzx¨ £õ]¯øh¢x C¸US®. 
 CøhÂhõ©À Â¯ºøÁ EshõS®. 
 ]Ö}º öÁÒÍõmk }øµ¨ ÷£õßÔ¸US®. 
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 ©»® \õ©¢v¨ §øÁ¨ ÷£õßÖ ©g\Ò |Ó©õP C¸US®. Áõ°À 
¦øP {õØÓ¬shõS®. 
{g_ ¬ÔÄ ¡À £UP Gs.27 
{g_ ¬ÔÄ: 
 BÁõµ® ÷Áº, øu÷ÁøÍ ÷Áº,  }¼÷Áº, _US, £¸zvCø» 
]Ö{õP¨§ ¬u¼¯ BÖ ö£õ¸mPøÍ²® Si}¶mk uµ P¢uPU 
SØÓ® }[S®. 
 uõ©øµ Âzøu CÍ}¶À Aøµzxsnz w¸®. 
 ªÍS, }¼÷Áº, ^µP® \¶ö¯øh Gkzx Si}¶mk öPõkUP P¢uP 
{g_ ¬øÓ²®. 
 ©nzuUPõÎ ÷Áº£møh 10 Qµõ®, A¶]z v¨¤¼ 10 Qµõ®, 
Av©xµ® 10 Qµõ® BQ¯ CøÁPøÍ Si}¶mk 1 ©sh»® 
AÀ»x ÷{õ´ }[S® Áøµ Põø» ©õø» uµÄ®. 
{g_ ¬ÔÄ ¡À £UP Gs.27,28 
 
 
 
 
 
] 
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Modern Aspect 
Sulfur 
Pure Sulfur is bright yellow. The color may be altered if impurities are present. 
Sulfur often occurs in petroleum deposits, where it is found coated with greasy black 
petroleum.  
Sulfur is soft, light in weight, and very brittle. Care must be exercised when 
handling and storing specimens. When kept moist or not allowed to dry when wet, 
hydrogen will mix with the Sulfur, forming hydrogen sulfide (H2S), which causes the 
deterioration of a specimen. To prevent this, Sulfur should not be stored under humid 
conditions..  
Sulfur is an essential element for all life, and is widely used in biochemical 
processes. In metabolic reactions, sulfur compounds serve as both fuels and respiratory 
(oxygen-alternative) materials for simple organisms. Sulfur in organic form is present in 
the vitamins biotin and thiamine.Sulfur is an important part of many enzymes and in 
antioxidant molecules like glutathione and thioredoxin. Organically bonded sulfur is a 
component of all proteins, as the amino acids cysteine and methionine. Disulfide bonds 
are largely responsible for the mechanical strength and insolubility of the protein keratin, 
found in outer skin, hair, and feathers, and the element contributes to their pungent odor 
when burned. 
Physical Characteristics 
 Color is a strong yellow color in thick crystals and duller yellow in small crystals 
to pale yellow in massive or powdery forms. Can also be reddish or greenish 
yellow with impurities.  
 Luster is vitreous to more often resinous or earthy in massive forms.  
 Transparency is transparent to translucent.  
 Crystal System is orthorhombic 
 Crystal Habits include mostly massive or powdery forms but well shaped blocky 
crystals are common. Crystals can be made up of two dipyramids, one with 
steeper faces than the other, prisms and/or pinacoids in various combinations.  
 Cleavage is very poor in two directions.  
 62 
 
 Fracture is conchoidal.  
 Streak is yellow.  
 Hardness is 2.  
 Specific Gravity is 2.0 - 2.1 (well below average)  
 Associated Minerals are celestite, calcite, aragonite and gypsum.  
 Other Characteristics: odor (see above), poor heat conductivity makes it brittle 
when heated and can actually crack if held tightly in a person's hand.  
 Notable Occurrences include Michigan and Ohio, USA; Sicily; Poland and 
Chile.  
 Best Field Indicators are color, odor, heat sensitivity, lack of good cleavage and 
crystal habit.  
Chemical Properties 
Atomic number    : 16 
Atomic mass     : 32.06 g.mol -1 
Electronegativity according to Pauling : 2.5 
Density     : 2.07 g.cm -3 at 20 °C 
Melting point     : 113 °C 
Boiling point     : 445 °C 
Vanderwaals radius    :  0.127 nm 
Ionic radius     : 0.184 (-2) nm ; 0.029 (+6) 
Isotopes: 5 
Electronic shell    :  [Ne] 3s23p4 
Energy of first ionization   : 999.3 kJ.mol -1 
Energy of second ionization   : 2252 kJ.mol -1  
Energy of tird ionization   : 3357 kJ.mol-1  
Standard potential    : - 0.51 V 
Discovered by    : The ancients 
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Occurrence, Localities and Origins 
Sulfur occurs most abundantly around hot springs in regions of active or extinct 
volcanoes in connection with volcanoes, as a result of fumerole action. It is also found in 
beds associated with limestone and gypsum.. 
Sources 
The vast majority is produced as a by-product of oil refining and natural gas 
processing. As part of four amino acids, sulfur is readily available in protein foods-meats, 
fish, poultry, eggs, milk, and legumes .Other foods that contain this somewhat smelly 
mineral are onions, garlic, cabbage, brussels sprouts, and turnips. Complete vegetarians  
and people on low-protein diets may not get sufficient amounts of sulfur; the resulting 
sulfur deficiency is difficult to differentiate clinically from protein deficiency. 
Applications 
The major derivative of sulphur is sulphuric acid (H2SO4), one of the most 
important elements used as an industrial raw material. Sulphur is also used in batteries, 
detergents, fungicides, manufacture of fertilizers, gun power, matches and fireworks.  
Health Effects of Sulphur 
All living things need sulphur. It is especially important for humans because it is 
part of the amino acid methionine, which is an absolute dietary requirement for us. The 
amino acid cysteine also contains sulphur. The average person takes in around 900 mg of 
sulphur per day, mainly in the form of protein. 
Elemental sulphur is not toxic, but many simple sulphur derivates are, such as 
sulphur dioxide (SO2) and hydrogen sulfide. 
 
Globally sulfuric substances can have the following effects on human health 
 
- Neurological effects and behavioral changes 
- Disturbance of blood circulation 
- Heart damage 
- Effects on eyes and eyesight 
- Reproductive failure 
- Damage to immune systems 
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- Stomach and gastrointestinal disorder 
- Damage to liver and kidney functions 
- Hearing defects 
- Disturbance of the hormonal metabolism 
- Dermatological effects 
- Suffocation and lung embolism 
 
Effects of sulfur on the environment 
 
Sulfur can be found in the air in many different forms. It can cause irritations of 
the eyes and the throat with animals, when the uptake takes place through inhalation of 
sulfur in the gaseous phase.  
Laboratory tests with test animals have indicated that sulfur can cause serious 
vascular damage in veins of the brains, the heart and the kidneys. These tests have also 
indicated that certain forms of sulfur can cause foetal damage and congenital effects. 
Mothers can even carry sulfur poisoning over to their children through mother milk. 
 
Uses 
 In its elemental form, sulfur was used for many disorders during the nineteenth 
century. In the twentieth century, the focus is more on the sulfur-containing amino 
acids, used internally; or as elemental sulfur-containing ointments used for skin 
disorders such as eczema, dermatitis, and psoriasis.  
 Joint problems may be helped by chondroitin sulfate, which is found in high 
amounts in the joint tissues. Oral sulfur as sulfates in doses of 500-1,000 mg. may 
also reduce symptoms in some patients. Magnesium sulfate, which is not 
absorbed, used as a laxative. Taurine, another sulfur-containing amino acid, used 
in epilepsy treatment, usually along with zinc. A physiologic form of sulfur called 
methylsulfonyl methane (MSM) has recently become available and may be 
helpful in patients with allergies. 
 Used for treatment of Itchy skin or scalp, Psoriasis, Dermatitis, Eczema, Acne, 
Diaper rash, Coughs, Colds, Migraine headaches, Flatulence, Indigestion, 
Vomiting, Diarrhea, Hemorrhoids, Impotence in men, Painful and irregular 
menstruation, Sore throat, Toothache, Nosebleeds, Measles, Joint pain, Hay fever, 
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Fever (hot and cold sweats), Bedwetting, Furuncles, Breastfeeding problems, 
Cystitis. 
 It is used in the manufacture of black powder, matches and explosives. It is also 
used to create rubber, in dyes, and as an insecticide and fungicide also used in the 
manufacturing of sulfuric acid. 
 In recent years, the benefits of garlic have been widely studied. Research suggests 
that the beneficial effects of garlic in lowering cholesterol levels and blood 
pressure are likely due to the sulfur it contains. 
 It can also help gynecological problems such as premenstrual syndrome and 
menopausal discomforts. 
Side Effects 
Side effects such as skin dryness, itching, swelling and irritation while using 
sulfur to treat skin problems, says the University of Pittsburgh Medical Center. Applying 
sulfur to broken, wounded, sunburned or otherwise irritated skin can worsen the 
irritations. Don't cover the skin area with bandages or gauze after applying sulfur, because 
this could cause over-absorption. 
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Toxicological Aspect 
Acute toxicity 
 Sulfur is known to be of low toxicity, and poses very little if any risk to human 
and animal health. Short-term studies show that sulfur is of very low acute oral 
toxicity and does not irritate the skin (it has been placed in EPA Toxicity Category 
IV, the least toxic category, for these effects). Sulfur also is not a skin sensitizer. 
However, it can cause some eye irritation, dermal toxicity and inhalation hazards.  
 When taken orally, it has a mild laxative action. Acute exposure inhalation of 
large amounts of the dust may cause catarrhal inflammation of the nasal mucosa 
which may lead to hyperplasia with abundant nasal secretions. Trachiobronchitis 
is a frequent occurrence, with dyspnea, persistent cough and expectoration which 
may sometimes be streaked with blood. 
Chronic toxicity 
 Chronic exposure to elemental sulfur at low levels is generally recognized as safe. 
Epidemiological studies show that mine workers exposed to sulfur dioxide often 
had eye and respiratory disturbances, chronic bronchitis and chronic sinusitic 
effects. However, no known risks of oncogenic, teratogenic, or reproductive 
effects are associated with the use of sulfur. Also, sulfur has been shown to be 
non-mutagenic in microorganisms.  
 Repeated or prolonged exposure to dust may cause irritation to the mucous 
membranes. Bronchopulmonary disease may occur which, after several years, 
may be complicated by emphysema and bronchiectasis. Asthma is a frequent 
complication.  
 Organ Toxicity: Pulmonary function may be reduced. Radiological examinations 
have revealed irregular opacities in the lungs and occasionally nodulation has 
been reported, but not true nodular fibrosis 
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Manosilai 
(Arsenic Disulfide) 
 
Siddha Aspect 
©÷Úõ]ø» 
÷ÁÖ ö£¯º: 
 ]ø», ÂÀ, S{i, {õß¬Pß, ÷uÛ, \µ÷\õv, Áõo, öÁÒÍa], 
uõ©øµÁõ]Û. 
ö\´øP: 
 EhÀ÷uØÔ, öÁ¨£PØÔ, EhÀ Eµ©õUQ 
ÁøPPÒ: 
 Cx ¤ÓÂa \µUS, øÁ¨¦a  \µUS GÚ C¸ ÁøP¨£k®. 
 5 £[S öÁÒøÍ £õhõn¬®, 3 £[S P¢uP¬® ÷\º¢ux øÁ¨¦ 
\µUS. 
]Á¢u A¶uõµ®, ©hÀ A¶uõµ®, Svøµ¨£À £õhõn® CøÁPÒ 
©÷Úõ]ø»ø¯U SÔUS®. 
ö£õx Sn®: 
""öPõi¯ Sèh® Põ´a\À {kUP»á PÀ¼°øµ¨  
¦a]»¢v¨ ÷£]Ö© ÷Úõ]ø»US¨ ÷£_''. 
 Smh ÷uõÀ, SÎºPõ´a\À, Cøµ¨¦, ]»¢v {g_, SÇ¢øuPÐUS 
EshõS® öPõ¨¦Í® ¬u¼¯Ú ÷£õUPUTi¯x. 
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_zv ¬øÓPÒ: 
1. ©÷Úõ]ø»ø¯ J¸ \mi°À ¦ÎzuPõiÂmk  ©÷Úõ]ø»ø¯U 
QÈPmi öÁÒÍõmk A¬¶ø¯ J¸ \mi°À Âmk AvÀ ©¸¢øu 
x»õ¯¢vµ[Pmi G¶zx GkUP _zv¯õS®. 
¯õ÷Põ¦ øÁzv¯® & 300 £UP Gs.10 
2. Cg]a\õÖ, £Ça\õÖ, £_Âß÷©õº CøÁPÎÀ JßøÓ 
©÷Úõ]ø»USÂmk, 1 \õ©® {ßÓõ´ Aøµzx E»ºzv GkU 
_zv¯õS®. 
Sn£õh® uõx ^Á ÁS¨¦&£UP Gs.347 
3. ©÷Úõ]ø» 1 £»®, 5 £»® ¦Îzu ÷©õºÂmk ©÷Úõ]ø»z 
xskPøÍ Cmk öÁ´°¼À øÁzx QÍÔU öPõkUP ÷Ásk®. 
©õø»°À Gkzx }¶¼mkU PÊÂ ¬ßÚÍÄ ¦Îzu ÷©õºÂmk, 
©Ö{õÒ öÁ´°¼À øÁzx ¬ß ÷£õ» ö\´¯Ä®. CÆÂu® 3 ¬øÓ 
ö\´¯ _zv¯õS®. 
Sn£õh® uõx ^Á ÁS¨¦ & £UP Gs.347 
4. 5 £»® öPõi÷Á¼ ÷Áº¨£møhø¯ 3/4  £i }¶¼mk ßÔÀ 
JßÓõPU Põ´a] AvÀ 1 £»® ©÷Úõ]ø»z xskPøÍ Si}¶À 
£k®£i ÷uõ»õ¢vµ©õP }º_sk® Áøµ G¶UPÄ®. ¤ÓS J¸ 
£õshzvÀ  BmkU öPõÊ¨¦ 2 £»® Cmk ©÷Úõ]ø»z 
xskPøÍz xo°À ¬i¢x ÷£õmk xo P¸S®Áøµ 
ÁÖzöukzx Gsön´ £ø\ }[P xo¯õÀ xøhzxU öPõÒÍ 
÷Ásk®. Ca_zv, øÁzv¯ Cµ\Áõu ¬øÓPÐUS¨ £¯ß£k®. 
Sn£õh® uõx^Á ÁS¨¦ £UP Gs.348 
5. ©÷Úõ]ø» 2 £»zøu QÈPmi¨ ö£s öÁÒÍõmk zvµ® 1¼ 
£i°À ÷uõ»õ¯¢vµ©õ´ }º _sk® Áøµ A¶zx PÊÂ Gkzx, 
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PÀÁzv¼mk öÁÒÍõmk¨ ¤zx }º Âmk Aøµzx ]Ö 
ÂÀø»PÍõPa ö\´x öÁ°¼À E»ºzvU PÀÁzv¼mk 
¬ß÷£õ»¨ ¤zx}º Âmk Aøµzx E»ºzvU öPõÒÍÄ®. CÆÂu® 
7 ¬øÓ ö\´¯Ä®.  
Sn£õh® uõx ^Á ÁS¨¦ & £UP Gs.348 
÷\¸® ©¸¢xPÒ: 
1. PõÍ÷©P {õµõ¯n ö\¢yµ® 
 AÍÄ:  1/2  SßÔ 
 AÝ£õÚ® : v¨¤¼ ö£õi v¶ Pi AÍÄ 2 ÷ÁøÍ 15 {õÒ. 
 w¸® ÷{õ´ : Âµn®, PiÂå®, Aøµ¯õ¨¦, ¦ØÖ, ¥Û\®, ö{g_ 
÷{õ´, Põuøh¨¦, ©õµøh¨¦ w¸®. 
Psq\õª¯® GßÝ® øÁzv¯÷\Pµ® £UP Gs.120 
2. {Á £õåõnz øu»® 
 ¤µ÷¯õP® : Cøu ÷©¾USz ÷u´¨£uÚõÀ øP, PõÀ ¤i¨¦, 
Søha\À ¬u»õÚ \P» Áõu ÷µõP¬® w¸®. 
]Qa\õµzÚ w£® £UP Gs.205. 
3. Âèq \UPµ ©õzvøµ 
 AÍÄ :  SßÔ¯ÍÄ 
 AÝ£õÚ® : Cg] }º, ÷uß, v¶PkSzyÒ 
 w¸® ÷{õ´ : £UPÁõu®, ÂUPÀ, ÷\õø£, \ßÛ 13, H¨£®, ºaø\, 
Áõ² }[S®. 
]zu øÁzv¯ vµmk £UP Gs.44 
4. ©uÚ øÁµÁ® 
 AÍÄ :  \nÀ Âzx ¤µ©õn ©õzvøµ 
 AÝ£õÚ® : v¶PkS Si}º 
 70 
 
 w¸® ÷{õ´ : D¯a]zu¤µø© w¸®. 
]zu øÁzv¯ vµmk £UP Gs.37 
5. ñ¯ S»õ¢uPa ö\¢yµ® 
 AÍÄ : uUPAÍÄ,  AÝ£õÚ® : v¶PkS, ÷uß 
 w¸® ÷{õ´ : Põ\®, å¯®, _Áõ\®, P£÷{õ´PÒ w¸®. 
 £zv¯® : öÁÒÍõmh¨ £õÀ TmhÄ®, {õÍÍÄ : 10  
]zu øÁzv¯ vµmk £UP Gs.155 
6. Pzy¶ Pk¨¦ 
 AÍÄ : 1/2  1 SßÔ 
 AÝ£õÚ® : ÷uß, ¬ø»¨£õÀ, Cg]}º 
 w¸® ÷{õ´ : \Î, _µ®, C¸©À, Cøµ¨¦, P£÷{õ´PÒ w¸®. EhÀ 
]À¼mhõÀ CuøÚ öPõkUP `møh EshõUS®. 
]zu øÁzv¯ vµmk £UP Gs.326 
{a_ ¬ÔÄ: 
 _snõ®¦ öuÎ }º, BÁõµ® §, ^µP®, Põ]Û Âøu CÁØÔß 
Q¯õÇ[PøÍ öPõkUPÄ®. 
Âåªzu £uõºzu[PÐUS ¬ÔÄ £UP Gs.31 
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Modern Aspect 
Arsenic disulfide 
 An orange, red, or black compound As 4S 4, As 2S 2, or AsS occurring native as 
arsenic disulfide, also prepared artificially. Arsenic disulphide is insoluble in water and so 
poorly absorbed. It therefore represents a much less acute toxic hazard than soluble 
arsenic compound. 
Synonyms 
Red Arsenic glass, Realgar, red arsenic sulphide, arsenic sulfide, arsenic sulphide, 
Properties 
This product is massive or granular aggregates, irregular lumps. Dark red or orange-red, 
pale orange, streak, crystal face of diamond-like luster. Brittle, fragile, broken mask resin-
like luster. Slight specific odor, and tasteless. Ore powder, powdered or powder 
aggregates, quality crisp, hand pinching Serve pink, orange and yellow, dull. 
Molecular Weight : 139.0516 g/mol  
Molecular Formula : AsS2 
mp  : 360°C 
bp  : 565°C 
Density : 3.5 
Appearance :  red lustrous monoclinic crystals 
Fp  : 565°C 
Merck  : 13,804 
Stability : Stable. Forms explosive mixtures with potassium nitrate;  ignites in  
     chlorine. 
Physicochemical Properties 
Red lustrous monoclinic crystals. The main components of arsenic disulfide ore, 
orange powder, toxic, density of 3,4-4,6, melting point 307 ° C, insoluble in water for 
paint pigments, rodenticides and used for tanning, fireworks, etc. arsenopyrite ore and 
pyrite can be calcined sublimate formed. 
. Brittle, low melting point. Heated with charcoal, will emerge garlic odor of white 
smoke.. Arsenic disulfide is mainly produced in the low-temperature hydrothermal 
deposits, often with orpiment, stibnite, cinnabar symbiotic; arsenic disulfide produced in 
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the sediments of hot springs and sulfur volcanic jet hole sediments, often associated with 
orpimentsymbiosis.. 
Mechanism of action 
Arsenic disulfide and its metabolites disrupt ATP production through several 
mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase 
and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting 
energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. 
Hydrogen peroxide production is also increased, which might form reactive oxygen 
species and oxidative stress. Arsenic's carginogenicity is influenced by the arsenical 
binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. The 
binding of other arsenic protein targets may also cause altered DNA repair enzyme 
activity, altered DNA methylation patterns and cell proliferation. 
Uses 
 High-grade arsenic disulfide and orpiment ore for direct use as traditional Chinese 
medicine, and arsenic in Chinese products, drug name is arsenic. Arsenic disulfide ore 
powder can be used in the manufacture of firecrackers, fireworks and mosquito coils. 
 Insecticide detoxification, dampness expectorant, cut malaria. For carbuncles boils, 
Snake bites, insect abdominal pain, panic epilepsy, malaria. 
 Expectorant Anticonvulsant for Tansheng convulsions 
 Insecticide treatment sore for insects scabies disease 
 Used in the treatment of mumps. 
 Anti-tumor effect, can inhibit the growth of transplanted mouse sarcoma S-180, and 
the cells have a corrosive effect. 
 Absorption, antispasmodic, analgesic effect on the nerve; in vivo both insecticidal 
effect. Flooding agents against Staphylococcus aureus, human Mycobacterium 
tuberculosis, Proteus, green pus cocci, and a variety of fungal skin have different 
degrees of inhibition. 
 Baidu cancer, expectorant Anticonvulsant, insecticide sore treatment, anti-
inflammatory swelling back. 
 In Indian Ayurvedic medicines, arsenic disulfide is also a major component in 
bhasmas.  
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Toxicological Aspect 
Signs and Symptoms 
Symptoms of arsenic poisoning begin with headaches, confusion, severe diarrhea, 
and drowsiness. As the poisoning develops, convulsions and changes in fingernail 
pigmentation called leukonychia may occur. When the poisoning becomes acute, 
symptoms may include diarrhea, vomiting, blood in the urine, cramping muscles, hair 
loss, stomach pain, and more convulsions. The organs of the body that are usually 
affected by arsenic poisoning are the lungs, skin, kidneys, and liver.The final result of 
arsenic poisoning is coma to death. 
 
Dermal exposure 
 Arsenic compounds are irritating to the skin and mucous membranes 
withdermatitis the most common feature following occupational exposure. Erythema, 
burning and itching, eczematous eruptions and folliculitis are typical. 
 
Ocular exposure 
       Most injuries result from exposure to dusts, causing conjunctivitis, lacrimation, 
photophobia, and chemosis. 
 
Inhalation 
 Rhinitis, pharyngitis, laryngitis and tracheobronchitis may occur. Tracheal and 
bronchial haemorrhage may complicate severe cases. 
 
Ingestion 
 Insoluble, poorly absorbed compounds such as arsenic disulphide represent less 
of a toxic hazard than water soluble arsenic species. However, substantial ingestions may 
produce serious systemic toxicity. 
 
Gastrointestinal toxicity 
 Nausea, vomiting, abdominal pain and diarrhoea are likely after substantial 
arsenic disulphide ingestion. Other features include burning of the mouth and throat with 
dysphagia and hypersalivation. Gastrointestinal haemorrhage may lead to cardiovascular 
collapse.  
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Hepatotoxicity 
  Hepatic transaminase activities were moderately increased on admission 
(aspartate aminotransferase 206 IU/L). 
 
Nephrotoxicity 
 Hypotension or rhabdomyolysis following substantial arsenic disulphide 
ingestion may precipitate renal failure.  
 
Cardiovascular toxicity 
 Tachycardia is typical in cases of arsenic intoxication and is contributed to by 
anxiety, intravascular fluid depletion and possibly a direct cardiotoxic effect. 
 
Neurotoxicity 
 Acute substantial arsenical ingestion has caused muscle cramps, a sensorineural 
hearing deficit (Goldsmith and From, 1980), encephalopathy and seizures.A peripheral 
sensory and/or motor neuropathy has been described in survivors of severe acute arsenic 
poisoning although this is more typical following chronic exposure. 
 
Multi-organ toxicity 
 Severe acute arsenic poisoning may result in death from cardiorespiratory or 
hepatorenal failure. 
 
Peripheral Vascular and Cardiovascular toxicity 
 "Black foot disease" refers to a severe form of peripheral vascular disease seen 
in Taiwan in those who drink artesian well water with an high arsenic concentration. 
Initial paraesthesia and cold sensitivity progress to ulceration and gangrene (Chiou et al, 
1995). It has been suggested that mortality due to all vascular diseases may be increased 
in these populations. 
 Raynaud's syndrome has also been described in those chronically exposed to 
arsenic dust. 
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Haemotoxicity 
 Investigations in chronic arsenic poisoning often show anaemia, neutropenia, 
pancytopenia or evidence of haemolysis but macrocytosis without anaemia (Heaven et al, 
1994) and a myelodysplastic syndrome have been reported. 
Chronic arsenic exposure complicated by aplastic anaemia may predispose to acute 
myeloid leukaemia. 
 Disrupted haem metabolism with altered urinary porphyrin excretion has been 
reported. 
 
Endocrine toxicity 
 Epidemiological evidence from Taiwan and an occupational study among 
smelter workers in Sweden recently have associated chronic arsenic exposure with the 
development of diabetes mellitus. 
 
Treatment 
Chelation 
Chemical and synthetic methods are now used to treat arsenic poisoning. 
Dimercaprol and dimercaptosuccinic acid are chelating agents which sequester the arsenic 
away from blood proteins and are used in treating acute arsenic poisoning. The most 
important side effect is hypertension. Dimercaprol is considerably more toxic than 
succimer.  
 Mineral supplements 
Supplemental potassium decreases the risk of experiencing a life-threatening heart 
rhythm problem from arsenic trioxide.  
Nutritional intervention 
Rats daily dosed with arsenic in their water, in levels equivalent to those found in 
groundwater in Bangladesh and West Bengal were found to respond to garlic extracts, 
with 40 percent less arsenic in their blood and liver, and passed 45 percent more arsenic 
in their urine. The conclusion is that sulfur-containing substances in garlic scavenge 
arsenic from tissues and blood. The presentation concludes that people in areas at risk of 
arsenic contamination in the water supply should eat one to three cloves of garlic per day 
as a preventative. 
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Common Salt 
(Sodium Chloride) 
Siddha Aspect 
PÔ E¨¦ 
Sodium Chloride 
Common Salt 
÷ÁÖ ö£¯º : 
 PÔ²¨¦, ÷\õØÖ¨¦, Ph¾¨¦, Ãmk¨¦, C»Án®, \¬zvµ »Án® 
Sn® : E¨¤ØS ©nªÀø». 
_øÁ :  P¶¨¦. 
ußø© : GÎvÀ }¶À Pøµ²®, \õµõ¯zvÀ Pøµ¯õx. 
ö\´øP : £]zwzysi, ©»® ÷£õUQ, Áõ¢v EshõUQ, ¦ÊUöPõÀ¼, 
¬øÓöÁ¨£PØÔ. 
E¨¤ß ö£õx Sn® :  
AÍzv¾øÓ {À¾¨ £ÚÀ Áõu® ©õØÖ[  
PÍzx ÷{õ´ ußøÚ PøÍ²[- QøÍzuP£  
B_øh¯ ÁÀø» ÷{õ´ AèhSß© ¬®÷£õUS[  
Põ]Û²Ò ©õ÷u PÇÖ.  
¤zuÁõu®, PshUPÇø», P£®, PÀ½µÀ ÷{õ´, GsÁøP Sß©® w¸®. 
PÔ²¨¤ß Sn® : ©¢u®, ö£õ¸©À, Áõ²Ä®, P£®, }[S®. }µøh¨¦ 
w¸®. £]²® \©õUQÛ²® AvP¨£k®. 
 
 
 77 
 
_zv ¬øÓPÒ :  
 E¨ø£ 7 £[S }º (A) Põi}º Âmk Pøµzx ÁiPmi Põ´a] SÇ®¦ 
£USÁzvÀ CÓUQ, CÍg`miÀ £Ça\õÖ (A) ÷©õº ]ÔxÂmk 
öÁ´°¼À Põ¯ øÁUP E¨¦ EøÓ²® 10 ¬øÓ ö\´¯ _zv¯õS®. 
 E¨ø£ PhÀ}º (A) ©øÇ}º Âmk Pøµzx ÁiPmi Põ´a] SÇ®¦ 
£USÁzvÀ CÓUQ öÁ´°¼À Põ¯øÁzx GkUP E¨¦ EøÓ¢x 
_zv¯õS®. 
Sn¨£õh® uõx ^Á ÁS¨¦ & £UP Gs. 386. 
÷\¸® ©¸¢xPÒ :  
 PÔ E¨¦ vµõÁP® 
AÍÄ  : 5 xÎ 
AÝ£õÚ® : }º 
w¸® ÷{õ´ : ©¢uõUQÛ, xº£»®, Áõu÷{õ´, ö\¶¯õø© ¬u¼¯ 
÷{õ´PÒ w¸®. 
Sn¨£õh® uõx ^Á ÁS¨¦. £UP Gs. 391. 
 E÷»õP ©slµ ö\¢yµ® : 
w¸® ÷{õ´ : £õsk, ÷\õø£, Põ©õø», ©÷Põuµ®. 
]zu øÁzv¯ vµmk £UP Gs.141 
 {ÁE¨¦ ö©ÊS : 
AÍÄ & ªÍPÍÄ 
{õÍÍÄ & 1/4 ©sh»® 
w¸® ÷{õ´PÒ : `ø», ©÷Põuµ®, Á¼Sß©®, Qµ¢v, ÷©P®, 
}ºU÷PõøÁ, EuµÁõ², ÂhÁõu®, AshÁõu®, Á¼Áõu®, `uPÁõ² 
w¸®. 
Sn¨£õh® uõx ^Á ÁS¨¦ £UP Gs.406 
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E¨¦ {g_ SÔSn® : 
 Áõ¢v 
 Á°öÓ¶a\À 
 PÈa\À 
 }º¨ö£¸US 
 Eh®¦ uÍºa] }[S® 
{g_ ¬ÔÄ : 
 S¨ø£÷©Û Cø»a\õÖ & Põø», ©õø» 80 ª¼ uµÄ®. 
 uõøÇ ÂÊvß \õÖ & Põø», ©õø» 80 ª¼ uµÄ®. 
 ]Ô¯ A®©õß £a\¶] Cø»ø¯ Aøµzx ÷ÁøÍUS 
öPõmøh¨£õUPÍÄ {g_ }[S® Áøµ uµÄ®. 
{g_ ¬ÔÄ ¡À £UP Gs.31 
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Modern Aspect 
Sodium chloride 
Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic 
compound with the formula NaCl, representing equal proportions of sodium and chloride. 
Sodium chloride is the salt most responsible for the salinity of the ocean and of the 
extracellular fluid of many multicellular organisms. As the major ingredient in edible salt, 
it is commonly used as a condiment and food preservative. 
Uses 
 Sodium chloride (salt) is used to replace low levels of sodium in the body and to 
wash out wounds and remove foreign bodies from eyes. It is also used to mix with 
other medicines before they are given to patients. Sodium chloride in water is 
known as saline solution.  
 It is a type of electrolyte, sometimes known as a salt.  
 Sodium chloride in water (saline solution) is used to wash out wounds and eyes, 
especially if there is a foreign body, such as grit, in them.  
 It is also used to make up drug solutions. Sodium chloride injection is used to 
replace sodium that has been lost from the body. Sodium chloride tablets are used 
for the treatment and prevention of a lack of sodium chloride in the body (sodium 
chloride deficiency).  
 In general this drug is used as a wash for the eyes and wounds, to make up drugs 
in solution and to replace lost sodium chloride in the body.  
 Benefits of being on this drug can include replacement of sodium chloride in the 
body and sterile removal of foreign material from eyes and wounds. 
Over dose 
Taking too much sodium chloride injection may cause the following: feeling and 
being sick, diarrhoea, stomach cramps, thirst, reduced production of sweat and tears, 
sweating, fever, signs of low blood pressure (hypotension), such as dizziness and light-
headedness, fast heart beat (tachycardia), swelling, breathing problems, headache, 
restlessness, irritability, muscular twitching and rigidity, weakness, kidney problems, 
convulsions, coma. 
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Pirandai 
(Cissus quadrangularis) 
 
Siddha Aspect 
¤µsøh 
÷ÁÖ ö£¯º : Áa]µÁÀ¼. 
ÁÍ¸ªh® : C¢v¯õ, C»[øP ¬u¼¯ Ch[PÎÀ öÁ¨£ £õP[PÎÀ 
HµõÍ©õ´ EshõS®. 
ÁÍ¶¯À¦ : öPõi°Ú®. 
¤¶ÄPÒ : Kø»¨ ¤µsøh, E¸søh¨ ¤µsøh, ¬¨¤µsøh, 
\xµ¨¤µsøh, PÎ¨¤µsøh, w®¤µsøh, ¦Î¨¤µsøh. 
ö\´øP : EhØ÷ÓØÔ, ¸xÄshõUQ, £]zwzysi 
ö£õx Sn® :  
¤µsøhø¯ ö{´¯õÀ ÁÖzx¨ ¤ßÚøµzx ©õ÷u ! 
öÁ¸sihõ ÷uØÖ ÂÊ[QÀ & AµskÁ¸® 
»z vÚÁh[S® »Â µzu©Ö® 
bõ»zv ÝÒ÷Í {ÂÀ. 
CuÚõÀ G¸Áõ´ vÚÄ, S¸v »® JÈ²®. ÷©¾® ©¢u®, Sß©®, 
ÁÎUQÈa\À, ¬øÚ »®, PõÀ K´a\À }[S®. £] EshõS®. 
©¸zxÁ £¯ßPÒ : 
 ÁhP® & I¯÷{õ´PÐ®, ö\¶¯õø©²® ÷£õS®. 
 ¤µsøhø¯a ]Ö w°¼mk ÁuUQ \õÖ ¤È¢x PõvÀ 1&2 xÎ 
Âh Põx ^Ì ©õÖ®. 
 UQÀ Âh a]À Ái²® S¸v ©õÖ®. 
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 uUP AÍÂÀ öPõkUP `uPzøu \¶¨£kzx®. 
 ÷Áøµ E»ºzv ö£õizx 2 Qµõ® öPõkzxÁµ, ¬Ô¢u G¾®¦PÒ 
^UQµ® Tk®. 
 ]Ö xsk _snõ®¦ }¶À FÓøÁzx ÷ÁøÍUS JßÔµsk 
\õ¨¤h £]ø¯z ysk®. 
÷\¸® ©¸¢xPÒ : 
 ¤µsøh Si}º : Áõ´Ä ÷£õS®, Á°ØÖ¨ ¦ÊUPÒ öÁÎ¨£mk 
Âk®. 
 ¤µsøh `µn® :  
AÍÄ : ö{À¼UPõ¯ÍÄ.  
w¸® ÷{õ´PÒ : P£\ßÛ, ¤zuÁõu®, Eh®¦Á¼, Eß©zu® w¸®. 
 ¤µsøh ÁhP® :  
w¸® ÷{õ´PÒ : Sß©®, ÁÀø»UPmi ¬u¼¯ Euµ ÷{õ´PÒ 
}[S®. £], w£Ú® ¬u¼¯Ú EshõS®. 
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Modern Aspect 
Cissus quadrangularis 
 
Botanical name  : Cissus quadrangularis 
Family   : Vitaceae 
Actions   : Alterative, Emmenogogue, Stomachic. 
Medicinal Uses : 
1. The stem of the plant is used to bandage the part of body subjected to fracture or 
any bone injury. 
2. The oil prepared from juice of this plant and gingilee oil is externally applied over 
fractured part. 
3. The stem and leaf of plant is ground and the extracted juice along with equal 
quantity of honey is given in dose of 15-30 ml for irregular menstruation. 
4. Any disorders of ear like pus discharge or ear ache, can be cured by heating the 
stem in little flame extracting the juice and using it as ear drops. 
5. The dried root powder can be given in dose of 1-3 gm and this can also be applied 
externally after mixing with hot water for bone fracture. 
6. For digestive problems, the fresh leaves are dried, powdered and given along with 
powdered chukku (dried ginger) and powdered milagu (pepper). 
Cissus quadrangularis has been used as a medicinal plant since antiquity. In 
siddha medicine it is considered a tonic and analgesic, and is believed to help heal broken 
bones, thus its name asthisamharaka (that which prevents the destruction of bones). It is 
said to have antibacterial, antifungal, antioxidant, anthelmintic, antihemorrhoidal and 
analgesic activities.   
It has been found to contain a rich source of carotenoids, triterpenoids and 
ascorbic acid.  Its bactericidal effects on Helicobacter pylori hold promise as a potential 
treatment of gastric ulcers in conjunction with NSAID therapy.  A weight loss supplement 
containing Cissus quadrangularis and other ingredients including green tea, soy, 
selenium, chromium, and B vitamins was evaluated in an 8-week trial. The supplement 
helped reduce body weight by 4-8% ( placebo 2.4%) a clinically significant weight loss. 
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Betle Leaf 
Siddha Aspect 
 
öÁØÔø» 
(Pipper Betle, Linn.) 
÷ÁÖ ö£¯º : 
 uõ®§»®, uõ®§»ÁÀ¼, vøµ¯À, {õPÁÀ¼, ö©À¼ø», 
öÁÒÎø», ö©À»hS. 
ÁÍ¸ªh® : C¢v¯õÂÀ öÁ¨£ £õPzv¾® \x¨¦ÒÍ Ch[PÎ¾® £°º 
ö\´¯¨£k®. 
ÁÍ¶¯À¦ : ©µ÷©Ö® öPõi. 
ÁøPPÒ : Cø»°ß ©nzuõ¾®, |Ózuõ¾®, Põº¨¦ _øÁ¯õ¾® ßÖ 
ÁøP¨£k®. 
1. ªS¢u ©n¬®, Põµ¬®, P¸¨¦ |Ó¬® CÀ»õux "öÁØÔø»' 
2. P¸ø©²® Põµ¬® ªS¢ux & "P®©õÖ öÁØÔø»' 
3. P¸¨§µ ©n¬®, ]ÖPõµ¬¬øh¯x & "P¸¨§µ öÁØÔø»' 
£¯ß£k® EÖ¨¦ : Cø». 
_øÁ : ÂÖÂÖ¨¦, Põº¨¦ 
ußø© : öÁ¨£® 
¤¶Ä : Põº¨¦ 
ö\´øP : öÁ¨£¬shõUQ, APmkÁõ´ÁPØÔ, xÁº¨¤, Põ©® 
ö£¸UQ, AÊP»PØÔ, öÁ¨£PØÔ, £]zwzysi, £õØö£¸UQ, 
EªÌ}º¨ö£¸UQ. 
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ö£õx Sn® : 
 I¯® AÖ[Põs Auß\õµ[ öPõshUPõØ 
 ø£¯a \°zv¯®÷£õ® ø£¢öuõi÷¯ ! & ö©´°ß 
 Pi°ß Sn® ÷£õS[ PõµöÁØÔ ø»US¨ 
 £i²¬z ÷uõhªøu¨ £õº 
 öÁØÔø»°ß Cµ\zøu¨ £¸QÀ I¯®, \°zv¯®, PõnõUPi, 
¬¨¤o CøÁPÒ JÈ²®. 
©¸zxÁ¨ £¯ßPÒ : 
 £õuµ\® öÁØÔø» \õØÓõÀ y´ø©¯õS®. 
 öÁØÔø»a \õØÔÀ öPõg\® ÷Põ÷µõ\Ú® ÷\ºzx¨ ¦Pmh 
÷PõøÇUPmk, C¸©À, a_vnÓÀ Sn©õS®. 
 öÁØÔø»a \õØÖhß Cg]a\õÖ® ÷\ºzx ~øµ±µÀ \®£¢u©õP 
÷{õ°À ÁÇ[P»õ®. 
 CÍ® öÁØÔø»U öPõi ÷ÁÖ® ªÍS® ÷\ºzxa \õ¨¤mk Áµ 
©»møh EshõUS®. 
 öuõsøh Aøh¨¦, SµØP®©¼À öÁØÔø»ø¯²® \õ®¤µõo 
£u[Pzøu²® ö©ßÖ _øÁUS®£i ö\´¯»õ®. 
 öÁØÔø»ø¯ Põ´a_UPmi ÷\ºzx EshõÀ Aø\ÄØÓ £ØPÒ 
CÖS®. 
 ]Ö¤ÒøÍPÐUS EshõS® Á°ØÖö£õ¸©À, ©»UPmk 
CøÁPøÍ¨ ÷£õUP öÁØÔø»U Põ®ø£ B©nUS ö{´°À 
{øÚzx RÌÁõ°À øÁUP»õ®. 
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 £õÀ_µUPÄ®, £õÀ Pmi EshõS® ¬ø» ÃUPzøu PøµUPÄ® 
öÁØÔø»ø¯z un¼À Áõmi AkUPkUPõP øÁzx Pmh»õ®. 
 §µ _zvUS, P®©õÖ öÁØÔø» £¯ß£kQÓx. 
÷\¸® ©¸¢x :  
 Cµ\U PØ§µU SÎøP : 
AÍÄ : _søhUPõ¯ÍÄ (1 ©õzvøµ) 
2 ÷ÁøÍ, 7 {õÒ A¸¢uÄ®. 
w¸® ÷{õ´ : ÁÎUQµ¢v, C¼[P¨¦ØÖ, ö\õÔ, Qµ¢v, 
÷¯õÛ¨¦ØÖ, SÈ¨£mh Âµn®, SÈQµ¢v w¸®. 
Sn£õh® &uõx^Á ÁS¨¦ & £UP Gs. 285 
 £g\£õåõna ö\¢yµ®   
AÍÄ : £nöÁøh  
AÝ£õÚ® : ÷uß, Cg]\õÖ. 
w¸® ÷{õ´PÒ : \ßÛ, _µ®, öÁsSmh®, `ø», Áõ², Áõu®, ÷©P®, 
Sß©®, Qµõo, øPPõÀ ¬hUS, ¤ÍøÁ, ¦ØÖ, Psh©õø», SøÓ÷{õ´, 
A¶Pµ¨£õß, ÷u©À, ÁskPi, PÇÀÁõu®, PßÚ¨¦ØÖ, AshÁõu®, 
»¬øÍ w¸®. 
Sn£õh® uõx^Á ÁS¨¦ & £UP Gs. 346. 
 Cµ\z øu»®  
AÍÄ : 1/4 £»® 
w¸® ÷{õ´ : ~nõUPõ´ Qµ¢v Âµn[PÒ }[SÁuõS®. 
Sn£õh® uõx ^Á ÁS¨¦ & £UP Gs. 264. 
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Modern Aspect 
Piper Betle (or) Chavica Bettle, Miq. 
Vernacular name  
 Tamil  : Vettilai 
 Sanskrit : Tambula, Nagavalli 
 Hindi  : Pan Tamboli 
 English : Betel – leaf pepper 
 Telugu  : Naga – valli 
Habitat : Twinning plant cultivated very extensively in the warm & moist parts of South 
India & Ceylon for its leaves. 
Part used : Leaves & fruit. 
Constituents : Leaves yield aromatic essential volatile oil of sharp burning taste, 
aromatic odour. 
 Beetle oil contains also terpene and sesque terpene. 
 Beetle – phenol (chavi betol) 
 Alkaloid “arakene” 
 Chavicol – a phenol powerful antiseptic. 
Uses : 
 Diastase in the betel leaves likely to play an important part in starch digestion. 
 Warm leaves application to the chest in cases of bronchitis, difficulty of breathing 
and in coughs, especially those of infancy and childhood. 
 Warm polutice consisting of 2 parts of leaf juice and 1 part of hydrated slaked 
lime may be applied useful in sore throat laryngitis and bronchitis and over 
enlarged glands. 
 Leaf juice dropped into ear relieve ear ache, dropped into the eye for painful eye 
affections. 
 Leaf juice an ounce 3 times a day useful in general debility and is esteemed as an 
aphrodistac. 
 87 
 
Honey 
Siddha Aspect 
§¾ý 
 
¸¢ÕÀ¡¸Ã ºñÓ¸ ¦ºóàÃò¾¢ø §¾ý «ÛÀ¡ÉÁ¡¸ô ÀÂýÀÎ¸¢ÈÐ. 
§¾É£ì¸û §º÷òÐ ¨ÅìÌõ §¾ý ÜðÊÄ¢ÕóÐ §¾ý ±Îì¸ô ÀÎ¸¢ÈÐ 
 
Ò¾¢Â §¾É¡ÉÐ þÉ¢ôÀ¡Ôõ, þÇÁïºû ¿¢ÈÁ¡Ôõ þÕìÌõ. þ¾¢ø 
«¨ÉòÐ ºòÐì¸Ùõ þÕì¸¢ýÈÉ. þÐ 12 ¿¡Æ¢¨¸Â¢ø º£Ã½Á¡¸¢Å¢Îõ.  
 
¦ºö¨¸ 
¯ûÇÆÄ¡üÈ¢, ÁÄÁ¢Çì¸¢, ÐÅ÷ôÀ¢, «Ø¸Ä¸üÈ¢, §¸¡¨ÆÂ¸üÈ¢, 
§À¡º½¸¡ , Àº¢ò¾£àñÊ, àì¸Óñ¼¡ì¸¢ 
 
ÁÕòÐÅô ÀÂý¸û 
 
 §¾¨É ÌÆó¨¾¸ÙìÌ ¦¸¡Îì¸ «Ð º¢Ú ¿£¨Ã 
«¾¢¸ôÀÎòÐÅ§¾¡Î ÅÂ¢üÚ ¦À¡ÕÁ¨ÄÔõ ¾ÎìÌõ. 
 
 þ§Ä¸¢Âõ, À¡½¢¾õ, ¦ÁØÌ, ¦ºöÂ ÀÂýÀÎ¸¢ÈÐ. 
 
 ÀüÀõ, ¦ºóàÃõ, ÝÃ½õ, Á¡ò¾¢¨Ã¸ÙìÌ §¾ý ´Õ «ÛÀ¡ÉÁ¡¸ 
§º÷òÐì ¦¸¡ûÇôÀÎ¸¢ÈÐ. 
 
 ÌÆó¨¾¸Ç¢ý þÕÁÖìÌ §¾ý 2 «×ýÍ «øÄÐ ±ÖÁ¢îºõ ÀÆÃºõ 
ÜðÊ ¦¸¡Îì¸×õ. 
 
 ÍÅ¡º¸¡º §¿¡Â¢ø ÁÄò¨¾ì ¸Æ¢ì¸ º¢üÈ¡Á½ìÌ ¦¿ö ¸ÄóÐ 
¦¸¡Îì¸ §ÅñÎõ. 
 
 §¾¨É À¡Éõ ¦ºöÐ Åó¾¡ø ¸Àô À¢½¢¸û ¿£íÌõ ±ýÀ¨¾ 
"þÈ×Ç÷ «Ó¨¾¨Â þÈ×Ç¾¡ìÌõ" ±ýÈ ¸ ºø «ÊÂ¡ø 
«È¢ÂÄ¡õ. 
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 §¾¨É À¡÷Ä¢ ¸ïº¢Ô¼ý ¸ÄóÐ ÁÄÀó¾õ, ¦º Â¡¨Á, ¿£÷ì§¸¡¨Å, 
¦¾¡ñ¨¼ Å¢Ãñõ Ó¾Ä¢Â §¿¡ö¸ÙìÌ ¦¸¡Îì¸Ä¡õ. 
 
 þ¨Çò¾ ¯¼õÀ¢É÷ìÌõ, þ¾Âò¨¾ô ÀÄôÀÎò¾×õ ÅÆí¸Ä¡õ. 
 
 Å§Â¡¾¢¸÷¸ÙìÌì ¸¡Ïõ §¸¡¨Æ¨Â «¸üÈ¢, ¯¼Ä¢ø ¦ÅôÀò¨¾ 
¯ñÎÀñÏÅ¾üÌõ 
 
 ºì¾¢¨Â «¾¢¸ôÀÎòÐÅ¾üÌõ §¾ý ÀÂýÀÎ¸¢ÈÐ. 
 
 ÁÐ§Á¸ §¿¡Â¢ø ÅÆí¸ôÀÎõ ÁÕóÐ¸Ç¢ø §¾ý ´Õ Óì¸¢Â 
¦À¡ÕÇ¡¸ ÀÂýÀÎ¸¢ÈÐ. 
 
 §¾Û¼ý Íñ½¡õÒ ÜðÊ ¸ðÊ¸ÙìÌõ, ÀØôÀ¾ü¸¡¸×õ 
¾¼ÅÄ¡õ. 
 
 Å¡öì ¦¸¡ôÀÇ¢ìÌõ ÌÊ ¿£Õ¼ý §¾¨É ÜðÊ ¦¸¡ÎôÀÐñÎ. 
 
 ÅÂ¢Ú Å£ì¸ò¾¢ø «¾ý Á£Ð §¾¨É ¾¼Å¢ ÅÃ ÅÄ¢ Ì¨ÈóÐ, Å£ì¸õ 
ÅÊÔõ.  
 
 ¾£îÍð¼ Òñ, ¦Åó¿£÷ ÀÎÅ¾¢É¡ø ¯ñ¼¡Ìõ Òñ þ¨Å¸ÙìÌ 
§¾ý §À¡ðÎ ÅÃ º£ì¸¢Ãò¾¢ø ¬Úõ. 
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Modern Aspect 
Honey 
 Honey is obtained from “Bees”. Various ingredients of honey have helped it to 
become not only a sweet liquid but also a natural product with high nutritional and 
medicinal value. The medicinal quality, taste, texture, colour, aroma, of honey differs 
according to the geographical area and the species of plants from which it has been 
collected. 
Contents of Honey 
 Sugars like fructose, glucose, sucrose, maltose, lactose and other disaccharides 
and trisaccharides. 
 Vitamins like thiamin, riboflavin, niacin, pyridoxine, pantothenic acid, B12, 
ascorbic acid. 
 Minerals like calcium, chloride, copper, iron, magnesium, manganese, 
phosphorous, potassium, sodium, zinc. 
 Proteins, fats, enzymes and amino acids. 
 Volatile aromatic substances and water. 
Medical Research of Honey 
 It blocks the growth of oral bacteria, coats the throat and reduces throat irritation. 
 It is effective when used in the treatment of gastric and peptic ulcers. 
 It is also considered an antioxidant. This means it allows the blood to circulate 
better and provide more oxygen to areas of the body such as brain 
Uses 
1. It speeds up healing, growth of healing tissue and dries it up. 
2. Honey acts as a sedative and is very useful in bed wetting disorders. 
3. Honey has antibacterial properties due to its acidic nature and enzymatically produced  
    hydrogen peroxide. 
4. Constant use of honey strengthens the white blood corpuscles to fight bacteria and viral  
    diseases. Reduces effects of poison.  
Precautions to be taken before using honey 
 Honey should not be mixed with hot foods and should not be heated. Honey 
should not be consumed when you are working in hot environment, where you are 
exposed to more heat and should not mixed with rain water. 
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Chapter IV 
MATERIALS AND METHODS 
 
4.1. COLLECTION, IDENTIFICATION, PURIFICATION AND 
PREPARATION OF MEDICINE 
Collection 
 Drugs were collected from raw drug store in Chennai. 
Identification 
The drugs were identified and authenticated from the department of 
Pharmacognosy in Siddha Central Research Institute, Chennai.  
Purification 
Vaalai Rasam 
Break Lingam into pieces and placed in a mud pot, add Nannari root, over that place 
another mud pot and sealed it seven times with mud pasted cloth. Heat it in kaadakini for 
one samam(3 hrs). Open the seal and extract mercury which is settled in the upper mud 
pot. 
Gandhagam 
Gandhagam is heated with Ponankanni (Alternanthera sessilis) juice for 3 hours by using 
mild flame. Then the Gandhagam is washed with water and taken. 
Lingam 
Lime juice, cow’s milk and Indian Acalypha juice are mixed in equal proportion and 
allowed to fuse Cinnabar so as to get it in a consolidated potency state. 
Thalagam 
Thalagam is bundled and boiled with lime stone water by Thulayanthiram method with 
dipping. 
Manosilai 
Manosilai is taken and ground with lemon juice for 3 hours in a kalvam. 
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Veeram 
Take Veeram and Piper nigrum seeds in the ratio of 1:3.Grind the seeds with rice porridge                  
until paste form. Gently cover the veeram with that paste and tie it in a white cloth. 
Sufficient quantity of tender coconut water is add in to a mud pot. By the method of 
thulaiyandram the above prepared veeram was tied without dipping into the tender 
coconut water and apply heat for 1 ½ hours (1/2 samam). 
Pooram  
Vetrilai (Piper betel) and Milagu (Piper nigrum) is taken separately equal to the weight of 
Pooram. Ground paste of Vetrilai and Milagu is mixed with water in a mud pot. By the 
method of thulaiyandram prepared pooram is tied dipped into the mixture and taken after 
boiled well. 
Preparation of Kirubakara Shanmuga Chenduram 
Ingredients 
            Vaalai Rasam (Mercury)                    - 1 palam(35 gm), 
            Purified Lingam (Cinnabar)                                -        1 palam (35 gm), 
            Purified Veeram(Hydrargyrum per chloride)   -       1palam (35 gm), 
            Purified Pooram (Calomel)                   -  1 palam (35 gm), 
            Purified Thalagam (Arsenic trisulphide)                    -       1 palam (35 gm),  
            Purified Gandhagam (Sulphur)                                -       1 palam (35 gm), 
            Purified Manosilai (Arsenic disulphide)                     -       1/4 palam (8.75 gm), 
            Betle leaf juice (Piper beetle)                                       -        Required amount 
            Common salt (Nacl)                                                -         Required amount  
            Pirandai(Cissus quadrangularis)                                -       Required amount 
                The above fore mentioned drugs except vaalai rasam and gandhagam were 
ground in kalvam. Gandhagam was made like paste by grinding it with bettle leaf juice 
and it is applied on the inner surface of an earthern vessel and it’s lid, then dried. Inside 
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this ¾  of  the above ground drugs were added and in it’s centre a small pit was made and 
vaalai rasam was poured into it and again remaining ground drugs were added and sealed 
seven times with mud cloth. Then take two padi(2.6 lit) common salt and ten palam(350 
gm) of pirandai and both were mixed and this mixture taken in a mud pot upto three 
finger depth and above prepared earthern vessel is kept and remaining mixture is 
spreaded over it. The mouth of the mud pot is closed with suitable lid and sealed it with 
cloth and dried. Then it was burnt for one samam (three hours) as deepakini (mild fire), 
one samam as kamalakini (moderate fire), two samam (six hours) with katakini (severe 
fire) and bring cooled the final product was seen under the mud pot as melted form in red 
colour. This is drained and kept in a glass container.  
Note : while grinding the vaalai rasam and ghandhagam, if smoke comes add bettle leaf 
juice and ground until it disappears.          
Therapeutic dose     : One Thuvarai (202mg), twice a day. 
Adjuvant                  : Honey.                          
Therapeutic uses   : Eight types of Thadippu, Kuttam, Megaranam, Gunmam, Kaasam,  
                                  Sanni, Suram,Utkuthu, Purakuthu, Soolai, Moorchai  
                                   and Vatha disease. 
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VAALAI RASAM 
 
 
LINGAM`  
Before Purification     After Purification 
    
  
VEERAM 
Before Purification     After Purification 
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POORAM 
Before Purification     After Purification 
 
    
   
 
THALAGAM 
Before Purification     After Purification 
     
 
  
GANDHAGAM 
Before Purification     After Purification 
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MANOSILAI 
Before Purification     After Purification 
 
      
 
 
 
KIRUBAKARA SHANMUGA CHENDURAM 
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4.2. PHYSICO CHEMICAL PROPERTIES 
 
Sample description: Kirubakara Shanmuga Chenduram 
 
Colour  
About 50 gm of Kirubakara Shanmuga Chenduram was taken in a clean glass 
beaker and tested for its colour by viewing again a white opaque back ground under direct 
sunlight. 
 Odour  
  About 50 gm of Kirubakara Shanmuga Chenduram was placed in 100 ml of 
beaker and tested for its odour by wafting the air above the beaker. 
Loss On Drying 
5 gms of Kirubakara Shanmuga Chenduram was heated in a hot oven at 100º c to 
a constant .The percentage of loss of weight was calculated. 
pH 
The pH of the Kirubakara Shanmuga Chenduram was estimated as per the method 
prescribed in the Indian standard (IS) -6940(1982). One gram of the Kirubakara 
Shanmuga Chenduram was taken in to a 100ml graduated cylinder containing about 50 
ml of water and filled up to the mark with water. The cylinder was stopped and shaken 
vigorously for two minutes and the suspension was allowed to settle for hour at 25ºC to 
27ºC about 25 ml of the clear aqueous solution was transfered in to a 50 ml beaker and 
tested for pH using DIGISUN digital PH meter (DIGISUN electronics, Hyderabad, India) 
Determination Of Ash Value  
Weighed accurately 2gms of Kirubakara Shanmuga Chenduram in tarred platinum 
or silica dish and incinerate at a temperature not be exceeding  450 c until free from 
corban cooled and weighed calculate the percentage of ash with reference of the air dried 
drug was then calculated. 
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Water Soluble Ash 
To the Gooch curable containing to the total ash, added 25 ml of water and boiled 
for 5 minutes. Collected the insoluble matter in a sintered glass crucible for 15 minutes at 
a temperature not exceeding 450º C subtract the weight off the insoluble matter from the 
weight of the ash the difference of the weight represents the water soluble ash. Calculate 
the percentage of water soluble ash with the reference to the air dried drug. 
Acid Insoluble Ash 
Boiled ash 5minutes with 25 ml of 1:1 dil. HCL collect the insoluble matter 
Gooch crucible on an ash less filter paper wash without water and ignited, cooled in a 
desiccators and weighed , calculated the percentage of insoluble ash with reference to the 
air dried  drug. 
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4.3. QUALITATIVE ANALYSIS 
Chemical analysis: 
Analytical grade chemicals were procured from Golchha Chemicals Ltd.  
Jamshedpur and Himedia laboratories, Mumbai.  
Kirubakara Shanmuga Chenduram 
 
Experiment 
 
Observation 
 
 
Inference 
 
Appearance of the 
sample 
  
 
Solubility: 
a. A little of the sample is 
shaken well with distilled 
water. 
b. A little of the sample is 
Shaken well with con. Hcl 
and 
Con. H2SO4. 
 
Spraingly soluble 
 
 
 
Insoluble 
 
Presence of Silicate    
 
 
 
Absence of Silicate    
 
Action of Heat: 
A small amount of the 
sample is taken in a dry 
test tube and heated  
gently first and then strong 
 
white fumes evolved 
 
 
No white fumes evolved 
 
 
 
Presence of Carbonate 
 
 
Absence of Carbonate 
 
 
 
Flame Test: 
A small amount of the 
sample is made into a 
paste with con.Hcl in a 
watch glass and introduced 
into non-luminous part of 
the Bunsen flame. 
 
Appearance of bluish 
green flame 
 
No appearance of bluish 
green flame 
 
 
 
Presence of Copper 
 
 
Absence of Copper 
 
Ash Test: 
A filter paper is soaked 
into a mixture of sample 
and cobalt nitrate solution 
and introduced into the 
Bunsen flame and ignited. 
 
Appearance of yellow 
colour flame 
 
No appearance of yellow 
colour flame 
 
Presence of Sodium 
 
 
Absence  of Sodium 
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Preliminary Basic, Acidic Radicals and Biochemical studies 
Preparation of Extract 
5g of sample was taken in a 250 ml of clean beaker and 50 ml of distilled water was 
added to it. Then it was boiled well for about 10 min. Then it is allowed to cool and 
filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. This 
preparation is used for the qualitative analysis of acidic/ basic radicals and biochemical 
constituents in it. 
Test for Basic Radicals 
 
PROCEDURE 
 
OBSERVATION 
 
INFERENCE 
Test for Potassium: A pinch 
of sample is treated with 2ml 
of sodium nitrate solution and 
then treated with 2ml of 
cobalt nitrate in 30% of 
glacial acetic acid 
Formation of Yellow colour 
precipitate 
No Formation of Yellow 
colour precipitate 
Presence of  Potassium 
 
Absence of  Potassium 
Test for Calcium: 2 ml of 
extract is taken in a clean test 
tube. To this add 2 ml of 4% 
ammonium oxalate solution.   
Formation of White colour 
precipitate 
No formation of White 
colour precipitate 
Presence of Calcium 
 
Absence of calcium 
Test For Magnesium: 
To 2ml of extract, sodium 
hydroxide solution is added 
in drops to excess 
Formation of White colour 
precipitate  
No formation of White 
colour precipitate 
Presence  of  Magnesium 
 
Absence of Magnesium 
Test For Ammonium: 
To 2ml of extract few ml of 
Nessler's reagent and excess 
of sodium hydroxide solution 
are added. 
Appearance of Brown 
colour 
 
No appearance of Brown 
colour 
 
Presence of  Ammonium 
 
Absence of Ammonium 
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Test For Sodium: 
2 pinches of the substance is 
made into paste by using Hcl 
and introduced into the blue 
flame of Bunsen burner. 
Appearance of intense 
Yellow colour 
No appearance of intense 
Yellow colour 
Presence of  Sodium 
 
Absence of Sodium 
Test for Iron (Ferrous):    
The extract is treated with 
Conc. HNO3 and ammonium 
thiocynate. 
Appearance of Blood red 
colour 
No appearance of Blood red 
colour 
Presence of Ferrous iron 
Absence of Ferrous iron 
 
Test For Zinc: 
To 2m1 of the extract sodium 
hydroxide solution is added 
in drops to excess. 
Formation of White colour 
precipitate 
No formation of White 
colour precipitate 
Presence  of  Zinc 
 
Absence of  Zinc 
Test For Aluminium: 
To the 2m1of the extract 
sodium hydroxide is added in 
drops to excess. 
Characteristic changes 
No Characteristic changes 
Presence of  Aluminium 
Absenc of  Aluminium 
Test For Lead: 
2 ml of extract is added with 
2ml of potassium iodide 
solution. 
Formation of yellow colour 
precipitate 
No formation of yellow 
colour precipitate 
Presence of Lead
 
Absence  of  Lead 
Test for Copper: 
a. One pinch of substance is 
made into paste with con. Hcl 
in a watch glass and 
introduced into the non-
luminous part of the flame. 
b. 2 ml of extract is added 
with excess of ammonia 
solution. 
Formation of Blue colour 
Precipitate. 
No formation of Blue 
colour Precipitate. 
 
 
Presence of Copper 
 
Absence of Copper 
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Test For Mercury: 
2m1 of the extract is treated 
with 2ml of sodium 
hydroxide solution. 
Formation of Yellow 
precipitate 
No formation of Yellow 
precipitate 
Presence of Mercury 
Absence of Mercury 
Test for Arsenic:            
2m1 of the extract is treated 
With 2ml of sodium 
hydroxide solution. 
Formation of Brownish red 
precipitate 
No formation of Brownish 
red precipitate 
Presence of Arsenic 
 
Absence of Arsenic 
 
Test for Acidic Radicals 
 
Procedure 
 
Observation 
 
Inference 
Test for Sulphate:                  
   2 ml of the extract is added to 
5 % barium chloride solution. 
Formation of white 
precipitate 
No formation of white 
precipitate 
Presence of Sulphate 
Absence of Sulphate 
Test for Chloride :               
     The extract is treated with 
Silver nitrate solution. 
Formation of White 
precipitate 
No formation of White 
precipitate 
Presence of  Chloride 
Absence  of  Chloride 
Test for Phosphate :          
   The extract is treated with 
ammonium molybdate and 2ml 
of conc. HNO3. 
Formation of Yellow 
precipitate 
No formation of Yellow 
precipitate 
Presence of Phosphate 
Absence of  Phosphate 
Test for Carbonate :         
  The substance is treated with 
Conc. Hcl. 
Formation of effervesence 
No formation of 
effervesence 
Presence of carbonate 
Absence of carbonate 
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Test for fluoride &oxalate: 
  2ml of extract is added with 
2ml of dil. acetic acid and 2ml 
calcium chloride solution and 
heated.          
Formation of cloudy 
appearance 
No formation of cloudy 
appearance 
Presence of Fluoride & 
Oxalate 
Absence of Fluoride & 
Oxalate 
 
Test For Nitrate: 
  1gm of the substance is 
heated 
with copper turnings and 
concentrated H2SO4 and 
viewed the test tube vertically 
down 
Characteristic changes 
 
No characteristic changes 
 
 
Presence of Nitrate 
 
Absence of Nitrate 
 
 
Other Constituents 
 
PROCEDURE 
 
OBSERVATION 
 
INFERENCE 
Test for Starch:  The 
extract is added with  weak 
iodine solution.  
Formation of blue colour 
No formation of bluea 
colour 
Presence of Starch 
Absence of Starch 
Test for Reducing Sugar: 
5 ml of Benedict's 
qualitative solution is taken 
in a test tube and allowed to 
boil for 2 min. Add 8 to 10 
drops of extract and again 
boil it for 2min. The colour 
changes are noted. 
Brickred colour 
 
No brickred colour 
 
 
 
Presence of Reducing Sugar 
 
Absence of Reducing Sugar 
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Test for  Alkaloids: 
a. 2ml of the extract is 
treated with 2ml of 
potassium Iodide solution 
b. 2m1 of extract is treated 
with 2ml of picric acid 
c. 2m1 of the extract is 
treated with 2ml of 
phosphotungstic acid 
 
No  Red colour 
 
Appearance of Yellow 
colour 
No  white precipitate 
 
 
- 
 
Presence of Alkaloids 
 
- 
Test for amino acids:     
Dilute extract + 2ml of 
Ninhydrin’s solution. 
Appearance of violet 
colour 
No appearance of violet 
colour 
 
Presence of  Amino acids 
Absence of  Amino acids 
 
Test for Tannic acid :        
2ml  extract is treated with 
Ferric chloride.  
Formation of Blue black 
precipitate 
No formation of Blue 
black precipitate 
Presence of Tannic acid 
 
Absence  of Tannic acid 
Test for unsaturated 
Compound: 
2ml of the extract is treated 
with 2 ml of potassium 
permanganate solution is 
added. 
 
Appearance of Green 
colour 
 
Appearance of Red colour 
 
Appearance of Violet 
colour 
 
Appearance of Blue colour 
 
Presence of Oxyquinole, 
Epinephrine and Pyro catechol 
Presence of Anti pyrine, 
Aliphatic amino acids and 
Meconic acid 
Presence of Apomorphine 
Salicylate and Resorcinol 
Presence of Morphine, Phenol 
cresol and Hydroquinone 
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4.4. QUANTITATIVE ANALYSIS 
4.4.1. FOURIER TRANSFORM - INFRA RED SPECTROSCOPY 
(FTIR): PERKIN ELMER – SPECTRUM ONE 
Methodology 
 Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation characteristic of 
the interacting system may be absorbed (or emitted). The experimental data consist of the 
nature (frequency of wave length) and the amount (intensity) of the characteristic 
radiation absorbed or emitted. These data are correlated with the molecular and electronic 
structure of the substance and intra- and inter molecular interactions. 
 The Fourier Transform Infrared Spectroscopy (FTIR) measurements were 
performed using PE Spectrum 1 FTIR spectrometer in the frequency range 400- 4000 cm-
1 at 4 cm-1 resolution. To obtain a high signal/noise ratio 128 scans were accumulated for 
each sample. Initially, the spectra were fitted to parabolic function. Then the RMS (Root 
Mean Square) was calculated between the original spectrum and the one, fitted by the 
function. The area under the fitted spectrum was divided by the noise RMS, which is 
reported as Signal/ Noise Ratio (SNR). The Evaluate menu provided in the OPUS 
software performed the entire process automatically. As prescribed by Bruker, SNR was 
calculated in the range 4000- 400 cm-1. For each measurement 4-8 mg of finely 
powdered samples of Raw Kirubakara shanmuga chenduram (KSC), was used to make 
KBr discs. Vector normalization was applied to all the FTIR spectra reported in this 
study.  
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Table of Characteristic IR Absorptions 
 
frequency cm–1 bond functional group 
3640–3610 (s,sh) O–H stretch, free hydroxyl alcohols, phenols 
3500–3200 (s,b) O–H stretch, H–bonded alcohols, phenols 
3400–3250 (m) N–H stretch 1°, 2° amines, amides 
3300–2500 (m) O–H stretch carboxylic acids 
3330–3270 (n, s) –C C–H: C–H stretch alkynes (terminal) 
3100–3000 (s) C–H stretch aromatics 
3100–3000 (m) =C–H stretch alkenes 
3000–2850 (m) C–H stretch alkanes 
2830–2695 (m) H–C=O: C–H stretch aldehydes 
2260–2210 (v) C N stretch nitriles 
2260–2100 (w) –C C– stretch alkynes 
1760–1665 (s) C=O stretch carbonyls (general) 
1760–1690 (s) C=O stretch carboxylic acids 
1750–1735 (s) C=O stretch esters, saturated aliphatic 
1740–1720 (s) C=O stretch aldehydes, saturated aliphatic 
1730–1715 (s) C=O stretch , –unsaturated esters 
1715 (s) C=O stretch ketones, saturated aliphatic 
1710–1665 (s) C=O stretch , –unsaturated aldehydes, ketones 
1680–1640 (m) –C=C– stretch alkenes 
1650–1580 (m) N–H bend 1° amines 
1600–1585 (m) C–C stretch (in–ring) aromatics 
1550–1475 (s) N–O asymmetric stretch nitro compounds 
1500–1400 (m) C–C stretch (in–ring) aromatics 
1470–1450 (m) C–H bend alkanes 
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1370–1350 (m) C–H rock alkanes 
1360–1290 (m) N–O symmetric stretch nitro compounds 
1335–1250 (s) C–N stretch aromatic amines 
1320–1000 (s) C–O stretch alcohols, carboxylic acids, esters, 
ethers 
1300–1150 (m) C–H wag (–CH2X) alkyl halides 
1250–1020 (m) C–N stretch aliphatic amines 
1000–650 (s) =C–H bend alkenes 
950–910 (m) O–H bend carboxylic acids 
910–665 (s, b) N–H wag 1°, 2° amines 
900–675 (s) C–H “oop” aromatics 
850–550 (m) C–Cl stretch alkyl halides 
725–720 (m) C–H rock alkanes 
700–610 (b, s) –C C–H: C–H bend alkynes 
690–515 (m) C–Br stretch alkyl halides 
  
m=medium, w=weak, s=strong, n=narrow, 
b=broad, sh=sharp 
 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36 
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4.4.2. INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY (ICP-OES) 
Introduction 
The elemental composition of a sample is often an important part of the 
information needed to assess its properties. Hence there is a need for sensitive scientific 
instrumentation like ICP-OES which plays a pivotal role in the determination of these 
elements. ICP-OES is widely employed for the estimation of metals and metalloids at 
trace, minor and major concentrations.  
Principle  
In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons .The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer, so that intensities of the individual wavelength can 
be measured. The number of photons emitted is directly proportional to the concentration 
of the element. The photon may be detected either sequentially or simultaneously. 
Quantitative analysis is achieved by measuring the intensity of these specific wavelengths 
and after performing the calibration using known standards. 
 
Extraction of information  
Obtaining qualitative information, i.e., what elements are present in the sample, 
involves identifying the presence of emission at the wavelengths characteristic of the 
elements of interest. Obtaining quantitative information, i.e., how much of an element is 
in the sample, can be accomplished using plots of emission intensity versus concentration 
called calibration curves. Typical calibration graph is illustrated bellow 
 
              Typical ICP Calibration curve 
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Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36 
 
Sample preparation – Microwave Digestion 
 Weigh 0.25g of test sample and transfer into a liner provided with the instrument.  
 Slowly add 9ml of Nitric acid or Sulphuric acid such that no piece of sample 
sticks on the slides.  
 Mix thoroughly and allow reacting for few minutes.  
 Place the liner in the vessel jacket.  
 Close the screw cap hand-tight in clockwise direction.  
 Seal the vessel and place in the rotor fixed in microwave.  
 Set temperature to 180°C for 5 minutes; hold at 180°C for least 10 minutes.  
 Allow the vessels to cool down to a vessel interior temperature below 60°C and to 
a vessel surface temperature (IR) below 50°C before removing the rotor.  
 The digested sample was made upto 100ml with millipore water.  
 If visible insoluble particles exist, solution could be filtered through whatmann 
filter paper.  
 Transfer the digested solution into plastic containers and label them properly.  
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4.4.3. SCANNED ELECTRON MICROSCOPY (SEM) 
A SEM is essentially a high magnification microscope, which uses a focussed scanned 
electron beam to produce images of the sample, both top-down and, with the necessary 
sample preparation, cross-sections. The primary electron beam interacts with the sample 
in a number of key ways:- 
 Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic nature of the specimen.  
 Primary electrons can be backscattered which produces images with a high degree 
of atomic number (Z) contrast.  
 Ionized atoms can relax by electron shell-to-shell transitions, which lead to either 
X-ray emission or Auger electron ejection. The X-rays emitted are characteristic 
of the elements in the top few m of the sample.  
 
The SEM is carried out by using FEI-Quanta FEG 200-High Resolution Instrument. 
Resolution : 1.2 nm gold particle separation on a carbon substrate  
Magnification:  From a min of 12x to greater than 1, 00,000 X  
Application : To evaluate grain size, particle size distributions, material homogeneity     
     and inter metallic distributions. 
 
Sample Preparation 
Sample preparation can be minimal or elaborate for SEM analysis, depending on 
the nature of the samples and the data required. Minimal preparation includes acquisition 
of a sample that will fit into the SEM chamber and some accommodation to prevent 
charge build-up on electrically insulating samples. Most electrically insulating samples 
are coated with a thin layer of conducting material, commonly carbon, gold, or some 
other metal or alloy. The choice of material for conductive coatings depends on the data 
to be acquired: carbon is most desirable if elemental analysis is a priority, while metal 
coatings are most effective for high resolution electron imaging applications. 
Alternatively, an electrically insulating sample can be examined without a conductive 
coating in an instrument capable of "low vacuum" operation. 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36 
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4.4.4. X-RAY FLUORESCENCE (XRF) 
An X-ray fluorescence (XRF) spectrometer is an x-ray instrument used for 
routine, relatively non-destructive chemical analyses of rocks, minerals, sediments and 
fluids. It works on wavelength-dispersive spectroscopic principles that are similar to an 
electron microprobe (EPMA). However, an XRF cannot generally make analyses at the 
small spot sizes typical of EPMA work (2-5 microns), so it is typically used for bulk 
analyses of larger fractions of geological materials. The relative ease and low cost of 
sample preparation, and the stability and ease of use of x-ray spectrometers make this one 
of the most widely used methods for analysis of major and trace elements in rocks, 
minerals, and sediment. 
Fundamental Principles of X-Ray Fluorescence (XRF) 
The XRF method depends on fundamental principles that are common to several 
other instrumental methods involving interactions between electron beams and x-
rays with samples, including: X-ray spectroscopy (e.g., SEM - EDS), X-ray diffraction 
(XRD), and wavelength dispersive spectroscopy. Analysis of major and trace elements in 
geological materials by x-ray fluorescence is made possible by the behavior of atoms 
when they interact with radiation. When materials are excited with high-energy, short 
wavelength radiation (e.g., X-rays), they can become ionized. If the energy of the 
radiation is sufficient to dislodge a tightly-held inner electron, the atom becomes unstable 
and an outer electron replaces the missing inner electron. When this happens, energy is 
released due to the decreased binding energy of the inner electron orbital compared with 
an outer one. The emitted radiation is of lower energy than the primary incident X-rays 
and is termed fluorescent radiation. Because the energy of the emitted photon is 
characteristic of a transition between specific electron orbitals in a particular element, the 
resulting fluorescent X-rays can be used to detect the abundances of elements that are 
present in the sample. 
Procedure 
The analysis of major and trace elements in geological materials by XRF is made 
possible by the behavior of atoms when they interact with X-radiation. An XRF 
spectrometer works because if a sample is illuminated by an intense X-ray beam, known 
as the incident beam, some of the energy is scattered, but some is also absorbed within the 
sample in a manner that depends on its chemistry. The incident X-ray beam is typically 
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produced from a Rh target, although W, Mo, Cr and others can also be used, depending 
on the application.  
 
When this primary X-ray beam illuminates the sample, it is said to be excited. The 
excited sample in turn emits X-rays along a spectrum of wavelengths characteristic of the 
types of atoms present in the sample. How does this happen? The atoms in the sample 
absorb X-ray energy by ionizing, ejecting electrons from the lower (usually K and L) 
energy levels. The ejected electrons are replaced by electrons from an outer, higher 
energy orbital. When this happens, energy is released due to the decreased binding energy 
of the inner electron orbital compared with an outer one. This energy release is in the 
form of emission of characteristic X-rays indicating the type of atom present. If a sample 
has many elements present, as is typical for most minerals and rocks, the use of 
a Wavelength Dispersive Spectrometer much like that in an EPMA allows the separation 
of a complex emitted X-ray spectrum into characteristic wavelengths for each element 
present. Various types of detectors (gas flow proportional and scintillation) are used to 
measure the intensity of the emitted beam. The flow counter is commonly utilized for 
measuring long wavelength (>0.15 nm) X-rays that are typical of K spectra from elements 
lighter than Zn. The scintillation detector is commonly used to analyze shorter 
wavelengths in the X-ray spectrum (K spectra of element from Nb to I; L spectra of Th 
and U). X-rays of intermediate wavelength (K spectra produced from Zn to Zr and L 
spectra from Ba and the rare earth elements) are generally measured by using both 
detectors in tandem. The intensity of the energy measured by these detectors is 
proportional to the abundance of the element in the sample. The exact value of this 
proportionality for each element is derived by comparison to mineral or rock standards 
whose composition is known from prior analyses by other techniques. X-Ray 
fluorescence is particularly well-suited for investigations that involve 
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 bulk chemical analyses of major elements (Si, Ti, Al, Fe, Mn, Mg, Ca, Na, K, P) in 
rock and sediment 
 bulk chemical analyses of trace elements (in abundances >1 ppm; Ba, Ce, Co, Cr, 
Cu, Ga, La, Nb, Ni, Rb, Sc, Sr, Rh, U, V, Y, Zr, Zn) in rock and sediment - 
detection limits for trace elements are typically on the order of a few parts per 
million 
X-ray fluorescence is limited to analysis of 
 relatively large samples, typically > 1 gram 
 materials that can be prepared in powder form and effectively homogenized 
 materials for which compositionally similar, well-characterized standards are 
available 
 materials containing high abundances of elements for which absorption and 
fluorescence effects are reasonably well understood 
In most cases for rocks, ores, sediments and minerals, the sample is ground to a fine 
powder. At this point it may be analyzed directly, especially in the case of trace element 
analyses. However, the very wide range in abundances of different elements, especially 
iron, and the wide range of sizes of grains in a powdered sample, makes the 
proportionality comparison to the standards particularly troublesome. For this reason, it is 
common practice to mix the powdered sample with a chemical flux and use a furnace or 
gas burner to melt the powdered sample. Melting creates a homogenous glass that can be 
analyzed and the abundances of the (now somewhat diluted) elements calculated. 
Strengths 
X-Ray fluorescence is particularly well-suited for investigations that involve: 
 bulk chemical analyses of major elements (Si, Ti, Al, Fe, Mn, Mg, Ca, Na, K, P) in 
rock and sediment 
 bulk chemical analyses of trace elements (>1 ppm; Ba, Ce, Co, Cr, Cu, Ga, La, Nb, 
Ni, Rb, Sc, Sr, Rh, U, V, Y, Zr, Zn) in rock and sediment 
Experimental Procedure: Done at Sastra University,Tanjore.  
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4.5. TOXICOLOGICAL EVALUATION OF  
KIRUBAKARA SHANMUGA CHENDURAM 
 
Scope of Work 
 Assurance of safety, quality, and efficacy of Indian System of Medicine (ISM) is 
the key issue that needs to be addressed while conducting toxicity studies. It is an 
essential step, which will strengthen the acceptance of Siddha medicines by scientific 
community. Information of toxicity and adverse effects of these formulations are lacking. 
Some of the formulations are proved to be effective in various animal studies and many 
more are yet to be tested. 
 Hence the present study was carried out to evaluate the acute and 28 days repeated 
oral toxicity effects of Kirubakara Shanmuga Chenduram. 
 
Plan of Work 
The following studies were carried out on Kirubakara Shanmuga Chenduram, 
Toxicity studies 
 Acute oral toxicity study- OECD 423 
 28 days repeated oral toxicity study – OECD 407 
 
The principles of laboratory animal care were followed and the Animal Ethical 
Committee approved the use of animals and the study design. 
IAEC PROTOCOL NO. 1248/ac/09/CPCSEA/4-37/2011  
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4.5.1. ACUTE TOXICITY STUDY OF  
KIRUBAKARA SHANMUGACHENDURAM (KSC)  
OECD-423 
.Introduction 
The acute toxic class method is a stepwise procedure with the use of 3 female 
animals per step. Depending on the mortality and/or the moribund status of the animals, 
on average 2-4 steps may be necessary to allow judgement on the acute toxicity of the test 
substance. This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods. The acute toxic 
class method is based on biometric evaluations with fixed doses, adequately separated to 
enable a substance to be ranked for classification purposes and hazard assessment.  
 
In principle, the method is not intended to allow the calculation of a precise LD50, 
but does allow for the determination of defined exposure ranges where lethality is 
expected since death of a proportion of the animals is still the major endpoint of this test. 
The method allows for the determination of an LD50 value only when at least two doses 
result in mortality higher than 0% and lower than 100%. The use of a selection of pre-
defined doses, regardless of test substance, with classification explicitly tied to number of 
animals observed in different states improves the opportunity for laboratory to laboratory 
reporting consistency and repeatability.  
Principle  
           It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e.;  no further testing is needed,  dosing of three additional 
animals, with the same dose  dosing of three additional animals at the next higher or the 
next lower dose level. The method will enable a judgment with respect to classifying the 
test substance to one of a series of toxicity classes. 
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Test Substance   : Kirubakara Shanmuga Chenduram 
Animal Source   : Sri Ragavendra Enterprizes, Bangalore. 
Study place   : National Institute of Siddha.Chennai.  
Test Animals    : Female wistar albino Rats  
Age     : 6 weeks  
Body Weight on Day 0  : 150-200 gm  
Acclimatization   : Seven days prior to dosing.  
Veterinary examination  : Prior to and at the end of the acclimatization period.  
Route of administration : Oral 
Identification of animals  : By cage number, animal number and individual marking  
       on fur by using picric acid.  
Diet     : Pelleted feed supplied by Sai meera foods Pvt Ltd  
       Bangalore.  
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment  :The animals were housed in Polypropylene cages provided  
      with bedding of husk.  
Housing temperature  : 22°C±3°C 
Relative humidity   : Between 30% and 70%,  
Air changes    : 10 to 15 per hour  
Dark and light cycle   : Each of 12 hours (12:12) 
Study period   : 14 days 
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Methodology 
Randomization, Numbering and Grouping of Animals 
           Three female rats were in each group randomly divided into five groups. Each 
animal was  marked with picric acid. The females were nulliporous and non-pregnant.  
 
Preparation and Administration of Doses  
          Kirubakara Shanmuga Chenduram was suspended in  10% aqueous tween 80 
solution with vigourous mixing and was administered to the groups of wistar Albino  rats 
in a single oral dose by gavage using a feeding needle.It was administrated to Group 
I,II,III,IV at dose levels of 5,50,300 and 2000 mg/kg body weight was administered 
stepwise. After the substance has been administered, food was withheld for a further 3-4 
hours. The principle of laboratory animal care was followed.The control group received 
an equal volume of the vehicle. 
 
Observations 
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours, and daily thereafter, for a total of 14 days, except where they need to be removed 
from the study and humanely killed for animal welfare reasons or are found dead. It 
should be determined by the toxic reactions, time of onset and length of recovery period, 
and may thus be extended when considered necessary. The times at which signs of 
toxicity appear and disappear are important, especially if there is a tendency for toxic 
signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal.  
Behaviour 
The animals will be observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos , ptosis , akinesia , catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of traction, 
piloerection  reactivity of touch, salivation, scratching, sedation, stereotypes (chewing),  
stereotypes(head movements), stereotypes (sniffing), straub, tremor and writhes, diarrhea, 
leathery, sleep and coma. The principles and criteria summarised in the Humane 
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Endpoints Guidance Document taken into consideration. Animals found in a moribund 
condition and animals showing severe pain or enduring signs of severe distress was 
humanely killed. When animals are killed for humane reasons or found dead, the time of 
death should was recorded.  
 Body weight  
Body weights will be recorded at 1, 2, 7 and 14th day of the study. 
 
Mortality  
Animals will be observed for mortality throughout the entire period. 
Gross necropsy 
               At the end of 14th day animals will be sacrificed by excessive anaesthesia for 
gross necropsy. It includes examination of the external surface of the body, all orifices, 
and organs like brain, thymus, lungs, heart, spleen, liver, kidneys, adrenals and sex organs 
of all animals.If there will any occurrence of mortality during the trial period, the vital 
organs will be subjected to Necropsy. 
 
Results 
All data were summarized in tabular form, (Table-1) showing for each test group 
the number of animals used, the number of animals displaying signs of toxicity, the 
number of animals found dead during the test or killed for humane reasons, time of death 
of individual animals, a description and the time course of toxic effects and reversibility, 
and necropsy findings. 
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4.5.2. 28-DAYS REPEATED ORAL TOXICITY STUDY OF 
KIRUBAKARA SHANMUGA CHENDURAM IN RATS 
 
 
Test Substance   : Kirubakara Shanmuga Chenduram 
Animal Source   : King Institue, Guindy, Chennai. 
Study place   : National Institute of Siddha.Chennai.  
Test Animals    : Male and Female wistar albino Rats  
Age     : 6 weeks  
Body Weight on Day 0  : 150-200 gm  
Acclimatization   : Seven days prior to dosing.  
Veterinary examination  : Prior to and at the end of the acclimatization period.  
Identification of animals  : By cage number, animal number and individual marking  
       on fur by using picric acid.  
Diet     : Pelleted feed supplied by Sai meera foods Pvt Ltd  
       Bangalore.  
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment  :The animals were housed in Polypropylene cages provided  
      with bedding of husk.  
Housing temperature  : 22°C±3°C 
Relative humidity   : Between 30% and 70%,  
Air changes    : 10 to 15 per hour  
Dark and light cycle   : Each of 12 hours (12:12) 
Study period   : 28 days. 
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Methodology 
Randomization, Numbering and Grouping of Animals 
Six rats ( 3 males and 3 females )  were in each group randomly divided into four 
groups for dosing up to 28 days. Animals were allowed acclimatization period of 7 days 
to laboratory conditions prior to the initiation of treatment. Each animal was marked with 
picric acid on the fur. The females were nulliporous and non-pregnant.  
 
Justification for Dose Selection 
Three different dose levels low, mid and high were selected.Selected doses were 
calculated according to the body surface area (0.018)  and the therapeutic dose level (404 
mg) i.e 404 x 0.018 and it was fixed as x dose as low dose, 5x as mid dose  and 10x as 
high dose. 
 
Preparation and administration of dose 
Kirubakara Shanmuga Chenduram was suspended in 10% aqueous tween 80 
solution.  
     It was administered to group I (low dose) x dose (7.272 mg/animal), group II (mid 
dose) at 5x dose (36.36 mg / animal), group III (high dose) at 10x dose (72.72 
mg/animal). The control animals were administered vehicle only.Administration was 
given orally using an oral gavage once in daily for 28 consecutive days. 
Observations 
Experimental animals were kept under observation throughout the course of study 
for the following 
 
(i) Body Weight: Weight of each rat was recorded on day 0, at weekly intervals 
throughout the course of study. From the data, group mean body weight were calculated. 
(Table-2)  
 
(ii) Food and water Consumption: Food consumed per animal was calculated for 
control and the treated dose groups. (Table-3 & 4) 
 
(iii) Clinical signs: All animals were observed daily for clinical signs. The time of onset, 
intensity and duration of these symptoms, if any, were recorded.  
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(iv) Mortality: All animals were observed twice daily for mortality during entire course 
of study.  
 
(vi) Observations: Experimental animals were kept under observation through the course 
of the study with the following observation. 
Body weight of the animals was evaluated weekly; water, food consumption and 
mortality events was evaluated daily. 
Laboratory Investigations: By the end of 28 days, the animal will be sacrificed by 
excessive anesthesia.. The collected blood samples were kept in vaccum container tube 
which was coated with sodium heparin for blood chemistry and potassium EDTA  for 
Haematology as anticoagulant.  
Haematological and Biochemical Investigations: Hematological parameters included 
red blood cell count, white blood cell count, hemoglobin, mean corpuscular hemoglobin 
(MCH), mean corpuscular volume (MCV), platelet count, erythrocyte sedimentation rate 
(ESR), packed cell volume (PCV) and differential leucocyte count. Bio chemical 
parameters included Liver Function Test, Renal Function Test, lipid profile, blood 
glucose.  (Table-5,6, 7 & 8) 
Necropsy: Rats dying during the study and those terminated at end of the treatment and 
recovery periods underwent necropsy, including gross pathology and histopathological 
examination. All the animals were sacrificed at the end of 28th day. Necropsy of all 
animals was carried out. It includes examination of the external surface of the body, all 
orifices, and organs like brain, thymus, lungs, heart, spleen, liver, kidneys, adrenals and 
sex organs of all animals. 
Histopathology: Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group than 
the low, then the mid dose group will also be examined. Various organs will be collected 
from all animals and preserved in 10% buffered neutral formalin, sliced 5 or 6µm sections 
and it will be stained with hematoxylin and eosin, examined for histopathological 
changes. 
Statistical analysis: findings such as clinical signs of intoxication, body weight changes, 
food consumption, haematology and blood chemistry were subjected to One-way 
ANOVA followed by dunnet‘t‘ test using a computer software programme -INSTAT-V3 
version. 
 122 
 
Chapter V 
RESULTS 
 
CHEMICAL ANALYSIS 
PHYSICO CHEMICAL PROPERTIES 
 
Kirubakara Shanmuga Chenduram  
 
  Description   : Meroon coloured fine powder  
pH    : 8.9 to 9.1  
  Total ash value  : 8.23% w/w 
  Acid insoluble ash  : 0.46% w/w 
  Water soluble ash  : 6% w/w 
  Moisture content  : 10.02% w/w 
  Loss on Drying at 105°C : 0.86% 
 
 
 
Sieve Analysis 
S.No Sieve No (µ) % of particles 
retained 
1. 600 Nil 
2. 300 1.98 
3. 150 19.2 
4. 75 25.26 
5. Final product 52.61 
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QUALITATIVE ANALYSIS 
 
Kirubakara Shanmuga Chenduram: 
 
S. 
No. 
 
 
Experiment 
 
 
Observation 
 
Inference 
(KSC) 
1 Appearance of the 
sample 
Dark brown in 
colour 
Dark brown in colour  
2 Solubility: 
a. A little of the sample is 
shaken well with distilled 
water. 
b. A little of the sample is  
Shaken well with con. Hcl 
and Con. H2SO4. 
Completely 
soluble 
Absence of Silicate 
3 Action of Heat: 
A small amount of the 
sample is taken in a dry 
test tube and   heated 
gently first and then 
strongly. 
No white fumes  
 
No brown fumes 
Absence of carbonate 
 
Absence of nitrate 
4 Flame Test: 
A small amount of the 
sample is made into a 
paste with con.Hcl in a 
watch glass and 
introduced into non 
luminous part of the 
Bunsen flame. 
No bluish green 
flame appeared 
Absence of copper 
5 Ash Test:  
A filter paper is soaked 
into a  mixture of sample 
and cobalt nitrate solution 
and introduced into the 
Bunsen flame and ignited.  
No yellow colour 
flame 
Absence of sodium 
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Test for Basic Radicals 
 
 
S. 
No. 
 
 
Procedure 
 
 
Observation 
 
Inference 
(KSC) 
1 Test for Potassium:  
A pinch of sample is 
treated with 2ml of 
sodium nitrate solution 
and then treated with 2ml 
of cobalt nitrate in 30% of 
glacial acetic acid.  
No yellowish 
precipitate seen 
Absence of potassium 
2 Test for Calcium:  
2 ml of extract is taken in 
a clean test tube. To this 
add 2 ml of 4% 
ammonium oxalate 
solution.  
Cloudy appearance 
and white 
precipitate 
Presence of calcium 
3 Test For Magnesium:  
To 2ml of extract, sodium  
hydroxide solution is 
added in drops. 
No white 
precipitate 
obtained 
Absence of magnesium 
4 Test For Ammonium:  
To 2ml of extract few ml 
of Nessler's reagent and 
excess of sodium 
hydroxide solution are 
added.  
No brown colour 
appeared 
Absence of ammonium 
5 Test For Sodium:  
2 pinches of the substance 
is made into paste by 
using Hcl and introduced 
into the blue flame of 
Bunsen burner.   
No yellow colour 
appeared 
Absence of sodium 
6 Test for Iron (Ferrous):  
To 2 ml of extract 2 ml of 
ammonium thiocyanate 
solution and 2 ml of 
con.HNO3 is added.  
Appearance of 
Blood red colour 
Presence of Ferrous Iron 
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7 Test For Zinc:  
To 2m1 of the extract 
sodium hydroxide solution 
is added in drops. 
No white 
precipitate 
obtained 
Absence of Zinc 
8 Test For Aluminium:  
To the 2m1of the extract 
sodium hydroxide is 
added in drops. 
No Characteristic  
changes  
Absence of aluminium 
9 Test For Lead:  
2 ml of extract is added 
with 2ml of potassium 
iodide solution.  
No Characteristic  
changes 
Absence of lead 
10 Test for Copper:  
a. one pinch of substance 
is made into paste with 
con. Hcl in a watch glass 
and introduced into the 
non-luminous part of the 
flame.  
b. 2 ml of extract is added 
with excess of ammonia 
solution.  
No Blue colour 
precipitate 
Absence of copper 
11 Test For Mercury:  
2m1 of the extract is 
treated  with 2ml of 
sodium hydroxide 
solution.  
No yellow 
precipitate 
obtained 
Absence of mercury 
12 Test for Arsenic:  
2m1 of the extract is 
treated with 2ml of 
sodium hydroxide 
solution.  
No Brownish red 
precipitate 
obtained 
Absence of arsenic 
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Test for Acidic Radicals 
 
S. 
No. 
 
 
Procedure 
 
 
Observation 
 
Inference 
(KSC) 
1 Test for Sulphate:  
2 ml of extract is taken in 
a test tube to this is added 
2 ml of 4% ammonium 
oxalate solution. 
Cloudy appearance 
seen 
Presence of sulphate 
2 Test for Chloride :  
2 ml of extract is treated 
with dil. HNo3 till the 
effervescence ceases. 
Then 2 ml of  Silver 
nitrate solution is added.  
No cloudy 
appearance 
Absence of chloride 
3 Test for Phosphate :  
2 ml of extract is treated 
with 2 ml of ammonium 
molybdate and2 ml of 
conc. HNO3.  
No cloudy yellow 
appearance 
Absence of phophate 
4 Test for Carbonate :  
2 ml of the extract is 
treated with 2 ml 
magnesium sulphate 
solution. 
No cloudy 
appearance 
Absence of carbonate 
5 Test for fluoride 
&oxalate:  
2ml of extract is added 
with 2ml of dil.acetic acid 
and 2ml calcium chloride 
solution and heated.  
Formation of 
cloudy appearance 
Presence of fluoride & oxalate 
6 Test For Nitrate:  
1gm of the substance is 
heated  with copper 
turnings and concentrated 
H2SO4 and  viewed the 
test tube vertically down.  
No Characteristic 
changes  
 
Absence of nitrate 
7 Test For Sulphide: 
1 gm substance is treated 
with 2 ml of Con.Hcl 
No Rotten egg 
smelling gas 
evolved 
Absence of sulphide 
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8 Test For Nitrite: 
3 drops of extract is 
placed in a filter paper on 
that 2 drops of acetic acid 
and 2 drops of benzidine 
solution is placed 
No Characteristic 
changes  
 
Absence of nitrite 
9 Test For borate: 
2 pinches of substance is 
made into paste by using 
H2SO4 and alcohol (95%) 
and introduced into the 
blue flame.  
No bluish green 
flame appeared 
Absence of borate 
 
 
Other Constituents 
 
S. 
No. 
 
 
Procedure 
 
 
Observation 
 
Inference 
(KSC) 
1 Test for Starch :  
The extract is added with 
weak iodine solution.  
No blue colour 
appeared 
Absence of starch 
2 Test for Reducing 
Sugar:  
5 ml of Benedict's 
qualitative solution is 
taken in a test tube  and 
allowed to boil for 2 min. 
Add 8 to 10 drops of 
extract and again boil it 
for 2min. The colour 
changes are noted.  
No colour changes Absence of reducing sugar 
3 Test for Alkaloids:  
a. 2ml of the extract is 
treated with 2ml of 
potassium Iodide solution  
b. 2m1 of extract is 
treated with 2ml of picric 
acid  
c. 2m1 of the extract is 
No red colour 
developed 
 
 
 
No yellow colour 
developed 
 
No white colour 
 
 
 
 
 
Absence of alkaloids  
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treated with 2ml of 
phosphor tungstic  
acid  
precipitate  
 
4 Test for amino acids:  
2 drops of the extract is 
placed on a filter paper 
and dried well.  
No violet colour 
developed 
Absence of amino acids 
5 Test for Tannic acid : 
The 2 ml of extract is 
treated with 2 ml of Ferric 
chloride solution.  
No black 
precipitate 
obtained 
Absence of tannic acid 
6 Test for type of 
Compound:  
2ml of the extract is 
treated with 2 ml of ferric 
chloride solution. 
No colour change Absence of oxy quinole, 
epinephrine and pyrocatechol 
7 Test for Unsaturated 
Compound: 
2 ml of extract is treated 
with potassium 
permanganate solution. 
Potassium 
permanganate is not 
decolourised 
Absence of unsaturated 
compound 
 
The chemical constituents present in the Kirubakara Shanmuga Chenduram are 
 Calcium 
 Iron 
 Sulphate 
 Fluoride and Oxalates 
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QUANTITATIVE ANALYSIS 
 
 
 
 
ICP- OES 
Table. A 
 
 
S.No. 
 
Elements (Inorganic 
compounds) 
 
Wave Length  
(nm) 
Observation 
(Kirubakara 
Shanmuga 
Chenduram) 
1 Arsenic (As) 193.696 BDL 
2 Calcium (Ca) 317.933 8.995 mg/L 
3 Cadmium (Cd) 226.502 BDL 
4 Mercury (Hg) 253.652 3.168 ppm 
5 Phosphorus (P) 214.914 7.446 mg/L 
6 Lead (Pb) 230.204 BDL 
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HR SEM 
Kirubakara Shanmuga Chenduram 
 
  Distribution  : Overall Distributed 
  Shape   : Mixed (Rectangle and Spherical) 
  Size   : 50 to 100 nm 
  Surface  : Smooth 
  Flowability  : Normal 
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XRF 
 
 
Elemental analysis of Kirubakara Shanmuga Chenduram 
 
Table. B 
S. No. Formula Z Concentration 
1 Fe 26 44.04 % 
2 O 8 35.82 % 
3 Ca 20 9.84 % 
4 S 16 7.39 % 
5 Mg 12 1.23 % 
6 Si 14 0.42 % 
7 Mn 25 0.30 % 
8 Al 13 0.20 % 
9 Na 11 0.19 % 
10 P 15 0.15 % 
11 Cl 17 0.14 % 
12 Sr 38 0.09 % 
13 K 19 0.08 % 
14 Cr 24 0.05 % 
15 Ni 28 0.03 % 
16 Ti 22 0.02 % 
17 V 23 0.02 % 
18 As 33 86 ppm 
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Oxidal analysis of Kirubakara Shanmuga Chenduram 
 
S. No. Formula Z Concentration 
1 Fe2O3 26 62.96 % 
2 SO3 16 18.44 % 
3 CaO 20 13.76 % 
4 MgO 12 2.04 % 
5 SiO2 14 0.89 % 
6 Al2O3 13 0.39 % 
7 MnO 25 0.38 % 
8 P2O5 15 0.35 % 
9 Na2O 11 0.26 % 
10 Cl 17 0.14 % 
11 SrO 38 0.10 % 
12 K2O 19 0.10 % 
13 Cr2O3 24 0.07 % 
14 NiO 28 0.03 % 
15 V2O5 23 0.03 % 
16 TiO2 22 0.03 % 
17 As2O3 33 0.01 % 
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FTIR 
 
Kirubakara Shanmuga Chenduram 
 
 
Frequency Bond Compounds 
3413 O–H stretch, H–bonded alcohols, phenols 
2920 O–H stretch 
C–H stretch 
carboxylic acids 
alkanes 
2131 –C C– stretch alkynes 
1621 N–H bend 1° amines 
1437 C–C stretch (in–ring) aromatics 
1152 C–O stretch 
C–H wag (–CH2X) 
C–N stretch 
alcohols, carboxylic 
acids, esters, ethers. 
alkyl halides 
aliphatic amines 
676 =C–H bend 
–C C–H: C–H bend 
Alkenes 
alkynes 
594 C–Br stretch alkyl halides 
474 S-S, Disulfide - 
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Graph- FTIR 
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TOXICITY STUDY OF KIRUBAKARA SHANMUGA CHENDURAM 
Acute  Oral Toxicity Study 
 All data were summarized in tabular form (Table- 1), showing for each test group 
the number of animals used. In the dose level of 2000mg/kg/body weight after 4 hrs of 
administration produces the following characteristic signs like alertness, grooming, touch 
response listlessness, unching, porphyrin, motor incordination, muscular spasm in all the 
three animals.After 24 hrs 2 animals were found dead and 48 hrs third animal was also 
found dead. 5, 50, 300 mg/kg/body weight  displayed no signs of toxicity. Alertness, 
grooming, touch response were present.From these findings, as per the OECD guidelines 
the LD50 cut off value was concluded as 500 mg/kg/bw. 
 
Repeated Oral Toxicity Study 
Clinical signs 
Animals were shown no toxic signs during the dosing period of 28 days. 
Mortality 
All animals from control and all the treated dose groups survived throughout the 
dosing period of 28 days. The Kirubakara Shanmuga Chenduram did not cause any 
mortality. 
 Body weight  
Results of body weight determination of animals (Table 2) from control and 
different dose groups exhibited comparable body weight gain throughout the dosing 
period of 28 days. No differences in food intake or body weight were observed among the 
groups. 
Food consumption 
During dosing period, the quantity of food consumed by animals from different 
dose groups was found to be comparable and normal with that of control animals. 
Haematological Investigations 
The results of haematological investigations (Table- 5) conducted at the end of 
28th day, revealed no significant changes in the values of different parameters investigated 
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when compared with those of respective controls; the levels of RBC and hemoglobin in 
experimental animals were elevated when compared with that of the control. It is 
statistically significant (p<0.05). However, the alterations in the values obtained were 
within normal biological and laboratory limits or the effect was not dose dependent. 
Biochemical Investigations: 
Biochemical investigations conducted at the end of 28th day and recorded in 
(Table 6, 7, 8). In liver function test, there is significant increase(p<0.05) in ALP at 5x 
and 10x dose when compared to the control groups. In other biochemical parameters, the 
values obtained were within normal biological and laboratory limits.  
  
 
Histopathology 
Section from the Heart, Lungs, Liver, Kidney, Brain were found normal. 
Section from the Spleen showed normal appearing white pulp with central artery and 
congested red pulp.  
Necropsy   
Gross pathological examination of animals in control as well as the treated groups 
did not reveal any abnormalities. 
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HISTOPATHOLOGY 
 
 
 
HEART 
 Control 
Section from the heart shows normal cardiac myocytes with patent 
coronaries. 
 Low Dose (x) 
Section from the heart shows normal cardiac myocytes with patent 
coronaries. 
 Mid Dose (5x) 
Section from the heart shows normal cardiac myocytes with patent 
coronaries. 
 High Dose (10x) 
Section from the heart shows normal cardiac myocytes with patent 
coronaries. 
 
 
LUNGS 
 Control 
Section from the lungs shows normal bronchioles and alveoli. 
 Low Dose (x) 
Section from the lungs shows normal bronchioles and alveoli. 
 Mid Dose (5x) 
Section from the lungs shows normal bronchioles and alveoli. 
 High Dose (10x) 
Section from the lungs shows normal bronchioles and alveoli. 
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KIDNEY 
 Control 
Section from the kidney shows normal appearing glomeruli tubules and 
interstitium. 
 Low Dose (x) 
Section from the kidney shows normal appearing glomeruli tubules and 
interstitium. 
 Mid Dose (5x) 
Section from the kidney shows normal appearing glomeruli tubules and 
interstitium. 
 High Dose (10x) 
Section from the kidney shows normal appearing glomeruli tubules and 
interstitium. 
 
LIVER 
 Control 
Section from the liver shows normal appearing central vein with radiating 
cords of hepapocytes separated by sinusoids and portal triads. 
 Low Dose (x) 
Section from the liver shows normal appearing central vein with radiating 
cords of hepapocytes separated by sinusoids containing prominent kupfer cells. Portal 
triads appears normal. 
 Mid Dose (5x) 
Section from the liver shows normal appearing central vein with radiating 
cords of hepapocytes separated by sinusoids containing prominent kupfer cells. Portal 
triads appears normal. 
 High Dose (10x) 
Section from the liver shows normal appearing central vein with radiating 
cords of hepapocytes separated by sinusoids containing prominent kupfer cells. Portal 
triads appears normal. 
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SPLEEN 
 Control 
Section from the spleen shows normal appearing white pulp and red pulp. 
 Low Dose (x)  
Section from the spleen shows normal appearing white pulp with central artery 
and congested red pulp. 
 Mid Dose (5x) 
Section from the spleen shows normal appearing white pulp with central artery 
and congested red pulp. 
 High Dose (10x) 
Section from the spleen shows normal appearing white pulp with central artery 
and congested red pulp. 
 
 
BRAIN 
 Control 
Section from the brain shows normal appearing cerebral cortex in a fibrillary 
background. 
 Low Dose (x) 
Section from the brain shows normal appearing cerebral cortex in a fibrillary 
background. 
 Mid Dose (5x) 
Section from the brain shows normal appearing cerebral cortex in a fibrillary 
background. 
 High Dose (10x) 
Section from the brain shows normal appearing cerebral cortex in a fibrillary 
background. 
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Chapter VI 
SUMMARY AND DISSCUSSION 
           
            Kirubakara shanmuga chenduram is being widely used in siddha medicine 
prepared according to the process found in Pathartha Guna Vilakkam(thaathu 
vagupu)(page. no. 55-56).It contains ingredients of Vaalai rasam, Gandhagam, Lingam, 
Veeram, Pooram, Manosilai, Thalagam, Uppu and Pirandai and cures diseases like Eight 
types of Thadippu, Kuttam, Megaranam, Gunmam, Kaasam, Sanni, Suram,Utkuthu, 
Purakuthu, Soolai, Moorchai and Vatha disease.  
            The aim of the dissertation is to study the acute and 28 days repeated oral toxicity 
of the drug Kirubakara shanmuga chenduram in experimental animals. 
 The qualitative analysis of the drug Kirubakara shanmuga chenduram contains the 
presence of Calcium, Ferrous Iron, Sulphate, Flouride and Oxalates.  
The quantitative analysis of Kirubakara shanmuga chenduram by ICP- OES 
contains the presence of mercury in ppm level and arsenic ,cadmium, lead were present in 
below detectable limit showed in Table A. The elemental analysis of XRF study showed 
in Table B. In this heavy element arsenic was found in ppm level. Though the major 
ingredients of the drug KSC are mercury, mecurial compounds and arsenic compounds, in 
the final product the mercury and arsenic were found in the ppm level. 
In HR- SEM analysis the particle size of Kirubakara Shanmuga Chenduram was 
50 to 100 nm, mixed (Rectangle and Spherical) in shape. Surface was found smooth so 
the flowability was normal. The pH level is 8.9 to 9.1. It reveals the foremost preparation 
of the medicine KSC was done as per literature.   
 The FTIR spectrum of graph shows alcohols, phenols, carboxylic acids, alkanes, 
alkynes, 1° amines, aromatics, esters, ethers, alkyl halides, aliphatic amines, alkenes, 
disulfides present in Kirubakara Shanmuga Chenduram.  
The prepared medicine Kirubakara Shanmuga Chenduram was subjected to acute 
and repeated oral toxicity studies in wistar albino rats. 
During acute toxicity study the animals were fasted overnight given single oral 
dose of 2000 mg/kg/body weight of Kirubakara Shanmuga Chenduram suspended in 10% 
aqueous solution of tween 18 and the animals were observed for 14 days. After first 4 hrs 
of drug administration all the three animals showed the following characteristic activities 
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like alertness, grooming, touch response listlessness, unching, porphyrin, motor 
incordination, muscular spasm in all the three animals. After 24 hrs 2 animals were found 
dead and 48 hrs third animal was also found dead. 5, 50, 300 mg/kg/body weight  
displayed no signs of toxicity. Alertness, grooming, touch response were present. The 
acute toxicity study of KSC reported the LD 50 value of 500 mg/kg/body weight as per 
OECD guidelines. 
In repeated oral toxicity study, the doses selected for the study were x, 5x, 10x 
mg/kg body weight. During 28 days study there was no signs of toxic effect in all the 
animals and the body weight was gained significantly as that of control. The average 
water and food intake in the control group was not significantly (p>0.05) different from 
that of the test groups. the feed conversion efficiency followed the same pattern, thus 
indicating the normal metabolism of the animals.  At the end of 28 th day all animals 
were sacrificed and the gross necropsy does not show any abnormality in the organs.  
In hematological parameter the levels of RBC and hemoglobin in experimental 
animals were elevated when compared with that of the control. It is statistically 
significant (p<0.05). On the other hand, there was a significant increase (p<0.05) in the 
ALP, at mid dose (5x) and high dose (10x) dose treated groups when compared to the 
control groups. Other hematological and biochemical investigations the alterations in 
values was obtained within normal biological and laboratory limits or the effect was not 
dose dependent. 
In the histopathology study of KSC administered to low dose (x), mid dose (5x),  
high dose (10x), the sections of heart, lungs, liver, kidney, brain were found normal as 
comparable with that of the control. Sections of spleen showed normal appearing white 
pulp with congested red pulp. 
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Chapter VII 
CONCLUSION 
 
 In qualitative analysis, mercury, arsenic, lead, cadmium were found absent. In 
XRF study arsenic was found in ppm level and in ICP-OES mercury was found in ppm 
level. In acute toxicity study KSC produced neuro toxic symptoms and death in 2000 
mg/kg/bw, the LD50 cut off value was calculated as 500 mg/kg/bw as per OECD 
guidelines. In 28 days repeated oral toxicity study KSC at the dose of low dose (x), mid 
dose (5x),  high dose (10x), does not produce any toxic signs or death, only in 
histopathological study the spleen showed congested red pulp in all the three doses. It 
reveals that the therapeutic dose of KSC (i.e) 202 mg (thuvarai alavu) for human being 
which is mentioned in Pathaartha Guna Vilakkam (thaathu vaguppu) is the safe dosage 
for clinical use. The author interested to do further clinical trial of the KSC.  
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